CN103889245A - 被包封的甜味料组合物、用于制备所述被包封的甜味料组合物的方法及包括所述被包封的甜味料的咀嚼型胶基糖 - Google Patents
被包封的甜味料组合物、用于制备所述被包封的甜味料组合物的方法及包括所述被包封的甜味料的咀嚼型胶基糖 Download PDFInfo
- Publication number
- CN103889245A CN103889245A CN201280050255.8A CN201280050255A CN103889245A CN 103889245 A CN103889245 A CN 103889245A CN 201280050255 A CN201280050255 A CN 201280050255A CN 103889245 A CN103889245 A CN 103889245A
- Authority
- CN
- China
- Prior art keywords
- approximately
- entrapped
- soap
- composition
- sweetener composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000003599 food sweetener Nutrition 0.000 title claims abstract description 206
- 239000003765 sweetening agent Substances 0.000 title claims abstract description 206
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 195
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 191
- 239000000203 mixture Substances 0.000 title claims description 453
- 238000000034 method Methods 0.000 title claims description 74
- 238000002360 preparation method Methods 0.000 title description 16
- -1 poly(vinyl acetate) Polymers 0.000 claims abstract description 112
- 229920002689 polyvinyl acetate Polymers 0.000 claims abstract description 91
- 239000011118 polyvinyl acetate Substances 0.000 claims abstract description 91
- 239000000945 filler Substances 0.000 claims abstract description 76
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 23
- 229930195729 fatty acid Natural products 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims description 280
- 239000000344 soap Substances 0.000 claims description 119
- 239000002585 base Substances 0.000 claims description 71
- 239000002253 acid Substances 0.000 claims description 47
- 238000002156 mixing Methods 0.000 claims description 44
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
- 239000004376 Sucralose Substances 0.000 claims description 30
- 229940114926 stearate Drugs 0.000 claims description 30
- 235000019408 sucralose Nutrition 0.000 claims description 29
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 29
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 28
- KVHQNWGLVVERFR-ACMTZBLWSA-N (3s)-3-amino-4-[[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid;6-methyl-2,2-dioxooxathiazin-4-one Chemical compound CC1=CC(=O)[NH2+]S(=O)(=O)O1.[O-]C(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 KVHQNWGLVVERFR-ACMTZBLWSA-N 0.000 claims description 26
- 229960001504 aspartame acesulfame Drugs 0.000 claims description 26
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 25
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 24
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims description 23
- 239000011324 bead Substances 0.000 claims description 23
- 239000000454 talc Substances 0.000 claims description 23
- 235000012222 talc Nutrition 0.000 claims description 23
- 229910052623 talc Inorganic materials 0.000 claims description 23
- 229910052783 alkali metal Inorganic materials 0.000 claims description 21
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 20
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 19
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 19
- 235000013539 calcium stearate Nutrition 0.000 claims description 19
- 239000008116 calcium stearate Substances 0.000 claims description 19
- 235000010357 aspartame Nutrition 0.000 claims description 18
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 18
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 17
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 17
- 108010011485 Aspartame Proteins 0.000 claims description 17
- 229960003438 aspartame Drugs 0.000 claims description 17
- 239000000605 aspartame Substances 0.000 claims description 17
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 239000000619 acesulfame-K Substances 0.000 claims description 15
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 14
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 14
- 239000001512 FEMA 4601 Substances 0.000 claims description 13
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims description 13
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 13
- 229960004998 acesulfame potassium Drugs 0.000 claims description 13
- 235000010216 calcium carbonate Nutrition 0.000 claims description 13
- 230000001055 chewing effect Effects 0.000 claims description 13
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims description 13
- 235000019203 rebaudioside A Nutrition 0.000 claims description 13
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 12
- 229940013618 stevioside Drugs 0.000 claims description 12
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 12
- 235000019202 steviosides Nutrition 0.000 claims description 12
- 239000001506 calcium phosphate Substances 0.000 claims description 11
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 10
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 9
- 238000002844 melting Methods 0.000 claims description 9
- 230000008018 melting Effects 0.000 claims description 9
- 235000011164 potassium chloride Nutrition 0.000 claims description 8
- 239000001103 potassium chloride Substances 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 7
- 159000000007 calcium salts Chemical class 0.000 claims description 7
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 7
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 7
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 7
- 229940114930 potassium stearate Drugs 0.000 claims description 7
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 claims description 7
- 159000000003 magnesium salts Chemical class 0.000 claims description 6
- IJRHDFLHUATAOS-DPMBMXLASA-M sodium ricinoleate Chemical compound [Na+].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O IJRHDFLHUATAOS-DPMBMXLASA-M 0.000 claims description 6
- 159000000000 sodium salts Chemical class 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 5
- 241001409321 Siraitia grosvenorii Species 0.000 claims 12
- 239000000796 flavoring agent Substances 0.000 abstract description 158
- 235000019634 flavors Nutrition 0.000 abstract description 158
- 235000009508 confectionery Nutrition 0.000 abstract description 14
- 230000003111 delayed effect Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 description 100
- 239000000126 substance Substances 0.000 description 80
- 239000003814 drug Substances 0.000 description 42
- 235000000346 sugar Nutrition 0.000 description 42
- 239000011159 matrix material Substances 0.000 description 30
- 229920000642 polymer Polymers 0.000 description 30
- 239000003153 chemical reaction reagent Substances 0.000 description 28
- 210000000214 mouth Anatomy 0.000 description 25
- 239000003921 oil Substances 0.000 description 25
- 235000019198 oils Nutrition 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 235000011194 food seasoning agent Nutrition 0.000 description 23
- 235000019640 taste Nutrition 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 20
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 20
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 20
- 239000001993 wax Substances 0.000 description 19
- 239000002826 coolant Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 150000001875 compounds Chemical class 0.000 description 15
- 229920001971 elastomer Polymers 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 235000019605 sweet taste sensations Nutrition 0.000 description 15
- 206010022000 influenza Diseases 0.000 description 14
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 13
- 239000000806 elastomer Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 229940117958 vinyl acetate Drugs 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 125000005456 glyceride group Chemical group 0.000 description 12
- 230000000474 nursing effect Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000005720 sucrose Substances 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 11
- 230000003750 conditioning effect Effects 0.000 description 11
- 239000003292 glue Substances 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 230000002045 lasting effect Effects 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 238000007789 sealing Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 10
- 239000004902 Softening Agent Substances 0.000 description 10
- 235000009499 Vanilla fragrans Nutrition 0.000 description 10
- 244000263375 Vanilla tahitensis Species 0.000 description 10
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 9
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 235000010489 acacia gum Nutrition 0.000 description 9
- 239000000654 additive Substances 0.000 description 9
- 125000001931 aliphatic group Chemical group 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 150000005846 sugar alcohols Chemical class 0.000 description 9
- 239000000080 wetting agent Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000001125 extrusion Methods 0.000 description 8
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 8
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 8
- 239000002023 wood Substances 0.000 description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 7
- 235000005979 Citrus limon Nutrition 0.000 description 7
- 244000131522 Citrus pyriformis Species 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 7
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 7
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 7
- 244000185386 Thladiantha grosvenorii Species 0.000 description 7
- 244000078534 Vaccinium myrtillus Species 0.000 description 7
- 230000000996 additive effect Effects 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- ICFXZZFWRWNZMA-UHFFFAOYSA-N diethylpropion hydrochloride Chemical compound [Cl-].CC[NH+](CC)C(C)C(=O)C1=CC=CC=C1 ICFXZZFWRWNZMA-UHFFFAOYSA-N 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 235000019264 food flavour enhancer Nutrition 0.000 description 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 229920000084 Gum arabic Polymers 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- ZPXSCAKFGYXMGA-UHFFFAOYSA-N Mazindol Chemical compound N12CCN=C2C2=CC=CC=C2C1(O)C1=CC=C(Cl)C=C1 ZPXSCAKFGYXMGA-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 241001290151 Prunus avium subsp. avium Species 0.000 description 6
- 239000000205 acacia gum Substances 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 230000001458 anti-acid effect Effects 0.000 description 6
- 229940124584 antitussives Drugs 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 235000019693 cherries Nutrition 0.000 description 6
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 6
- 239000000686 essence Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 229920000609 methyl cellulose Polymers 0.000 description 6
- 239000001923 methylcellulose Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 229920001206 natural gum Polymers 0.000 description 6
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000012744 reinforcing agent Substances 0.000 description 6
- 239000012128 staining reagent Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000012976 tarts Nutrition 0.000 description 6
- 238000005979 thermal decomposition reaction Methods 0.000 description 6
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 5
- 244000215068 Acacia senegal Species 0.000 description 5
- 244000183685 Citrus aurantium Species 0.000 description 5
- 235000007716 Citrus aurantium Nutrition 0.000 description 5
- 239000004606 Fillers/Extenders Substances 0.000 description 5
- 235000014749 Mentha crispa Nutrition 0.000 description 5
- 244000078639 Mentha spicata Species 0.000 description 5
- 235000004357 Mentha x piperita Nutrition 0.000 description 5
- 241001183990 Mesosphaerum suaveolens Species 0.000 description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 244000299461 Theobroma cacao Species 0.000 description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 229930002875 chlorophyll Natural products 0.000 description 5
- 235000019804 chlorophyll Nutrition 0.000 description 5
- 229940106705 chlorophyll Drugs 0.000 description 5
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 5
- 235000020971 citrus fruits Nutrition 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 150000001982 diacylglycerols Chemical class 0.000 description 5
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 5
- 239000003172 expectorant agent Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 235000011087 fumaric acid Nutrition 0.000 description 5
- 239000001530 fumaric acid Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 229960004274 stearic acid Drugs 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- 235000010215 titanium dioxide Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 239000000811 xylitol Substances 0.000 description 5
- 235000010447 xylitol Nutrition 0.000 description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 5
- 229960002675 xylitol Drugs 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 241000522254 Cassia Species 0.000 description 4
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 244000246386 Mentha pulegium Species 0.000 description 4
- 235000016257 Mentha pulegium Nutrition 0.000 description 4
- 239000006057 Non-nutritive feed additive Substances 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 240000007651 Rubus glaucus Species 0.000 description 4
- 235000011034 Rubus glaucus Nutrition 0.000 description 4
- 235000009122 Rubus idaeus Nutrition 0.000 description 4
- 235000007303 Thymus vulgaris Nutrition 0.000 description 4
- 240000002657 Thymus vulgaris Species 0.000 description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 description 4
- 240000006365 Vitis vinifera Species 0.000 description 4
- 235000014787 Vitis vinifera Nutrition 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 239000004411 aluminium Substances 0.000 description 4
- 235000010210 aluminium Nutrition 0.000 description 4
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 4
- 230000003444 anaesthetic effect Effects 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 230000001387 anti-histamine Effects 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 230000002155 anti-virotic effect Effects 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000021014 blueberries Nutrition 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000005660 chlorination reaction Methods 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 4
- 229960003082 galactose Drugs 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 239000000416 hydrocolloid Substances 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 229960001855 mannitol Drugs 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 229920003052 natural elastomer Polymers 0.000 description 4
- 229920001194 natural rubber Polymers 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000021313 oleic acid Nutrition 0.000 description 4
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- VMXUWOKSQNHOCA-UKTHLTGXSA-N ranitidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-UKTHLTGXSA-N 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- 229960005137 succinic acid Drugs 0.000 description 4
- 229940034887 tenuate Drugs 0.000 description 4
- 229940124597 therapeutic agent Drugs 0.000 description 4
- 239000001585 thymus vulgaris Substances 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 3
- VEPOHXYIFQMVHW-PVJVQHJQSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;(2s,3s)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 VEPOHXYIFQMVHW-PVJVQHJQSA-N 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 244000144725 Amygdalus communis Species 0.000 description 3
- 235000011437 Amygdalus communis Nutrition 0.000 description 3
- 244000099147 Ananas comosus Species 0.000 description 3
- 235000007119 Ananas comosus Nutrition 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- 241000335053 Beta vulgaris Species 0.000 description 3
- 235000005881 Calendula officinalis Nutrition 0.000 description 3
- 240000001432 Calendula officinalis Species 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 description 3
- HCYAFALTSJYZDH-UHFFFAOYSA-N Desimpramine Chemical compound C1CC2=CC=CC=C2N(CCCNC)C2=CC=CC=C21 HCYAFALTSJYZDH-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 240000002943 Elettaria cardamomum Species 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 3
- 240000009088 Fragaria x ananassa Species 0.000 description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 3
- 239000000899 Gutta-Percha Substances 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 206010022004 Influenza like illness Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 235000011430 Malus pumila Nutrition 0.000 description 3
- 235000015103 Malus silvestris Nutrition 0.000 description 3
- 240000002636 Manilkara bidentata Species 0.000 description 3
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 3
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 3
- 240000000342 Palaquium gutta Species 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 240000008474 Pimenta dioica Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 244000018633 Prunus armeniaca Species 0.000 description 3
- 235000017848 Rubus fruticosus Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 102000006463 Talin Human genes 0.000 description 3
- 108010083809 Talin Proteins 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229920004482 WACKER® Polymers 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 3
- 235000020224 almond Nutrition 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 235000012665 annatto Nutrition 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000001741 anti-phlogistic effect Effects 0.000 description 3
- 239000002830 appetite depressant Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000012733 azorubine Nutrition 0.000 description 3
- 235000016302 balata Nutrition 0.000 description 3
- 235000021029 blackberry Nutrition 0.000 description 3
- 235000012709 brilliant black BN Nutrition 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 235000005300 cardamomo Nutrition 0.000 description 3
- 235000012730 carminic acid Nutrition 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229960001380 cimetidine Drugs 0.000 description 3
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 3
- 229930016911 cinnamic acid Natural products 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229940108928 copper Drugs 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000006471 dimerization reaction Methods 0.000 description 3
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 3
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 3
- CJMJLDQKTOJACI-BGQAIRJTSA-N ergotamine d-tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-BGQAIRJTSA-N 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 235000012732 erythrosine Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229920000588 gutta-percha Polymers 0.000 description 3
- 235000001050 hortel pimenta Nutrition 0.000 description 3
- 235000011167 hydrochloric acid Nutrition 0.000 description 3
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 229930007503 menthone Natural products 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000008375 oral care agent Substances 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 229940098695 palmitic acid Drugs 0.000 description 3
- 235000012658 paprika extract Nutrition 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229960000620 ranitidine Drugs 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 239000001488 sodium phosphate Substances 0.000 description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229920003051 synthetic elastomer Polymers 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 2
- ABTRFGSPYXCGMR-KXQOOQHDSA-N (3R)-beta,psi-caroten-3-ol Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C ABTRFGSPYXCGMR-KXQOOQHDSA-N 0.000 description 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 241001116389 Aloe Species 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 244000189799 Asimina triloba Species 0.000 description 2
- 235000006264 Asimina triloba Nutrition 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 235000004936 Bromus mango Nutrition 0.000 description 2
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- AKJDEXBCRLOVTH-UHFFFAOYSA-N Carbetapentane citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C1(C(=O)OCCOCCN(CC)CC)CCCC1 AKJDEXBCRLOVTH-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000009467 Carica papaya Nutrition 0.000 description 2
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 241000723347 Cinnamomum Species 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 241000675108 Citrus tangerina Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 239000001879 Curdlan Substances 0.000 description 2
- 229920002558 Curdlan Polymers 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- BXZVVICBKDXVGW-NKWVEPMBSA-N Didanosine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(NC=NC2=O)=C2N=C1 BXZVVICBKDXVGW-NKWVEPMBSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 229930186291 Dulcoside Natural products 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241001465251 Ephedra sinica Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 description 2
- 244000004281 Eucalyptus maculata Species 0.000 description 2
- 239000004211 Flavoxanthin Substances 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- 235000017048 Garcinia mangostana Nutrition 0.000 description 2
- 240000006053 Garcinia mangostana Species 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- WYCLKVQLVUQKNZ-UHFFFAOYSA-N Halazepam Chemical compound N=1CC(=O)N(CC(F)(F)F)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 WYCLKVQLVUQKNZ-UHFFFAOYSA-N 0.000 description 2
- AKDLSISGGARWFP-UHFFFAOYSA-N Homodihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCCC(C)C)=CC=C1O AKDLSISGGARWFP-UHFFFAOYSA-N 0.000 description 2
- 241000735432 Hydrastis canadensis Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 235000003325 Ilex Nutrition 0.000 description 2
- 241000209035 Ilex Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- 235000014826 Mangifera indica Nutrition 0.000 description 2
- 240000007228 Mangifera indica Species 0.000 description 2
- 244000217433 Melampodium divaricatum Species 0.000 description 2
- 241001479543 Mentha x piperita Species 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 235000009421 Myristica fragrans Nutrition 0.000 description 2
- 244000270834 Myristica fragrans Species 0.000 description 2
- 240000009023 Myrrhis odorata Species 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- BYEIJZFKOAXBBV-ATZCPNFKSA-N N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine Chemical compound CC(C)[C@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)CCC[C@H](N)C(O)=O BYEIJZFKOAXBBV-ATZCPNFKSA-N 0.000 description 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- VQEONGKQWIFHMN-UHFFFAOYSA-N Nordihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCC(C)C)=CC=C1O VQEONGKQWIFHMN-UHFFFAOYSA-N 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- 240000000783 Origanum majorana Species 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- MFOCDFTXLCYLKU-CMPLNLGQSA-N Phendimetrazine Chemical compound O1CCN(C)[C@@H](C)[C@@H]1C1=CC=CC=C1 MFOCDFTXLCYLKU-CMPLNLGQSA-N 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 235000016551 Potentilla erecta Nutrition 0.000 description 2
- 240000000103 Potentilla erecta Species 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 241000965132 Pulmonaria officinalis Species 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- 239000004216 Rhodoxanthin Substances 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 244000143590 Salvia chinensis Species 0.000 description 2
- 235000007154 Salvia chinensis Nutrition 0.000 description 2
- 235000005794 Salvia japonica Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000009184 Spondias indica Nutrition 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- 240000000377 Tussilago farfara Species 0.000 description 2
- 235000004869 Tussilago farfara Nutrition 0.000 description 2
- 241001473768 Ulmus rubra Species 0.000 description 2
- 239000004213 Violaxanthin Substances 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HUCJFAOMUPXHDK-UHFFFAOYSA-N Xylometazoline Chemical compound CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCCN1 HUCJFAOMUPXHDK-UHFFFAOYSA-N 0.000 description 2
- WREGKURFCTUGRC-POYBYMJQSA-N Zalcitabine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)CC1 WREGKURFCTUGRC-POYBYMJQSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229950006790 adenosine phosphate Drugs 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000000464 adrenergic agent Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- VWXMLZQUDPCJPL-JCFHCUBBSA-N all-trans-Rhodoxanthin Natural products CC(=C/C=C/C(=C/C=C/1C(=CC(=O)CC1(C)C)C)/C)C=CC=CC(=CC=CC(=CC=C2/C(=CC(=O)CC2(C)C)C)C)C VWXMLZQUDPCJPL-JCFHCUBBSA-N 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 229960004538 alprazolam Drugs 0.000 description 2
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 239000001670 anatto Substances 0.000 description 2
- 229940118324 anisotropine Drugs 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000003434 antitussive agent Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 2
- 229960000396 atropine Drugs 0.000 description 2
- 239000004176 azorubin Substances 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 229940090012 bentyl Drugs 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- ANFSNXAXVLRZCG-RSAXXLAASA-N benzphetamine hydrochloride Chemical compound [Cl-].C([C@H](C)[NH+](C)CC=1C=CC=CC=1)C1=CC=CC=C1 ANFSNXAXVLRZCG-RSAXXLAASA-N 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 239000004126 brilliant black BN Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000001390 capsicum minimum Substances 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- OFAIGZWCDGNZGT-UHFFFAOYSA-N caramiphen Chemical compound C=1C=CC=CC=1C1(C(=O)OCCN(CC)CC)CCCC1 OFAIGZWCDGNZGT-UHFFFAOYSA-N 0.000 description 2
- 229960004160 caramiphen Drugs 0.000 description 2
- 229940098391 carbetapentane citrate Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000004075 cariostatic agent Substances 0.000 description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- XGGHHHBGPSNXFE-ZSHCYNCHSA-N chembl1186610 Chemical compound C1[C@H](OC(=O)C(CCC)CCC)C[C@@H]2CC[C@H]1[N+]2(C)C XGGHHHBGPSNXFE-ZSHCYNCHSA-N 0.000 description 2
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 229960003405 ciprofloxacin Drugs 0.000 description 2
- 229940043350 citral Drugs 0.000 description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000019244 cryptoxanthin Nutrition 0.000 description 2
- 239000001081 curcuma longa l. root oleoresin Substances 0.000 description 2
- 235000019316 curdlan Nutrition 0.000 description 2
- 229940078035 curdlan Drugs 0.000 description 2
- UVKZSORBKUEBAZ-UHFFFAOYSA-N cyclizine Chemical compound C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UVKZSORBKUEBAZ-UHFFFAOYSA-N 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- WHBIGIKBNXZKFE-UHFFFAOYSA-N delavirdine Chemical compound CC(C)NC1=CC=CN=C1N1CCN(C(=O)C=2NC3=CC=C(NS(C)(=O)=O)C=C3C=2)CC1 WHBIGIKBNXZKFE-UHFFFAOYSA-N 0.000 description 2
- GUBNMFJOJGDCEL-UHFFFAOYSA-N dicyclomine hydrochloride Chemical group [Cl-].C1CCCCC1C1(C(=O)OCC[NH+](CC)CC)CCCCC1 GUBNMFJOJGDCEL-UHFFFAOYSA-N 0.000 description 2
- 229960002656 didanosine Drugs 0.000 description 2
- XYYVYLMBEZUESM-UHFFFAOYSA-N dihydrocodeine Natural products C1C(N(CCC234)C)C2C=CC(=O)C3OC2=C4C1=CC=C2OC XYYVYLMBEZUESM-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 2
- 229960005426 doxepin Drugs 0.000 description 2
- BZEWSEKUUPWQDQ-UHFFFAOYSA-N dyclonine Chemical compound C1=CC(OCCCC)=CC=C1C(=O)CCN1CCCCC1 BZEWSEKUUPWQDQ-UHFFFAOYSA-N 0.000 description 2
- 229960000385 dyclonine Drugs 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 239000004174 erythrosine Substances 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 229940093503 ethyl maltol Drugs 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 2
- 229960001596 famotidine Drugs 0.000 description 2
- 235000019243 flavoxanthin Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000007983 food acid Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 229960002737 fructose Drugs 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000005679 goldenseal Nutrition 0.000 description 2
- 235000012701 green S Nutrition 0.000 description 2
- 239000004120 green S Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 235000019314 gum ghatti Nutrition 0.000 description 2
- 229960002158 halazepam Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 229960003210 hyoscyamine Drugs 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000000905 isomalt Substances 0.000 description 2
- 235000010439 isomalt Nutrition 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 229960004752 ketorolac Drugs 0.000 description 2
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- 235000010187 litholrubine BK Nutrition 0.000 description 2
- 239000004335 litholrubine BK Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229960004391 lorazepam Drugs 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 229960000299 mazindol Drugs 0.000 description 2
- 229940057917 medium chain triglycerides Drugs 0.000 description 2
- 239000001771 mentha piperita Substances 0.000 description 2
- 150000002729 menthone derivatives Chemical class 0.000 description 2
- 229960000582 mepyramine Drugs 0.000 description 2
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229960002009 naproxen Drugs 0.000 description 2
- CMWTZPSULFXXJA-VIFPVBQESA-M naproxen(1-) Chemical compound C1=C([C@H](C)C([O-])=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-M 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 239000001702 nutmeg Substances 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 239000008601 oleoresin Substances 0.000 description 2
- 229960000381 omeprazole Drugs 0.000 description 2
- SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 2
- 229960004535 oxazepam Drugs 0.000 description 2
- ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 2
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000001688 paprika extract Substances 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000021017 pears Nutrition 0.000 description 2
- 239000007967 peppermint flavor Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229960000436 phendimetrazine Drugs 0.000 description 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
- 229960002695 phenobarbital Drugs 0.000 description 2
- 229960003562 phentermine Drugs 0.000 description 2
- 229960001277 phentermine hydrochloride Drugs 0.000 description 2
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 2
- 229960000395 phenylpropanolamine Drugs 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 229940095590 phrenilin Drugs 0.000 description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 229960000786 propylhexedrine Drugs 0.000 description 2
- JCRIVQIOJSSCQD-UHFFFAOYSA-N propylhexedrine Chemical compound CNC(C)CC1CCCCC1 JCRIVQIOJSSCQD-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000012752 quinoline yellow Nutrition 0.000 description 2
- 239000004172 quinoline yellow Substances 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000015227 regulation of liquid surface tension Effects 0.000 description 2
- 235000019246 rhodoxanthin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000004170 rice bran wax Substances 0.000 description 2
- 235000019384 rice bran wax Nutrition 0.000 description 2
- 235000009514 rubixanthin Nutrition 0.000 description 2
- 239000000455 rubixanthin Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical class C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229940079864 sodium stannate Drugs 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000012756 tartrazine Nutrition 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- GMMAPXRGRVJYJY-UHFFFAOYSA-J tetrasodium 4-acetamido-5-hydroxy-6-[[7-sulfonato-4-[(4-sulfonatophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,7-disulfonate Chemical compound [Na+].[Na+].[Na+].[Na+].OC1=C2C(NC(=O)C)=CC=C(S([O-])(=O)=O)C2=CC(S([O-])(=O)=O)=C1N=NC(C1=CC(=CC=C11)S([O-])(=O)=O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 GMMAPXRGRVJYJY-UHFFFAOYSA-J 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 235000013975 turmeric oleoresin Nutrition 0.000 description 2
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- 229920006163 vinyl copolymer Polymers 0.000 description 2
- 235000019245 violaxanthin Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229960000523 zalcitabine Drugs 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 229960002555 zidovudine Drugs 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- UAYWVJHJZHQCIE-UHFFFAOYSA-L zinc iodide Chemical compound I[Zn]I UAYWVJHJZHQCIE-UHFFFAOYSA-L 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- AELCINSCMGFISI-DTWKUNHWSA-N (1R,2S)-tranylcypromine Chemical compound N[C@@H]1C[C@H]1C1=CC=CC=C1 AELCINSCMGFISI-DTWKUNHWSA-N 0.000 description 1
- ZERWDZDNDJBYKA-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)ON1C(=O)CCC1=O ZERWDZDNDJBYKA-UHFFFAOYSA-N 0.000 description 1
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- DRAWQKGUORNASA-UHFFFAOYSA-N (2-hydroxy-3-octadec-9-enoyloxypropyl) octadec-9-enoate Chemical compound CCCCCCCCC=CCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCC=CCCCCCCCC DRAWQKGUORNASA-UHFFFAOYSA-N 0.000 description 1
- 239000001112 (2E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene Substances 0.000 description 1
- UQXZSKHOYOHVIH-UGDNZRGBSA-N (2R,3R,4S,5S,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 UQXZSKHOYOHVIH-UGDNZRGBSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- MQHLMHIZUIDKOO-OKZBNKHCSA-N (2R,6S)-2,6-dimethyl-4-[(2S)-2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine Chemical compound C1=CC(C(C)(C)CC)=CC=C1C[C@H](C)CN1C[C@@H](C)O[C@@H](C)C1 MQHLMHIZUIDKOO-OKZBNKHCSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- SERLAGPUMNYUCK-BLEZHGCXSA-N (2xi)-6-O-alpha-D-glucopyranosyl-D-arabino-hexitol Chemical compound OCC(O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-BLEZHGCXSA-N 0.000 description 1
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 1
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 1
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 description 1
- IUAXSWPNEQYKDR-GXTZACRKSA-N (4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one 2,3-dihydroxybutanedioic acid dihydrate Chemical compound O.O.OC(C(O)C(O)=O)C(O)=O.COc1ccc2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5Oc1c2[C@]45CCN3C IUAXSWPNEQYKDR-GXTZACRKSA-N 0.000 description 1
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- ALARQZQTBTVLJV-CYBMUJFWSA-N (5r)-5-ethyl-1-methyl-5-phenyl-1,3-diazinane-2,4,6-trione Chemical compound C=1C=CC=CC=1[C@]1(CC)C(=O)NC(=O)N(C)C1=O ALARQZQTBTVLJV-CYBMUJFWSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
- ULDHMXUKGWMISQ-VIFPVBQESA-N (S)-(+)-Carvone Natural products CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- RUZIUYOSRDWYQF-HNNXBMFYSA-N (S)-glaucine Chemical compound CN1CCC2=CC(OC)=C(OC)C3=C2[C@@H]1CC1=C3C=C(OC)C(OC)=C1 RUZIUYOSRDWYQF-HNNXBMFYSA-N 0.000 description 1
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 1
- WSPOMRSOLSGNFJ-AUWJEWJLSA-N (Z)-chlorprothixene Chemical compound C1=C(Cl)C=C2C(=C/CCN(C)C)\C3=CC=CC=C3SC2=C1 WSPOMRSOLSGNFJ-AUWJEWJLSA-N 0.000 description 1
- ZEHYJZXQEQOSON-AATRIKPKSA-N (e)-1-chloro-3-ethylpent-1-en-4-yn-3-ol Chemical compound CCC(O)(C#C)\C=C\Cl ZEHYJZXQEQOSON-AATRIKPKSA-N 0.000 description 1
- PMGQWSIVQFOFOQ-BDUVBVHRSA-N (e)-but-2-enedioic acid;(2r)-2-[2-[1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCC[C@@H]1CCOC(C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 PMGQWSIVQFOFOQ-BDUVBVHRSA-N 0.000 description 1
- YGFGZTXGYTUXBA-UHFFFAOYSA-N (±)-2,6-dimethyl-5-heptenal Chemical compound O=CC(C)CCC=C(C)C YGFGZTXGYTUXBA-UHFFFAOYSA-N 0.000 description 1
- NTXGFKWLJFHGGJ-ACCUITESSA-N 1,1-Diethoxy-3,7-dimethyl-2,6-octadiene Chemical compound CCOC(OCC)\C=C(/C)CCC=C(C)C NTXGFKWLJFHGGJ-ACCUITESSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 description 1
- JQIFJRXHLHKEAJ-UHFFFAOYSA-N 1-(2-chloroethyl)-4-[1-(2-chloroethyl)piperidin-4-yl]piperidine Chemical compound C1CN(CCCl)CCC1C1CCN(CCCl)CC1 JQIFJRXHLHKEAJ-UHFFFAOYSA-N 0.000 description 1
- CHLICZRVGGXEOD-UHFFFAOYSA-N 1-Methoxy-4-methylbenzene Chemical compound COC1=CC=C(C)C=C1 CHLICZRVGGXEOD-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- BKRNGBZBKWSHTC-UHFFFAOYSA-N 1-tert-butylcyclohexane-1-carboxamide Chemical class CC(C)(C)C1(C(N)=O)CCCCC1 BKRNGBZBKWSHTC-UHFFFAOYSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CBOBADCVMLMQRW-UHFFFAOYSA-N 2,6-dimethyloctanal Chemical compound CCC(C)CCCC(C)C=O CBOBADCVMLMQRW-UHFFFAOYSA-N 0.000 description 1
- PTUSXMWNCXRKAX-UHFFFAOYSA-N 2-(1h-inden-1-yl)acetic acid Chemical class C1=CC=C2C(CC(=O)O)C=CC2=C1 PTUSXMWNCXRKAX-UHFFFAOYSA-N 0.000 description 1
- LOVYCUYJRWLTSU-UHFFFAOYSA-N 2-(3,4-dichlorophenoxy)-n,n-diethylethanamine Chemical compound CCN(CC)CCOC1=CC=C(Cl)C(Cl)=C1 LOVYCUYJRWLTSU-UHFFFAOYSA-N 0.000 description 1
- UNNGUFMVYQJGTD-UHFFFAOYSA-N 2-Ethylbutanal Chemical compound CCC(CC)C=O UNNGUFMVYQJGTD-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- FSSICIQKZGUEAE-UHFFFAOYSA-N 2-[benzyl(pyridin-2-yl)amino]ethyl-dimethylazanium;chloride Chemical compound Cl.C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 FSSICIQKZGUEAE-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- MCNJOIMMYWLFBA-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCOC(=O)CS(O)(=O)=O MCNJOIMMYWLFBA-UHFFFAOYSA-N 0.000 description 1
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 1
- DEQJBORXLQWRGV-UHFFFAOYSA-N 2-hydroxypropanoic acid;iron Chemical compound [Fe].CC(O)C(O)=O.CC(O)C(O)=O DEQJBORXLQWRGV-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- LWUCCEQXWQPHFM-UHFFFAOYSA-N 3-methyl-4-(5-methyl-2-propan-2-ylcyclohexyl)oxy-4-oxobutanoic acid Chemical class CC(C)C1CCC(C)CC1OC(=O)C(C)CC(O)=O LWUCCEQXWQPHFM-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- DCTLYFZHFGENCW-UUOKFMHZSA-N 5'-xanthylic acid Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 DCTLYFZHFGENCW-UUOKFMHZSA-N 0.000 description 1
- PJJGZPJJTHBVMX-UHFFFAOYSA-N 5,7-Dihydroxyisoflavone Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=CC=C1 PJJGZPJJTHBVMX-UHFFFAOYSA-N 0.000 description 1
- CTMTYSVTTGVYAW-FRRDWIJNSA-N 5-[(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl]oxy-5-oxopentanoic acid Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)CCCC(O)=O CTMTYSVTTGVYAW-FRRDWIJNSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- NFLLKCVHYJRNRH-UHFFFAOYSA-N 8-chloro-1,3-dimethyl-7H-purine-2,6-dione 2-(diphenylmethyl)oxy-N,N-dimethylethanamine Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC(Cl)=N2.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 NFLLKCVHYJRNRH-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000011470 Adenanthera pavonina Nutrition 0.000 description 1
- 240000001606 Adenanthera pavonina Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 239000004377 Alitame Substances 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- KFYRPLNVJVHZGT-UHFFFAOYSA-N Amitriptyline hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KFYRPLNVJVHZGT-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- 235000011514 Anogeissus latifolia Nutrition 0.000 description 1
- 244000106483 Anogeissus latifolia Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- YXSLJKQTIDHPOT-UHFFFAOYSA-N Atracurium Dibesylate Chemical compound C1=C(OC)C(OC)=CC=C1CC1[N+](CCC(=O)OCCCCCOC(=O)CC[N+]2(C)C(C3=CC(OC)=C(OC)C=C3CC2)CC=2C=C(OC)C(OC)=CC=2)(C)CCC2=CC(OC)=C(OC)C=C21 YXSLJKQTIDHPOT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- HRQKOYFGHJYEFS-UHFFFAOYSA-N Beta psi-carotene Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C HRQKOYFGHJYEFS-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- HEYVINCGKDONRU-UHFFFAOYSA-N Bupropion hydrochloride Chemical compound Cl.CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 HEYVINCGKDONRU-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- DCFGGGCMICWSJX-SNAWJCMRSA-N Butyl oleate sulfate Chemical compound CCCCOC(=O)CCCCCCC\C=C\CCCCCCCCOS(O)(=O)=O DCFGGGCMICWSJX-SNAWJCMRSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- RTMBGDBBDQKNNZ-UHFFFAOYSA-L C.I. Acid Blue 3 Chemical compound [Ca+2].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1.C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=C(O)C=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 RTMBGDBBDQKNNZ-UHFFFAOYSA-L 0.000 description 1
- NCVQVCRIORLULH-UHFFFAOYSA-N CC1=CCC(C=C1C(=O)O)C(=O)O Chemical compound CC1=CCC(C=C1C(=O)O)C(=O)O NCVQVCRIORLULH-UHFFFAOYSA-N 0.000 description 1
- RDSLSIIVSGZAGJ-ONYUMSKCSA-N CCCCCC\C=C\CCCCCCCCCC(O)=O.CCCCCC\C=C\CCCCCCCCCC(O)=O Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O.CCCCCC\C=C\CCCCCCCCCC(O)=O RDSLSIIVSGZAGJ-ONYUMSKCSA-N 0.000 description 1
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 description 1
- UNMYWSMUMWPJLR-UHFFFAOYSA-L Calcium iodide Chemical compound [Ca+2].[I-].[I-] UNMYWSMUMWPJLR-UHFFFAOYSA-L 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- YSVBPNGJESBVRM-ZPZFBZIMSA-L Carmoisine Chemical compound [Na+].[Na+].C1=CC=C2C(/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)O)=CC=C(S([O-])(=O)=O)C2=C1 YSVBPNGJESBVRM-ZPZFBZIMSA-L 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 244000302413 Carum copticum Species 0.000 description 1
- 235000007034 Carum copticum Nutrition 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- ZCKAMNXUHHNZLN-UHFFFAOYSA-N Chlorphentermine Chemical compound CC(C)(N)CC1=CC=C(Cl)C=C1 ZCKAMNXUHHNZLN-UHFFFAOYSA-N 0.000 description 1
- 235000019743 Choline chloride Nutrition 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- GDLIGKIOYRNHDA-UHFFFAOYSA-N Clomipramine Chemical compound C1CC2=CC=C(Cl)C=C2N(CCCN(C)C)C2=CC=CC=C21 GDLIGKIOYRNHDA-UHFFFAOYSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 241000305791 Commidendrum rugosum Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 239000004212 Cryptoxanthin Substances 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 description 1
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- TUSIZTVSUSBSQI-UHFFFAOYSA-N Dihydrocarveol acetate Chemical compound CC1CCC(C(C)=C)CC1OC(C)=O TUSIZTVSUSBSQI-UHFFFAOYSA-N 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- XIQVNETUBQGFHX-UHFFFAOYSA-N Ditropan Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCC#CCN(CC)CC)C1CCCCC1 XIQVNETUBQGFHX-UHFFFAOYSA-N 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- XPOQHMRABVBWPR-UHFFFAOYSA-N Efavirenz Natural products O1C(=O)NC2=CC=C(Cl)C=C2C1(C(F)(F)F)C#CC1CC1 XPOQHMRABVBWPR-UHFFFAOYSA-N 0.000 description 1
- 241000508725 Elymus repens Species 0.000 description 1
- XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 235000014755 Eruca sativa Nutrition 0.000 description 1
- 244000024675 Eruca sativa Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- JUTKIGGQRLHTJN-UHFFFAOYSA-N Eugenyl formate Chemical compound COC1=CC(CC=C)=CC=C1OC=O JUTKIGGQRLHTJN-UHFFFAOYSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 1
- 229930195503 Fortimicin Natural products 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- DABPOQZSGVNAAS-UHFFFAOYSA-N Glaucocalactone Natural products O=CC12C3C(C4)OC(=O)C2C(C)(C)CCC1OC(=O)C13CC4C(=C)C1OC(=O)C DABPOQZSGVNAAS-UHFFFAOYSA-N 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- UXDDRFCJKNROTO-UHFFFAOYSA-N Glycerol 1,2-diacetate Chemical compound CC(=O)OCC(CO)OC(C)=O UXDDRFCJKNROTO-UHFFFAOYSA-N 0.000 description 1
- CGBXSWXZXBQCMR-UHFFFAOYSA-N Glycerol 1-hexadecanoate Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCC(O)=O CGBXSWXZXBQCMR-UHFFFAOYSA-N 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 244000259229 Grindelia squarrosa Species 0.000 description 1
- 235000005717 Grindelia squarrosa Nutrition 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 239000001922 Gum ghatti Substances 0.000 description 1
- 235000008418 Hedeoma Nutrition 0.000 description 1
- 240000001194 Heliotropium europaeum Species 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- 241000243328 Hydridae Species 0.000 description 1
- 229920001144 Hydroxy alpha sanshool Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
- STECJAGHUSJQJN-USLFZFAMSA-N LSM-4015 Chemical compound C1([C@@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-USLFZFAMSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- 240000007707 Mentha arvensis Species 0.000 description 1
- 235000018978 Mentha arvensis Nutrition 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- JRRNZNSGDSFFIR-UHFFFAOYSA-M Mepenzolate bromide Chemical compound [Br-].C1[N+](C)(C)CCCC1OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 JRRNZNSGDSFFIR-UHFFFAOYSA-M 0.000 description 1
- NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
- GZHFODJQISUKAY-UHFFFAOYSA-N Methantheline Chemical compound C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 GZHFODJQISUKAY-UHFFFAOYSA-N 0.000 description 1
- CESYKOGBSMNBPD-UHFFFAOYSA-N Methyclothiazide Chemical compound ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CCl)NC2=C1 CESYKOGBSMNBPD-UHFFFAOYSA-N 0.000 description 1
- SIDLZWOQUZRBRU-UHFFFAOYSA-N Methyprylon Chemical compound CCC1(CC)C(=O)NCC(C)C1=O SIDLZWOQUZRBRU-UHFFFAOYSA-N 0.000 description 1
- NZXKDOXHBHYTKP-UHFFFAOYSA-N Metohexital Chemical compound CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O NZXKDOXHBHYTKP-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- WMSYWJSZGVOIJW-ONUALHDOSA-L Mivacurium chloride Chemical compound [Cl-].[Cl-].C([C@@H]1C2=CC(OC)=C(OC)C=C2CC[N+]1(C)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]1(CCC=2C=C(C(=CC=2[C@H]1CC=1C=C(OC)C(OC)=C(OC)C=1)OC)OC)C)C1=CC(OC)=C(OC)C(OC)=C1 WMSYWJSZGVOIJW-ONUALHDOSA-L 0.000 description 1
- GQWNECFJGBQMBO-UHFFFAOYSA-N Molindone hydrochloride Chemical compound Cl.O=C1C=2C(CC)=C(C)NC=2CCC1CN1CCOCC1 GQWNECFJGBQMBO-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- IJHNSHDBIRRJRN-UHFFFAOYSA-N N,N-dimethyl-3-phenyl-3-(2-pyridinyl)-1-propanamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=CC=C1 IJHNSHDBIRRJRN-UHFFFAOYSA-N 0.000 description 1
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- DUDKAZCAISNGQN-UHFFFAOYSA-N Oxyphencyclimine Chemical compound CN1CCCN=C1COC(=O)C(O)(C=1C=CC=CC=1)C1CCCCC1 DUDKAZCAISNGQN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241001495453 Parthenium argentatum Species 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 240000002690 Passiflora mixta Species 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- RGCVKNLCSQQDEP-UHFFFAOYSA-N Perphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 RGCVKNLCSQQDEP-UHFFFAOYSA-N 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- RMUCZJUITONUFY-UHFFFAOYSA-N Phenelzine Chemical compound NNCCC1=CC=CC=C1 RMUCZJUITONUFY-UHFFFAOYSA-N 0.000 description 1
- ISFHAYSTHMVOJR-UHFFFAOYSA-N Phenindamine Chemical compound C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 ISFHAYSTHMVOJR-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000016787 Piper methysticum Nutrition 0.000 description 1
- 240000005546 Piper methysticum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- UJEWTUDSLQGTOA-UHFFFAOYSA-N Piretanide Chemical compound C=1C=CC=CC=1OC=1C(S(=O)(=O)N)=CC(C(O)=O)=CC=1N1CCCC1 UJEWTUDSLQGTOA-UHFFFAOYSA-N 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 241000208966 Polygala Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002642 Polysorbate 65 Polymers 0.000 description 1
- CYLWJCABXYDINA-UHFFFAOYSA-N Polythiazide Polymers ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)N(C)C(CSCC(F)(F)F)NC2=C1 CYLWJCABXYDINA-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MWQCHHACWWAQLJ-UHFFFAOYSA-N Prazepam Chemical compound O=C1CN=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2N1CC1CC1 MWQCHHACWWAQLJ-UHFFFAOYSA-N 0.000 description 1
- XLBIBBZXLMYSFF-UHFFFAOYSA-M Propantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(C(C)C)C(C)C)C3=CC=CC=C3OC2=C1 XLBIBBZXLMYSFF-UHFFFAOYSA-M 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000010401 Prunus avium Nutrition 0.000 description 1
- 240000008296 Prunus serotina Species 0.000 description 1
- 235000014441 Prunus serotina Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- IKMPWMZBZSAONZ-UHFFFAOYSA-N Quazepam Chemical compound FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12 IKMPWMZBZSAONZ-UHFFFAOYSA-N 0.000 description 1
- SOKRNBGSNZXYIO-UHFFFAOYSA-N Resinone Natural products CC(=C)C1CCC2(C)C(O)CC3(C)C(CCC4C5(C)CCC(=O)C(C)(C)C5CCC34C)C12 SOKRNBGSNZXYIO-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- VWXMLZQUDPCJPL-ZDHAIZATSA-N Rhodoxanthin Chemical compound CC\1=CC(=O)CC(C)(C)C/1=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C1\C(C)=CC(=O)CC1(C)C VWXMLZQUDPCJPL-ZDHAIZATSA-N 0.000 description 1
- VWXMLZQUDPCJPL-XPZLFLLQSA-N Rhodoxanthin Natural products O=C1C=C(C)/C(=C\C=C(/C=C/C=C(\C=C\C=C\C(=C/C=C/C(=C\C=C\2/C(C)=CC(=O)CC/2(C)C)/C)\C)/C)\C)/C(C)(C)C1 VWXMLZQUDPCJPL-XPZLFLLQSA-N 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
- CEEMRWKKNNEQDT-UHFFFAOYSA-N Rosmanol Natural products CC(C)c1cc2C(OC(=O)C)C3OC(=O)C4(CCCC(C)(C)C34)c2c(OC(=O)C)c1OC(=O)C CEEMRWKKNNEQDT-UHFFFAOYSA-N 0.000 description 1
- PSIOOHPZLJTGJH-UHFFFAOYSA-M S(=O)(=O)([O-])[O-].[NH4+].[Zn+] Chemical compound S(=O)(=O)([O-])[O-].[NH4+].[Zn+] PSIOOHPZLJTGJH-UHFFFAOYSA-M 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- PSKIOIDCXFHNJA-UHFFFAOYSA-N Sanshool Natural products CC=CC=CC=CCCC=CC=CC(=O)NC(C)C PSKIOIDCXFHNJA-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000689674 Soleirolia Species 0.000 description 1
- XNKLLVCARDGLGL-JGVFFNPUSA-N Stavudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1C=C[C@@H](CO)O1 XNKLLVCARDGLGL-JGVFFNPUSA-N 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- IGWHDMPTQKSDTL-JXOAFFINSA-N TMP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IGWHDMPTQKSDTL-JXOAFFINSA-N 0.000 description 1
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- KLBQZWRITKRQQV-UHFFFAOYSA-N Thioridazine Chemical compound C12=CC(SC)=CC=C2SC2=CC=CC=C2N1CCC1CCCCN1C KLBQZWRITKRQQV-UHFFFAOYSA-N 0.000 description 1
- 240000005761 Thrinax parviflora Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- UFLGIAIHIAPJJC-UHFFFAOYSA-N Tripelennamine Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CC=C1 UFLGIAIHIAPJJC-UHFFFAOYSA-N 0.000 description 1
- BGDKAVGWHJFAGW-UHFFFAOYSA-N Tropicamide Chemical compound C=1C=CC=CC=1C(CO)C(=O)N(CC)CC1=CC=NC=C1 BGDKAVGWHJFAGW-UHFFFAOYSA-N 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 1
- WPVFJKSGQUFQAP-GKAPJAKFSA-N Valcyte Chemical compound N1C(N)=NC(=O)C2=C1N(COC(CO)COC(=O)[C@@H](N)C(C)C)C=N2 WPVFJKSGQUFQAP-GKAPJAKFSA-N 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000018718 Verbena officinalis Nutrition 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- UYCAGRPOUWSBIQ-WOYAITHZSA-N [(1s)-1-carboxy-4-(diaminomethylideneamino)butyl]azanium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OC(=O)[C@@H]1CCC(=O)N1.OC(=O)[C@@H](N)CCCN=C(N)N UYCAGRPOUWSBIQ-WOYAITHZSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- 229960004748 abacavir Drugs 0.000 description 1
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229960003792 acrivastine Drugs 0.000 description 1
- PWACSDKDOHSSQD-IUTFFREVSA-N acrivastine Chemical compound C1=CC(C)=CC=C1C(\C=1N=C(\C=C\C(O)=O)C=CC=1)=C/CN1CCCC1 PWACSDKDOHSSQD-IUTFFREVSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 1
- 229960003205 adefovir dipivoxil Drugs 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229960001391 alfentanil Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000019409 alitame Nutrition 0.000 description 1
- 108010009985 alitame Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- SBXYHCVXUCYYJT-UEOYEZOQSA-N alpha-Sanshool Chemical compound C\C=C\C=C\C=C/CC\C=C\C(=O)NCC(C)C SBXYHCVXUCYYJT-UEOYEZOQSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960005174 ambroxol Drugs 0.000 description 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960005119 amitriptyline hydrochloride Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229960001040 ammonium chloride Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 229960003204 amorolfine Drugs 0.000 description 1
- 229960002519 amoxapine Drugs 0.000 description 1
- QWGDMFLQWFTERH-UHFFFAOYSA-N amoxapine Chemical compound C12=CC(Cl)=CC=C2OC2=CC=CC=C2N=C1N1CCNCC1 QWGDMFLQWFTERH-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940098184 amytal Drugs 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 229940105969 annatto extract Drugs 0.000 description 1
- 239000000420 anogeissus latifolia wall. gum Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001967 antemetic effect Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000002484 anti-cholesterolemic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003208 anti-thyroid effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 description 1
- 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
- 229940043671 antithyroid preparations Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- UORJNBVJVRLXMQ-UHFFFAOYSA-N aprobarbital Chemical compound C=CCC1(C(C)C)C(=O)NC(=O)NC1=O UORJNBVJVRLXMQ-UHFFFAOYSA-N 0.000 description 1
- 229960003153 aprobarbital Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- BIDUPMYXGFNAEJ-APGVDKLISA-N astromicin Chemical compound O[C@@H]1[C@H](N(C)C(=O)CN)[C@@H](OC)[C@@H](O)[C@H](N)[C@H]1O[C@@H]1[C@H](N)CC[C@@H]([C@H](C)N)O1 BIDUPMYXGFNAEJ-APGVDKLISA-N 0.000 description 1
- 229960001862 atracurium Drugs 0.000 description 1
- 229960000383 azatadine Drugs 0.000 description 1
- SEBMTIQKRHYNIT-UHFFFAOYSA-N azatadine Chemical compound C1CN(C)CCC1=C1C2=NC=CC=C2CCC2=CC=CC=C21 SEBMTIQKRHYNIT-UHFFFAOYSA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- TVWOWDDBXAFQDG-DQRAZIAOSA-N azorubine Chemical compound C1=CC=C2C(\N=N/C3=C(C4=CC=CC=C4C(=C3)S(O)(=O)=O)O)=CC=C(S(O)(=O)=O)C2=C1 TVWOWDDBXAFQDG-DQRAZIAOSA-N 0.000 description 1
- IIOPLILENRZKRV-UHFFFAOYSA-N azosemide Chemical compound C=1C=CSC=1CNC=1C=C(Cl)C(S(=O)(=O)N)=CC=1C1=NN=N[N]1 IIOPLILENRZKRV-UHFFFAOYSA-N 0.000 description 1
- 229960004988 azosemide Drugs 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092732 belladonna alkaloid Drugs 0.000 description 1
- 229960003515 bendroflumethiazide Drugs 0.000 description 1
- HDWIHXWEUNVBIY-UHFFFAOYSA-N bendroflumethiazidum Chemical compound C1=C(C(F)(F)F)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1NC2CC1=CC=CC=C1 HDWIHXWEUNVBIY-UHFFFAOYSA-N 0.000 description 1
- YNKMHABLMGIIFX-UHFFFAOYSA-N benzaldehyde;methane Chemical compound C.O=CC1=CC=CC=C1 YNKMHABLMGIIFX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- MAFMQEKGGFWBAB-UHFFFAOYSA-N benzonatate Chemical compound CCCCNC1=CC=C(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C=C1 MAFMQEKGGFWBAB-UHFFFAOYSA-N 0.000 description 1
- 229960003789 benzonatate Drugs 0.000 description 1
- YXKTVDFXDRQTKV-HNNXBMFYSA-N benzphetamine Chemical compound C([C@H](C)N(C)CC=1C=CC=CC=1)C1=CC=CC=C1 YXKTVDFXDRQTKV-HNNXBMFYSA-N 0.000 description 1
- 229960002837 benzphetamine Drugs 0.000 description 1
- 229960001541 benzthiazide Drugs 0.000 description 1
- NDTSRXAMMQDVSW-UHFFFAOYSA-N benzthiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(S(N2)(=O)=O)=C1N=C2CSCC1=CC=CC=C1 NDTSRXAMMQDVSW-UHFFFAOYSA-N 0.000 description 1
- 239000003781 beta lactamase inhibitor Substances 0.000 description 1
- 239000001652 beta-apo-8'-carotenal Substances 0.000 description 1
- 235000013735 beta-apo-8'-carotenal Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-FKKUPVFPSA-N beta-cryptoxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-FKKUPVFPSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- YZXZAUAIVAZWFN-UHFFFAOYSA-N bis(5-methyl-2-propan-2-ylcyclohexyl) butanedioate Chemical compound CC(C)C1CCC(C)CC1OC(=O)CCC(=O)OC1C(C(C)C)CCC(C)C1 YZXZAUAIVAZWFN-UHFFFAOYSA-N 0.000 description 1
- GERIGMSHTUAXSI-UHFFFAOYSA-N bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-phenyl-2,3-dihydro-1h-naphthalene-1,4-dicarboxylate Chemical compound CN1C(C2)CCC1CC2OC(=O)C(C1=CC=CC=C11)CCC1(C(=O)OC1CC2CCC(N2C)C1)C1=CC=CC=C1 GERIGMSHTUAXSI-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000019481 bixa orellana extract Nutrition 0.000 description 1
- 235000002333 black apple Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 229940046049 bontril Drugs 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- NUNIWXHYABYXKF-UHFFFAOYSA-N bromazine Chemical compound C=1C=C(Br)C=CC=1C(OCCN(C)C)C1=CC=CC=C1 NUNIWXHYABYXKF-UHFFFAOYSA-N 0.000 description 1
- 229960003166 bromazine Drugs 0.000 description 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 1
- 229960003870 bromhexine Drugs 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 1
- ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
- 229960000725 brompheniramine Drugs 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 description 1
- 229960004064 bumetanide Drugs 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 description 1
- 229960002495 buspirone Drugs 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- UZVHFVZFNXBMQJ-UHFFFAOYSA-N butalbital Chemical compound CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O UZVHFVZFNXBMQJ-UHFFFAOYSA-N 0.000 description 1
- 229960002546 butalbital Drugs 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229940046413 calcium iodide Drugs 0.000 description 1
- 229910001640 calcium iodide Inorganic materials 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- PBKZPPIHUVSDNM-WNHSNXHDSA-N canrenoic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)CCC(O)=O)[C@@H]4[C@@H]3C=CC2=C1 PBKZPPIHUVSDNM-WNHSNXHDSA-N 0.000 description 1
- UJVLDDZCTMKXJK-WNHSNXHDSA-N canrenone Chemical compound C([C@H]1[C@H]2[C@@H]([C@]3(CCC(=O)C=C3C=C2)C)CC[C@@]11C)C[C@@]11CCC(=O)O1 UJVLDDZCTMKXJK-WNHSNXHDSA-N 0.000 description 1
- 229960005057 canrenone Drugs 0.000 description 1
- FDSDTBUPSURDBL-DKLMTRRASA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-DKLMTRRASA-N 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 239000001325 capsicum annuum l. var. longum oleoresin Substances 0.000 description 1
- 235000009132 capsorubin Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960000428 carbinoxamine Drugs 0.000 description 1
- OJFSXZCBGQGRNV-UHFFFAOYSA-N carbinoxamine Chemical compound C=1C=CC=NC=1C(OCCN(C)C)C1=CC=C(Cl)C=C1 OJFSXZCBGQGRNV-UHFFFAOYSA-N 0.000 description 1
- 229960000456 carbinoxamine maleate Drugs 0.000 description 1
- GVNWHCVWDRNXAZ-BTJKTKAUSA-N carbinoxamine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(OCCN(C)C)C1=CC=C(Cl)C=C1 GVNWHCVWDRNXAZ-BTJKTKAUSA-N 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000003575 carbonaceous material Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical group OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 1
- 229940031019 carmoisine Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013709 carrot oil Nutrition 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 229960004342 cetirizine hydrochloride Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 1
- MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012829 chemotherapy agent Substances 0.000 description 1
- 229960004630 chlorambucil Drugs 0.000 description 1
- JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 description 1
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 1
- 229960002155 chlorothiazide Drugs 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 229950007046 chlorphentermine Drugs 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 229960001552 chlorprothixene Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 1
- 229960003178 choline chloride Drugs 0.000 description 1
- 229940046374 chromium picolinate Drugs 0.000 description 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960000724 cidofovir Drugs 0.000 description 1
- VYVRIXWNTVOIRD-LRHBOZQDSA-N ciguatoxin CTX1B Chemical compound C([C@@]12[C@@H](C)[C@@H]([C@@H]3[C@H]([C@H]([C@H](C)[C@H]4O[C@H]5C[C@@H](C)C[C@H]6O[C@@]7(C)[C@H](O)C[C@H]8O[C@H]9C=C[C@H]%10O[C@H]%11C[C@@H]%12[C@H]([C@@H]([C@H]%13O[C@H](C=CC[C@@H]%13O%12)\C=C\[C@H](O)CO)O)O[C@@H]%11C=C[C@@H]%10O[C@@H]9C\C=C/C[C@@H]8O[C@@H]7C[C@@H]6O[C@@H]5C[C@@H]4O3)O)O2)C)[C@H](O)CO1 VYVRIXWNTVOIRD-LRHBOZQDSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000011538 cleaning material Substances 0.000 description 1
- 229960002689 clemastine fumarate Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- WRCHFMBCVFFYEQ-UHFFFAOYSA-N clofedanol Chemical compound C=1C=CC=C(Cl)C=1C(O)(CCN(C)C)C1=CC=CC=C1 WRCHFMBCVFFYEQ-UHFFFAOYSA-N 0.000 description 1
- 229960004472 clofedanol Drugs 0.000 description 1
- 229960004606 clomipramine Drugs 0.000 description 1
- DGBIGWXXNGSACT-UHFFFAOYSA-N clonazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1Cl DGBIGWXXNGSACT-UHFFFAOYSA-N 0.000 description 1
- 229960003120 clonazepam Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960004170 clozapine Drugs 0.000 description 1
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000008373 coffee flavor Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 description 1
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- PNZXMIKHJXIPEK-UHFFFAOYSA-N cyclohexanecarboxamide Chemical compound NC(=O)C1CCCCC1 PNZXMIKHJXIPEK-UHFFFAOYSA-N 0.000 description 1
- 229950009125 cynarine Drugs 0.000 description 1
- YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical group CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229960005319 delavirdine Drugs 0.000 description 1
- 229960003914 desipramine Drugs 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960001882 dexchlorpheniramine Drugs 0.000 description 1
- SOYKEARSMXGVTM-HNNXBMFYSA-N dexchlorpheniramine Chemical compound C1([C@H](CCN(C)C)C=2N=CC=CC=2)=CC=C(Cl)C=C1 SOYKEARSMXGVTM-HNNXBMFYSA-N 0.000 description 1
- 229960001985 dextromethorphan Drugs 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- ORYOIBJWFDNIPD-UHFFFAOYSA-N diacetyl 2,3-dihydroxybutanedioate Chemical compound CC(=O)OC(=O)C(O)C(O)C(=O)OC(C)=O ORYOIBJWFDNIPD-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960005081 diclofenamide Drugs 0.000 description 1
- GJQPMPFPNINLKP-UHFFFAOYSA-N diclofenamide Chemical compound NS(=O)(=O)C1=CC(Cl)=C(Cl)C(S(N)(=O)=O)=C1 GJQPMPFPNINLKP-UHFFFAOYSA-N 0.000 description 1
- 229940120144 didrex Drugs 0.000 description 1
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- XJQPQKLURWNAAH-UHFFFAOYSA-N dihydrocapsaicin Chemical compound COC1=CC(CNC(=O)CCCCCCC(C)C)=CC=C1O XJQPQKLURWNAAH-UHFFFAOYSA-N 0.000 description 1
- RBCYRZPENADQGZ-UHFFFAOYSA-N dihydrocapsaicin Natural products COC1=CC(COC(=O)CCCCCCC(C)C)=CC=C1O RBCYRZPENADQGZ-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- RBOXVHNMENFORY-DNJOTXNNSA-N dihydrocodeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC RBOXVHNMENFORY-DNJOTXNNSA-N 0.000 description 1
- 229960000920 dihydrocodeine Drugs 0.000 description 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
- 229960004704 dihydroergotamine Drugs 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- TVQLLNFANZSCGY-UHFFFAOYSA-N disodium;dioxido(oxo)tin Chemical compound [Na+].[Na+].[O-][Sn]([O-])=O TVQLLNFANZSCGY-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- RMGVZKRVHHSUIM-UHFFFAOYSA-N dithionic acid Chemical compound OS(=O)(=O)S(O)(=O)=O RMGVZKRVHHSUIM-UHFFFAOYSA-N 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- 229940099182 dramamine Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000019258 ear infection Diseases 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- XPOQHMRABVBWPR-ZDUSSCGKSA-N efavirenz Chemical compound C([C@]1(C2=CC(Cl)=CC=C2NC(=O)O1)C(F)(F)F)#CC1CC1 XPOQHMRABVBWPR-ZDUSSCGKSA-N 0.000 description 1
- 229960003804 efavirenz Drugs 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960000366 emtricitabine Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 229960000980 entecavir Drugs 0.000 description 1
- YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 229940089481 ergomar Drugs 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- AVOLMBLBETYQHX-UHFFFAOYSA-N etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 1
- 229960003199 etacrynic acid Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 229960004447 ethchlorvynol Drugs 0.000 description 1
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 1
- AFSIMBWBBOJPJG-UHFFFAOYSA-N ethenyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC=C AFSIMBWBBOJPJG-UHFFFAOYSA-N 0.000 description 1
- GXRZIMHKGDIBEW-UHFFFAOYSA-N ethinamate Chemical compound NC(=O)OC1(C#C)CCCCC1 GXRZIMHKGDIBEW-UHFFFAOYSA-N 0.000 description 1
- 229960002209 ethinamate Drugs 0.000 description 1
- MFGZXPGKKJMZIY-UHFFFAOYSA-N ethyl 5-amino-1-(4-sulfamoylphenyl)pyrazole-4-carboxylate Chemical compound NC1=C(C(=O)OCC)C=NN1C1=CC=C(S(N)(=O)=O)C=C1 MFGZXPGKKJMZIY-UHFFFAOYSA-N 0.000 description 1
- 235000012656 ethyl ester of beta-apo-8'-carotenic acid Nutrition 0.000 description 1
- 239000001684 ethyl ester of beta-apo-8'-carotenic acid (C30) Substances 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960003976 etidocaine Drugs 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 229960001690 etomidate Drugs 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 108010079553 euphauserase Proteins 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- SPIUTQOUKAMGCX-UHFFFAOYSA-N flavoxate Chemical compound C1=CC=C2C(=O)C(C)=C(C=3C=CC=CC=3)OC2=C1C(=O)OCCN1CCCCC1 SPIUTQOUKAMGCX-UHFFFAOYSA-N 0.000 description 1
- 229960000855 flavoxate Drugs 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229960001258 fluphenazine hydrochloride Drugs 0.000 description 1
- 229960003528 flurazepam Drugs 0.000 description 1
- SAADBVWGJQAEFS-UHFFFAOYSA-N flurazepam Chemical compound N=1CC(=O)N(CCN(CC)CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F SAADBVWGJQAEFS-UHFFFAOYSA-N 0.000 description 1
- 229960004038 fluvoxamine Drugs 0.000 description 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 239000011663 gamma-carotene Substances 0.000 description 1
- 235000000633 gamma-carotene Nutrition 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940113086 glaucine Drugs 0.000 description 1
- 229930004041 glaucine Natural products 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074049 glyceryl dilaurate Drugs 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229960002462 glycopyrronium bromide Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- WDPIZEKLJKBSOZ-UHFFFAOYSA-M green s Chemical compound [Na+].C1=CC(N(C)C)=CC=C1C(C=1C2=CC=C(C=C2C=C(C=1O)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](C)C)C=C1 WDPIZEKLJKBSOZ-UHFFFAOYSA-M 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 229930183009 gymnemic acid Natural products 0.000 description 1
- 235000019668 heartiness Nutrition 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- TVHALOSDPLTTSR-UHFFFAOYSA-H hexasodium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O TVHALOSDPLTTSR-UHFFFAOYSA-H 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- MLJGZARGNROKAC-VQHVLOKHSA-N homocapsaicin Chemical compound CCC(C)\C=C\CCCCC(=O)NCC1=CC=C(O)C(OC)=C1 MLJGZARGNROKAC-VQHVLOKHSA-N 0.000 description 1
- JKIHLSTUOQHAFF-UHFFFAOYSA-N homocapsaicin Natural products COC1=CC(CNC(=O)CCCCCC=CC(C)C)=CC=C1O JKIHLSTUOQHAFF-UHFFFAOYSA-N 0.000 description 1
- JZNZUOZRIWOBGG-UHFFFAOYSA-N homocapsaicin-II Natural products COC1=CC(CNC(=O)CCCCC=CCC(C)C)=CC=C1O JZNZUOZRIWOBGG-UHFFFAOYSA-N 0.000 description 1
- GOBFKCLUUUDTQE-UHFFFAOYSA-N homodihydrocapsaicin-II Natural products CCC(C)CCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 GOBFKCLUUUDTQE-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000004276 hyalin Anatomy 0.000 description 1
- 229940104084 hycodan Drugs 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- LLPOLZWFYMWNKH-CMKMFDCUSA-N hydrocodone Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)CC(=O)[C@@H]1OC1=C2C3=CC=C1OC LLPOLZWFYMWNKH-CMKMFDCUSA-N 0.000 description 1
- 229960000240 hydrocodone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- WVLOADHCBXTIJK-YNHQPCIGSA-N hydromorphone Chemical compound O([C@H]1C(CC[C@H]23)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O WVLOADHCBXTIJK-YNHQPCIGSA-N 0.000 description 1
- 229960001410 hydromorphone Drugs 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960003220 hydroxyzine hydrochloride Drugs 0.000 description 1
- 229960001560 hydroxyzine pamoate Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 1
- 229960001101 ifosfamide Drugs 0.000 description 1
- XZZXIYZZBJDEEP-UHFFFAOYSA-N imipramine hydrochloride Chemical compound [Cl-].C1CC2=CC=CC=C2N(CCC[NH+](C)C)C2=CC=CC=C21 XZZXIYZZBJDEEP-UHFFFAOYSA-N 0.000 description 1
- 229960002102 imipramine hydrochloride Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- NDDAHWYSQHTHNT-UHFFFAOYSA-N indapamide Chemical compound CC1CC2=CC=CC=C2N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 NDDAHWYSQHTHNT-UHFFFAOYSA-N 0.000 description 1
- 229960004569 indapamide Drugs 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 1
- 229960001936 indinavir Drugs 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229960001178 iodinated glycerol Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229940036543 ionamin Drugs 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004407 iron oxides and hydroxides Substances 0.000 description 1
- 235000010213 iron oxides and hydroxides Nutrition 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 229960004849 isoconazole Drugs 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- ZCGOMHNNNFPNMX-KYTRFIICSA-N levocabastine Chemical compound C1([C@@]2(C(O)=O)CCN(C[C@H]2C)[C@@H]2CC[C@@](CC2)(C#N)C=2C=CC(F)=CC=2)=CC=CC=C1 ZCGOMHNNNFPNMX-KYTRFIICSA-N 0.000 description 1
- 229960001120 levocabastine Drugs 0.000 description 1
- 229960005464 levopropoxyphene napsylate Drugs 0.000 description 1
- GBKONKCASNNUQD-VMJMSTHCSA-N levopropoxyphene napsylate Chemical compound [H+].O.C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21.C([C@@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 GBKONKCASNNUQD-VMJMSTHCSA-N 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- YQZBAXDVDZTKEQ-UHFFFAOYSA-N loxapine succinate Chemical compound [H+].[H+].[O-]C(=O)CCC([O-])=O.C1CN(C)CCN1C1=NC2=CC=CC=C2OC2=CC=C(Cl)C=C12 YQZBAXDVDZTKEQ-UHFFFAOYSA-N 0.000 description 1
- 229940089527 loxitane Drugs 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229940041033 macrolides Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229960004090 maprotiline Drugs 0.000 description 1
- QSLMDECMDJKHMQ-GSXCWMCISA-N maprotiline Chemical compound C12=CC=CC=C2[C@@]2(CCCNC)C3=CC=CC=C3[C@@H]1CC2 QSLMDECMDJKHMQ-GSXCWMCISA-N 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 229940099214 melfiat Drugs 0.000 description 1
- 229960001924 melphalan Drugs 0.000 description 1
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- 229960003092 mepenzolate Drugs 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- 229960004815 meprobamate Drugs 0.000 description 1
- SLVMESMUVMCQIY-UHFFFAOYSA-N mesoridazine Chemical compound CN1CCCCC1CCN1C2=CC(S(C)=O)=CC=C2SC2=CC=CC=C21 SLVMESMUVMCQIY-UHFFFAOYSA-N 0.000 description 1
- 229960000300 mesoridazine Drugs 0.000 description 1
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 description 1
- TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- 229960001470 methantheline Drugs 0.000 description 1
- FLOSMHQXBMRNHR-DAXSKMNVSA-N methazolamide Chemical compound CC(=O)\N=C1/SC(S(N)(=O)=O)=NN1C FLOSMHQXBMRNHR-DAXSKMNVSA-N 0.000 description 1
- 229960004083 methazolamide Drugs 0.000 description 1
- 229960002683 methohexital Drugs 0.000 description 1
- 229960003739 methyclothiazide Drugs 0.000 description 1
- SZJUWKPNWWCOPG-UHFFFAOYSA-N methyl 2-anilinoacetate Chemical compound COC(=O)CNC1=CC=CC=C1 SZJUWKPNWWCOPG-UHFFFAOYSA-N 0.000 description 1
- RUAIJHHRCIHFEV-UHFFFAOYSA-N methyl 4-amino-5-chlorothiophene-2-carboxylate Chemical compound COC(=O)C1=CC(N)=C(Cl)S1 RUAIJHHRCIHFEV-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 229960001703 methylphenobarbital Drugs 0.000 description 1
- AQCHWTWZEMGIFD-UHFFFAOYSA-N metolazone Chemical compound CC1NC2=CC(Cl)=C(S(N)(=O)=O)C=C2C(=O)N1C1=CC=CC=C1C AQCHWTWZEMGIFD-UHFFFAOYSA-N 0.000 description 1
- 229960002817 metolazone Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000198 mezlocillin Drugs 0.000 description 1
- YPBATNHYBCGSSN-VWPFQQQWSA-N mezlocillin Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC=CC=1)C(=O)N1CCN(S(C)(=O)=O)C1=O YPBATNHYBCGSSN-VWPFQQQWSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 229960003793 midazolam Drugs 0.000 description 1
- DDLIGBOFAVUZHB-UHFFFAOYSA-N midazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NC=C2CN=C1C1=CC=CC=C1F DDLIGBOFAVUZHB-UHFFFAOYSA-N 0.000 description 1
- 229940037361 midrin Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 229960001437 mivacurium chloride Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229960004684 molindone hydrochloride Drugs 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 201000003152 motion sickness Diseases 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 229940066491 mucolytics Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229940087004 mustargen Drugs 0.000 description 1
- RLWRMIYXDPXIEX-UHFFFAOYSA-N muzolimine Chemical compound C=1C=C(Cl)C(Cl)=CC=1C(C)N1N=C(N)CC1=O RLWRMIYXDPXIEX-UHFFFAOYSA-N 0.000 description 1
- 229960001788 muzolimine Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229960005016 naphazoline Drugs 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 229940087524 nardil Drugs 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229960001800 nefazodone Drugs 0.000 description 1
- VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical compound O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 description 1
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001158 nortriptyline Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 229940124636 opioid drug Drugs 0.000 description 1
- 229960003752 oseltamivir Drugs 0.000 description 1
- NENPYTRHICXVCS-YNEHKIRRSA-N oseltamivir acid Chemical compound CCC(CC)O[C@@H]1C=C(C(O)=O)C[C@H](N)[C@H]1NC(C)=O NENPYTRHICXVCS-YNEHKIRRSA-N 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- 229960005434 oxybutynin Drugs 0.000 description 1
- 229960001528 oxymetazoline Drugs 0.000 description 1
- 229960002369 oxyphencyclimine Drugs 0.000 description 1
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 description 1
- NPIJXCQZLFKBMV-YTGGZNJNSA-L pancuronium bromide Chemical compound [Br-].[Br-].C[N+]1([C@@H]2[C@@H](OC(C)=O)C[C@@H]3CC[C@H]4[C@@H]5C[C@@H]([C@@H]([C@]5(CC[C@@H]4[C@@]3(C)C2)C)OC(=O)C)[N+]2(C)CCCCC2)CCCCC1 NPIJXCQZLFKBMV-YTGGZNJNSA-L 0.000 description 1
- 229960003379 pancuronium bromide Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- DYUUPIKEWLHQGQ-SDXBLLFJSA-N paprika oleoresin Chemical compound C(\[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=C[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-SDXBLLFJSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000001499 parasympathomimetic effect Effects 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960001179 penciclovir Drugs 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-N perisophthalic acid Natural products OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 1
- 229960000762 perphenazine Drugs 0.000 description 1
- 229960003534 phenindamine Drugs 0.000 description 1
- 229960001190 pheniramine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
- 229960001526 phenyltoloxamine Drugs 0.000 description 1
- 229960002808 pholcodine Drugs 0.000 description 1
- GPFAJKDEDBRFOS-FKQDBXSBSA-N pholcodine Chemical compound O([C@@H]1[C@]23CCN([C@H](C4)[C@@H]3C=C[C@@H]1O)C)C1=C2C4=CC=C1OCCN1CCOCC1 GPFAJKDEDBRFOS-FKQDBXSBSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- PZTQVMXMKVTIRC-RZLHGTIFSA-L pigment rubine Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1\N=N\C1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-RZLHGTIFSA-L 0.000 description 1
- 229960003634 pimozide Drugs 0.000 description 1
- YVUQSNJEYSNKRX-UHFFFAOYSA-N pimozide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC(N2C(NC3=CC=CC=C32)=O)CC1 YVUQSNJEYSNKRX-UHFFFAOYSA-N 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 description 1
- 229940081310 piperonal Drugs 0.000 description 1
- RMHMFHUVIITRHF-UHFFFAOYSA-N pirenzepine Chemical compound C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 RMHMFHUVIITRHF-UHFFFAOYSA-N 0.000 description 1
- 229960004633 pirenzepine Drugs 0.000 description 1
- 229960001085 piretanide Drugs 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940099511 polysorbate 65 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229960005483 polythiazide Drugs 0.000 description 1
- 229920000046 polythiazide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 229960000206 potassium canrenoate Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- HQEROMHPIOLGCB-DFWYDOINSA-M potassium;(2s)-2-aminopentanedioate;hydron Chemical compound [K+].[O-]C(=O)[C@@H](N)CCC(O)=O HQEROMHPIOLGCB-DFWYDOINSA-M 0.000 description 1
- 229960004856 prazepam Drugs 0.000 description 1
- 229960001807 prilocaine Drugs 0.000 description 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940099209 probanthine Drugs 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 229960002601 protriptyline Drugs 0.000 description 1
- BWPIARFWQZKAIA-UHFFFAOYSA-N protriptyline Chemical compound C1=CC2=CC=CC=C2C(CCCNC)C2=CC=CC=C21 BWPIARFWQZKAIA-UHFFFAOYSA-N 0.000 description 1
- 229940035613 prozac Drugs 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 229960001964 quazepam Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- AGMMTXLNIQSRCG-UHFFFAOYSA-N quinethazone Chemical compound NS(=O)(=O)C1=C(Cl)C=C2NC(CC)NC(=O)C2=C1 AGMMTXLNIQSRCG-UHFFFAOYSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000000395 remineralizing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 1
- 229960000311 ritonavir Drugs 0.000 description 1
- 229960001549 ropivacaine Drugs 0.000 description 1
- LCAZOMIGFDQMNC-FORWCCJISA-N rosmanol Chemical compound C1CCC(C)(C)[C@@H]2[C@H]3[C@@H](O)C(C=C(C(=C4O)O)C(C)C)=C4[C@]21C(=O)O3 LCAZOMIGFDQMNC-FORWCCJISA-N 0.000 description 1
- ABTRFGSPYXCGMR-SDPRXREBSA-N rubixanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=C(\CC/C=C(\C)/C)/C)\C)/C)\C)/C)=C(C)C1 ABTRFGSPYXCGMR-SDPRXREBSA-N 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- NNNVXFKZMRGJPM-KHPPLWFESA-N sapienic acid Chemical compound CCCCCCCCC\C=C/CCCCC(O)=O NNNVXFKZMRGJPM-KHPPLWFESA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000010018 saw palmetto extract Substances 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- KQPKPCNLIDLUMF-UHFFFAOYSA-N secobarbital Chemical compound CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O KQPKPCNLIDLUMF-UHFFFAOYSA-N 0.000 description 1
- 229960002060 secobarbital Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 1
- 229960002639 sildenafil citrate Drugs 0.000 description 1
- 229960001516 silver nitrate Drugs 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- CMXPERZAMAQXSF-UHFFFAOYSA-M sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate;1,8-dihydroxyanthracene-9,10-dione Chemical compound [Na+].O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O.CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC CMXPERZAMAQXSF-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229960001203 stavudine Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960004739 sufentanil Drugs 0.000 description 1
- GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 description 1
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 description 1
- 229960005256 sulbactam Drugs 0.000 description 1
- 229960002673 sulfacetamide Drugs 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical compound OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 description 1
- 229960003708 sumatriptan Drugs 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000035918 sweet taste sensation Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- 229960004556 tenofovir Drugs 0.000 description 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 1
- 229960002871 tenoxicam Drugs 0.000 description 1
- LZNWYQJJBLGYLT-UHFFFAOYSA-N tenoxicam Chemical compound OC=1C=2SC=CC=2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 LZNWYQJJBLGYLT-UHFFFAOYSA-N 0.000 description 1
- 229940103784 tepanil Drugs 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- YUSMZDVTEOAHDL-NTMALXAHSA-N tert-butyl (3z)-3-(dimethylaminomethylidene)-4-oxopiperidine-1-carboxylate Chemical compound CN(C)\C=C1\CN(C(=O)OC(C)(C)C)CCC1=O YUSMZDVTEOAHDL-NTMALXAHSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CBYCSRICVDBHMZ-UHFFFAOYSA-N tetracosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCCCC(O)=O CBYCSRICVDBHMZ-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229940015849 thiophene Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 229960000257 tiotropium bromide Drugs 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical compound C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 description 1
- 229960004045 tolterodine Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- LLPOLZWFYMWNKH-UHFFFAOYSA-N trans-dihydrocodeinone Natural products C1C(N(CCC234)C)C2CCC(=O)C3OC2=C4C1=CC=C2OC LLPOLZWFYMWNKH-UHFFFAOYSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960003991 trazodone Drugs 0.000 description 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical compound ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960001288 triamterene Drugs 0.000 description 1
- 229960003386 triazolam Drugs 0.000 description 1
- JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
- 229960004813 trichlormethiazide Drugs 0.000 description 1
- LMJSLTNSBFUCMU-UHFFFAOYSA-N trichlormethiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC(C(Cl)Cl)NS2(=O)=O LMJSLTNSBFUCMU-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 229960002324 trifluoperazine Drugs 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- CHQOEHPMXSHGCL-UHFFFAOYSA-N trimethaphan Chemical compound C12C[S+]3CCCC3C2N(CC=2C=CC=CC=2)C(=O)N1CC1=CC=CC=C1 CHQOEHPMXSHGCL-UHFFFAOYSA-N 0.000 description 1
- 229940035742 trimethaphan Drugs 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 229960002431 trimipramine Drugs 0.000 description 1
- ZSCDBOWYZJWBIY-UHFFFAOYSA-N trimipramine Chemical compound C1CC2=CC=CC=C2N(CC(CN(C)C)C)C2=CC=CC=C21 ZSCDBOWYZJWBIY-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229960003223 tripelennamine Drugs 0.000 description 1
- 229960000732 tripelennamine hydrochloride Drugs 0.000 description 1
- 229960001128 triprolidine Drugs 0.000 description 1
- CBEQULMOCCWAQT-WOJGMQOQSA-N triprolidine Chemical compound C1=CC(C)=CC=C1C(\C=1N=CC=CC=1)=C/CN1CCCC1 CBEQULMOCCWAQT-WOJGMQOQSA-N 0.000 description 1
- 229960004791 tropicamide Drugs 0.000 description 1
- 229960001844 tubocurarine Drugs 0.000 description 1
- JFJZZMVDLULRGK-URLMMPGGSA-O tubocurarine Chemical compound C([C@H]1[N+](C)(C)CCC=2C=C(C(=C(OC3=CC=C(C=C3)C[C@H]3C=4C=C(C(=CC=4CCN3C)OC)O3)C=21)O)OC)C1=CC=C(O)C3=C1 JFJZZMVDLULRGK-URLMMPGGSA-O 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229940093257 valacyclovir Drugs 0.000 description 1
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 229960002149 valganciclovir Drugs 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- VEPSYABRBFXYIB-PWXDFCLTSA-M vecuronium bromide Chemical compound [Br-].N1([C@@H]2[C@@H](OC(C)=O)C[C@@H]3CC[C@H]4[C@@H]5C[C@@H]([C@@H]([C@]5(CC[C@@H]4[C@@]3(C)C2)C)OC(=O)C)[N+]2(C)CCCCC2)CCCCC1 VEPSYABRBFXYIB-PWXDFCLTSA-M 0.000 description 1
- 229960004298 vecuronium bromide Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229960004688 venlafaxine Drugs 0.000 description 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 229940023080 viracept Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 229960004740 voriconazole Drugs 0.000 description 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
- 235000015041 whisky Nutrition 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 229960000833 xylometazoline Drugs 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- SRWMQSFFRFWREA-UHFFFAOYSA-M zinc formate Chemical compound [Zn+2].[O-]C=O SRWMQSFFRFWREA-UHFFFAOYSA-M 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
- XLMCDAMBOROREP-UHFFFAOYSA-N zinc;3-phosphonooxypropane-1,2-diolate Chemical compound [Zn+2].OP(O)(=O)OCC([O-])C[O-] XLMCDAMBOROREP-UHFFFAOYSA-N 0.000 description 1
- AGFGXVAAIXIOFZ-UHFFFAOYSA-L zinc;butanedioate Chemical compound [Zn+2].[O-]C(=O)CCC([O-])=O AGFGXVAAIXIOFZ-UHFFFAOYSA-L 0.000 description 1
- NDKWCCLKSWNDBG-UHFFFAOYSA-N zinc;dioxido(dioxo)chromium Chemical compound [Zn+2].[O-][Cr]([O-])(=O)=O NDKWCCLKSWNDBG-UHFFFAOYSA-N 0.000 description 1
- 229940020965 zoloft Drugs 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 229940126085 β‑Lactamase Inhibitor Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
- A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Confectionery (AREA)
- General Preparation And Processing Of Foods (AREA)
- Seasonings (AREA)
Abstract
通过将甜味料包封在特定量的聚(醋酸乙烯酯)、填充剂和脂肪酸盐中来提供甜味料在咀嚼型胶基糖中的延迟的释放。当被加入咀嚼型胶基糖中时,被包封于聚(醋酸乙烯酯)、填充剂和脂肪酸盐中的甜味料提供比被包封于单独的聚(醋酸乙烯酯)中的甜味料更加延迟的甜风味的释放。
Description
发明背景
为了提供咀嚼型胶基糖中更持久的风味,咀嚼型胶基糖制造商进行了长期的努力。在延长风味的一种途径中,包括风味物、甜味料和食品级酸(以提供酸味)的成分已被包封以聚合物来延迟和延长其释放。举例来说,参阅授予Cherukuri等的美国专利号4,931,293、5,057,328、5,064,658和5,110,608。在另一种途径中,用聚合物和质地改进剂和/或填充剂(如单硬脂酸甘油酯、氢化油、碳酸钙或滑石)包封甜味料。举例来说,参阅美国专利号7,727,565、7,879,376和美国专利申请号2010/0104689。在再其他途径中,甜味料和口腔护理成分(如硬脂酸钠)被包封于聚合物和质地改进剂(如氢化油)和/或填充剂(如碳酸钙、磷酸二钙或滑石)中。举例来说,参阅美国专利申请号2005/0260266、US20100104689A1和国际专利号WO/2010/088519。
其他途径还包括用于咀嚼型胶基糖中的被包封的甜味料组合物,其中甜味料是使用分子量低至中等分子量的聚合物和质地改进剂来包封的。举例来说,参阅美国专利号4,981,698、5,229,148、5,433,960、7,244,454。最后,在一种途径中,咀嚼型胶基糖具有用聚合物和无机盐包封的甜味料,所述无机盐可以是碳酸钙以辅助加工并且提供硬而易碎的包封产品。在该途径中,可以在共混物中包括少量的硬脂酸镁(共混物的约0.50重量百分数)作为加工助剂。举例来说,参阅美国专利号5154939。
然而,延迟这样的甜味料的释放已经尤为困难,在通过将甜味料包封于高分子量聚合物而暴露于高温时所述甜味料倾向于热降解。由于需要将甜味料暴露于高的加工温度下,提供稳定的过程,通过该过程将热不稳定的甜味料包封在高分子量聚合物中已经更加困难。相应地,热可降解的甜味料已经普遍地被包封于低分子量至中等分子量的聚合物中以降低加工期间甜味料被暴露于的热的量。最后,抵消在咀嚼型胶基糖料团(bolus)中并入高分子量聚合物包封物导致的咀嚼期间的硬化作用也已经是难以克服的。因此,存在对于能够延迟和延长咀嚼型胶基糖中甜味料的释放,同时提供更加稳定生产过程和咀嚼型胶基糖料团的改进的质地的材料和方法的需要。
发明内容
一个实施方案是被包封的甜味料组合物,所述被包封的甜味料组合物包括包封材料和甜味料,所述包封材料包括聚(醋酸乙烯酯)、基于被包封的甜味料组合物的总重量的约2至约20重量百分数的脂肪酸盐和基于被包封的甜味料组合物的总重量的约2至约20重量百分数的填充剂,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组;其中所述包封材料至少部分地包封所述甜味料。
另一个实施方案是咀嚼型胶基糖组合物,所述咀嚼型胶基糖组合物包括:胶基糖基础剂、未被包封的甜味料,和被包封的甜味料组合物,所述被包封的甜味料组合物包括包封材料和甜味料,所述包封材料包括聚(醋酸乙烯酯)、基于所述被包封的甜味料组合物的总重量的约2至约20重量百分数的脂肪酸盐和基于所述被包封的甜味料组合物的总重量的约2至约20重量百分数的填充剂,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组,其中所述包封材料至少部分地包封所述甜味料。
一个实施方案是制备咀嚼型胶基糖组合物的方法,所述方法包括将聚(醋酸乙烯酯)、约2至约20重量百分数的脂肪酸盐和约2至约20重量百分数的填充剂以及甜味料熔融共混以形成被包封的甜味料组合物,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组;其中所述包封材料至少部分地包封所述甜味料,并且其中所有重量百分数是基于所述被包封的甜味料组合物的总重量;以及随后将胶基糖基础剂和所述被包封的甜味料组合物熔融共混,以形成咀嚼型胶基糖组合物。
另一个实施方案是一种制备被包封的甜味料组合物的方法,所述方法包括:将聚(醋酸乙烯酯)、约2至约20重量百分数的脂肪酸盐和约2至约20重量百分数的填充剂,以及甜味料熔融共混以形成被包封的甜味料组合物,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组;其中所述包封材料至少部分地包封所述甜味料,并且其中所有重量百分数是基于所述被包封的甜味料组合物的总重量。
这些实施方案和其他实施方案在下文中被详细地描述。
附图说明
图1是针对实施例1和比较实施例1的甜味料包封物的溶解属性(dissolution profiles)示出了甜味料释放的百分数(%)对时间(小时:分钟:秒)的标绘图。
图2是针对(a)比较实施例4和(b)实施例4的咀嚼型胶基糖示出了胶基糖硬度关于咀嚼时间(分钟)的函数的条形图,比较实施例4的咀嚼型胶基糖是包含用单独的聚(醋酸乙烯酯)包封的甜味料的咀嚼型胶基糖,实施例4的咀嚼型胶基糖是包含用聚(醋酸乙烯酯)、脂肪酸盐和填充剂包封的甜味料的的咀嚼型胶基糖。
图3是针对(a)比较实施例4和(b)实施例4的咀嚼型胶基糖示出胶基糖甜味关于咀嚼时间(分钟)的函数的条形图,比较实施例4的咀嚼型胶基糖是包含用单独的聚(醋酸乙烯酯)包封的甜味料的咀嚼型胶基糖,实施例4的咀嚼型胶基糖是包含用聚(醋酸乙烯酯)、脂肪酸盐和填充剂包封的甜味料的咀嚼型胶基糖。
具体实施方式
本发明针对于用于延长或延迟来自口服组合物(oral composition)(如食料(foodstuff)、药物或个人护理产品)的甜味料的释放的递送系统。优选的食料包括咀嚼型胶基糖、糖食、硬熬煮糖和其他基于食糖的糖果、胶冻软糖、软糖、可食性膜、糖锭(lozenges)、压片、谷物棒等等。药物可以以咀嚼型胶基糖、药片、胶囊、溶液、酊剂(tincture)、润喉止咳糖浆(linctus)、糖浆等形式被递送。可选地,糖食和固体药物递送形式可以可选地是被包覆的。示例性的个人产品包括咀嚼型胶基糖、牙膏、口腔喷雾(mouth spray)和漱口水(moth wash)。
在一些实施方案中,口服组合物可以是冷冻或冷藏的/易腐坏的产品。这样的冷冻或冷藏的食料可以包括,但不限于,冷冻的甜品、冷冻的糖制食品、酸乳、布丁、冷冻的焙烤商品和搅打顶端配料(whipped topping)。
在一些实施方案中,口服组合物可以包括胶基糖基础剂和本文所描述的任何被包封的甜味料组合物。在一些实施方案中,一些或者所有的甜味料是处于被包封的形式的。作为进一步的可替换的选择,口服组合物可以包括一些被包封形式的甜味料和一些游离形式的甜味料。在一些实施方案中,咀嚼型胶基糖包括两种或更多种被包封的甜味料组合物。
如本文所使用的,术语“被包封的甜味料组合物”和其他类似的术语指代曾经被包封材料至少部分地包封的甜味料或增甜剂。包封材料由至少一种聚合物、一种脂肪酸盐和一种填充剂构成。被包封的甜味料组合物可以可选地进一步包括附加成分和活性物。术语“被包封的甜味料组合物”与术语“被包封的甜味料”同义。
如本文所使用的,术语“包封(encapsulate)”、“包封(encapsulates)”、“包封(encapsulation)”或其他类似的术语指代至少部分地围绕甜味料或增甜剂的覆层或聚合物基体。本文中,覆层或聚合物基体还可以被称为“包封材料”、“包封层”或“包封基体”。
如本文所使用的,术语“至少部分地”在被用于被包封的甜味料组合物的上下文中时意指包封材料部分或者完全地围绕或包封甜味料。
本发明针对的是制备被包封于聚(醋酸乙烯酯)、填充剂和脂肪酸盐中的甜味料的组合物和方法,以及含有所述被包封于聚(醋酸乙烯酯)、填充剂和脂肪酸盐中的甜味料的咀嚼型胶基糖组合物,所述咀嚼型胶基糖组合物可以为最终使用者提供延长或延迟的味觉体验。更具体地,咀嚼时,使用者能够在保持所述胶基糖的软的咀嚼质地的同时,体验调味物、甜味料和食品酸(food acid)的延长和/或延迟的释放。举例来说,当咀嚼型胶基糖被咀嚼时,为了延长甜味感觉,更大量的被包封的甜味料组合物必须被加入咀嚼型胶基糖中,这将更多的聚合物(例如聚(醋酸乙烯酯))加入咀嚼型胶基糖基础剂中。这反而会通过硬化咀嚼型胶基糖料团(bolus)使得后期咀嚼质地恶化。
此外,制备本发明的被包封的甜味料组合物和咀嚼型胶基糖的方法提供了一种将热可降解的甜味料包封于高分子量聚合物中的手段。这提供了具有改进的持久性质的被包封的甜味料组合物和咀嚼型胶基糖组合物,所述持久性质延迟了甜味料由聚合物基体的释放,这转而提供了这样的咀嚼型胶基糖,其中咀嚼期间给予使用者的甜味的感知被延长。通过允许所述甜味料暴露于较高的加工温度下而不降解所述甜味料从而改进了加工稳定性,本发明的方法还提供了将热可降解的甜味料包封于高分子量聚合物中的方法。
根据本发明,已经出乎意料地发现,将甜味料包封在聚(醋酸乙烯酯)、填充剂和脂肪酸盐中,通过允许甜味料在高分子量聚合物中的包封,可以延长或延迟所述甜味料的释放。为了更准确地控制甜风味被最终使用者体验的强度和时机而不使所述咀嚼型胶基糖的后期咀嚼质地恶化,聚(醋酸乙烯酯)、填充剂和脂肪酸盐包封的甜味料组合物可以进一步被加入咀嚼型胶基糖组合物中。对于实现在长的咀嚼时间下降低的胶基糖硬度和具有物理完整性的被包封的酸和改进的加工稳定性的期望的组合,使用约2至约20重量百分数的脂肪酸盐和约2至约20重量百分数的填充剂是重要的。当所述脂肪酸盐的量显著小于2重量百分数时,咀嚼时的咀嚼型胶基糖质地变硬,并且未观察到咀嚼型胶基糖料团的柔软度的改进。而当所述脂肪酸盐的量显著大于20重量百分数时,游离脂肪酸形成为液体并观察到这些液体脂肪酸/硬脂酸自被包封的聚合物基体的分离。当填充剂的量显著小于2重量百分数时,未观察到可加工性的改进。而当填充剂的量显著大于20重量百分数时,包封聚合物基体变弱导致受控释放效力的损失。
在一个实施方案中,存在被包封的甜味料组合物,所述甜味料组合物包含聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料。在另一个实施方案中,所述被包封的食品级活性成分被加入还包括胶基糖基础剂的咀嚼型胶基糖中。
一个实施方案是制备咀嚼型胶基糖组合物的方法,所述方法包括:熔融共混包封试剂和甜味料以形成被包封的甜味料组合物,所述包封试剂包括聚(醋酸乙烯酯)、约2至约20重量百分数的脂肪酸盐、约2至约20重量百分数的填充剂,其中所有重量百分数是基于被包封的甜味料组合物的总重量;以及熔融共混胶基糖基础剂和所述被包封的甜味料组合物以形成咀嚼型胶基糖组合物。
在一些实施方案中,聚(醋酸乙烯酯)具有至少75,000原子质量单位的重均分子量。在一些实施方案中,聚(乙醋酸乙烯酯)的重均分子量是约75,000至约500,000原子质量单位,更具体地,约80,000至约300,000原子质量单位。
聚(醋酸乙烯酯)可以以被包封的甜味料组合物的约35至约90重量百分数的量存在。在一些实施方案中,聚(醋酸乙烯酯)以被包封的甜味料组合物的约35至约80重量百分数,更具体地,约35至约75重量百分数,更具体地,约40至约60重量百分数的量存在。
如本文所使用的,术语“脂肪酸盐”意指包括适合用于食品级应用的任何C16-C36脂肪族羧酸的碱金属或碱土金属盐。举例来说,用于制备所述被包封的甜味料组合物的适当的脂肪酸盐包括C16-C36脂肪族羧酸的钠盐、C16-C36脂肪族羧酸的钾盐、C16-C36脂肪族羧酸的钙盐、C16-C36脂肪族羧酸的镁盐及其组合。在上述脂肪酸盐的上下文中,适当的C16-C36脂肪族羧酸包括饱和脂肪酸,举例来说,如棕榈酸、硬脂酸、花生酸、二十二酸(behenicacid)、二十四酸(lignoceric acid)以及蜡酸。同样是在上述脂肪酸盐的上下文中,C16-C36脂肪族羧酸还包括不饱和脂肪酸,举例来说,如棕榈油酸、sapienic acid、油酸、反油酸、异油酸(vaccenic acid)、亚油酸、亚麻酸、α-亚麻酸、花生四烯酸、二十碳五烯酸、芥酸以及二十二碳六烯酸。
在一些实施方案中,脂肪酸盐选自碱土金属硬脂酸盐、碱金属硬脂酸盐及其组合。在一些实施方案中,脂肪酸盐包括碱土金属硬脂酸盐。在再其他实施方案中,脂肪酸盐是C16-C36脂肪族羧酸的镁盐或C16-C36脂肪族羧酸的钙盐(例如硬脂酸镁、硬脂酸钙),或其组合。脂肪酸盐以基于所述被包封的甜味料组合物的总重量的约2至约20重量百分数的量存在。在一些实施方案中,脂肪酸盐的量是约5至约15重量百分数,具体地,约9至约12重量百分数。
相较于碱金属硬脂酸盐(举例来说,如硬脂酸钠和硬脂酸钾),碱土金属硬脂酸盐(举例来说,如硬脂酸钙和硬脂酸镁)具有优越的质地改进性质,因为碱土金属硬脂酸盐由于其较低的水溶性而被胶基糖料团保留更长的时间段。碱土金属硬脂酸盐,还降低了聚合物熔体的粘性而不更改所述聚合物的机械性质,所述机械性质允许在较低的挤出机筒温度下的高分子量聚合物的挤出。在较低的较低的温度下的高分子量聚合物的挤出允许包括热不稳定的组分,举例来说,如热可降解的甜味料。然而,聚合物基体的机械强度没有被改变,从而允许在高强度、高分子量聚合物基体中包括由于高的加工温度而不能预先加入的组分。
进一步地,碱土金属硬脂酸盐起到酸清除剂的作用,以防止甜味料的热分解和变暗,所述变暗表明甜味料的热分解。某些甜味料(举例来说,如双甜(TwinSweet)(阿斯巴甜和乙酰磺胺酸钾)和三氯蔗糖)含有或能够产生催化聚合物基体以及甜味料分解而导致甜味料变暗的酸性部分,所述变暗通过所述甜味料的黄变、褐变或炭化来表明。该反应以自催化的方式进行,并且因此一旦反应开始就非常难以停止。碱土金属硬脂酸盐通过中和这些酸性部分中断分解反应路径,从而防止引起甜味料的变色的酸分解副产物。
举例来说,用于制备被包封的甜味料组合物的合适的甜味料包括食糖甜味料、无食糖甜味料、高强度甜味料或其组合。合适的甜味料可以包括本文所列举的任何甜味料或增甜剂。在一个实施方案中,甜味料包括罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸或其组合。在另一个实施方案中,甜味料选自罗汉果、三氯蔗糖、莫那亭、阿斯巴甜-乙酰磺胺酸及其组合。被包封的甜味料组合物可以包括基于所述被包封的甜味料总重量的约5至约50重量百分数的量的甜味料。在一些实施方案中,甜味料的量是约10至约40重量百分数,具体地,约20至约40重量百分数。在一个实施方案中,被包封的甜味料组合物包括约20至约40重量百分数的量的三氯蔗糖。
在一些实施方案中,用于形成被包封的甜味料组合物的甜味料具有约1至约400微米的数均粒径。在一些实施方案,甜味料具有约1至约200微米,具体地,约10至约100微米,更具体地,约10至约75微米的数均粒径。
如本文所使用的,当被用于被包封的甜味料的上下文中,术语“填充剂”指代为了改进可加工性、改进聚合物基体的结构完整性且降低生产成本,而包括在聚合物基体/包封材料中的惰性粉末材料。
举例来说,用于制备被包封的甜味料组合物的合适的填充剂包括滑石、碳酸钙、磷酸二钙、硅石及其组合。合适的填充剂可以包括本文所列举的任何填充剂。在一些实施方案中,填充剂包括滑石。被包封的甜味料组合物可以包括基于所述被包封的甜味料组合物总重量的约2至约20重量百分数。在一些实施方案中,甜味料的量是约2至约15重量百分数,具体地,约2至约12重量百分数。
在一些实施方案中,被包封的甜味料组合物还包括一种或更多种附加的活性成分,所述附加的活性成分可以在将甜味料包封于递送系统中之前被加入所述甜味料。举例来说,这样的活性成分可以包括调味物、食品级酸、口腔护理试剂、抗氧化剂、营养剂、药物活性物及其组合。
在优选的实施方案中,被包封的甜味料组合物包括约2至约20重量百分数的量的脂肪酸盐和约2至约20重量百分数的量的填充剂。在另一个优选的实施方案中,被包封的甜味料组合物包括约2至约20重量百分数的量的脂肪酸盐、约5至约50重量百分数的量的甜味料、约2至约20重量百分数的量的填充剂和约35至约90重量百分数的量的聚(醋酸乙烯酯)。
在所述被包封的甜味料组合物的一个实施方案中,脂肪酸盐和甜味料以约1∶0.25至约1∶25的重量比存在。在一些实施方案中,脂肪酸盐和甜味料以约1∶0.66至约1∶8的重量比,更具体地,以约1∶1.6至约1∶4.4的重量比存在。在所述被包封的甜味料组合物的一个实施方案中,脂肪酸盐和聚(醋酸乙烯酯)以约1∶1.75至约1∶45的重量比存在。在一些实施方案中,脂肪酸盐和聚(醋酸乙烯酯)以约1∶2.3至约1∶16的重量比,更具体地,以约1∶3.3至约1∶6的重量比存在。在所述被包封的甜味料组合物的一个实施方案中,甜味料和聚(醋酸乙烯酯)以约1∶0.7至约1∶18的重量比存在。在一些实施方案中,甜味料和聚(醋酸乙烯酯)以约1∶0.875至约1∶8的重量比,更具体地,以约1∶1至约1∶3的重量比存在。
在一个优选的实施方案中,脂肪酸盐是硬脂酸镁、硬脂酸钙或其组合;甜味料是罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A(rebaudioside A)、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合;填充剂是滑石;甜味剂具有约1至约400微米的数均粒径;被包封的甜味料组合物包括重量比为约1∶0.25至约1∶25的脂肪酸盐和甜味料;被包封的甜味料组合物包括重量比为约1∶1.75至约1∶45的脂肪酸盐和聚(醋酸乙烯酯);被包封的甜味料组合物包括重量比为约1∶0.7至约1∶18的甜味料和聚(醋酸乙烯酯);被包封的甜味料组合物颗粒具有小于或等于420微米的数均粒径;其中咀嚼型胶基糖组合物包括约0.25至约11重量百分数的被包封的甜味料组合物;并且咀嚼型胶基糖还包括游离的(未被包封的)甜味料、游离的(未被包封的)食品级酸或其组合。
咀嚼型胶基糖
如本文中使用的,术语“胶基糖(gum)”、“咀嚼型胶基糖(chewing gum)”和“吹泡型胶基糖(bubble gum)”被可互换地使用,并且意图包括任何胶基糖组合物。至于咀嚼型胶基糖组合物,这样的组合物包含胶基糖基础剂、风味增强组合物和各种添加剂。
在一个实施方案中,被包封的甜味料组合物是被加入咀嚼型胶基糖中的。除被包封的甜味料组合物以外,咀嚼型胶基糖包括胶基糖基础剂和未被包封的甜味料。基于咀嚼型胶基糖组合物重量,被包封的甜味料组合物的量可以是约0.25至约11重量百分数,具体地,约1至约10重量百分数,更具体地,约2至约9重量百分数,更加具体地,约3至约7重量百分数。在一些实施方案中,被包封的甜味料组合物是以具有小于或等于约500微米的数均粒径的颗粒物(particulate)形式存在于咀嚼型胶基糖组合物中的。在一些实施方案中,被包封的甜味料组合物是以具有约5至约500微米,具体地,约10至约450微米,更具体地,约20至约420微米的数均粒径的颗粒物形式存在于咀嚼型胶基糖组合物中的。在一些实施方案中,被包封的甜味料组合物是以具有约420微米的数均粒径的颗粒物形式存在于咀嚼型胶基糖组合物中的。
咀嚼型胶基糖组合物通常包括胶基糖基础剂、增量甜味料、高强度甜味料、风味料、着色试剂、暖味剂、凉味剂、麻刺剂以及任意其他可选的添加剂,包括咽喉舒缓剂、香料、牙齿增白剂、口气清新剂、维生素、矿物质、咖啡因,药品(例如,药剂、草本剂和营养补充剂)、口腔护理产品及包括至少一种前述添加剂的组合物。
通常,咀嚼型胶基糖组合物包括水不溶性胶基糖基础剂部分和由附加成分(也称作添加剂)构成的增量部分。胶基糖基础剂可以取决于各种因素变化很大,所述各种因素例如期望的基础剂类型、期望的胶基糖稠度和其他用在所述组合物中以制成最终咀嚼型胶基糖产品的组分。在一些实施方案中,咀嚼型胶基糖基础剂以约5至约90重量百分数的量存在,其中所述重量百分数是基于咀嚼型胶基糖组合物的总重量。在约5至约90的范围内,水不溶性胶基糖基础剂可以以约10至约50重量百分数的量存在,具体地,胶基糖基础剂可以以约15至约40重量百分数的量存在,并且甚至更具体地,胶基糖基础剂可以以约20至约30重量百分数的量存在。
如本文使用的,术语“水溶性”包含在25摄氏度具有至少1克/升的水溶解度的化合物。如本文使用的,术语“水不溶性”包含在25摄氏度具有小于至少1克/升的水溶解度的化合物。
胶基糖基础剂可以是在本领域已知的任何水不溶的胶基糖基础剂,并且包括用于咀嚼型胶基糖和吹泡型胶基糖的那些胶基糖基础剂。胶基糖基础剂中适当的聚合物的例证性实施例包括天然和合成弹性体和橡胶两者。举例来说,天然弹性体和橡胶包括植物来源的物质,如熏制的(smoked)或液体乳胶和银菊胶,天然树胶如节路顿胶、夹竹桃科产胶树胶、香豆树胶、香豆果胶、二齿铁线子胶(massaranduba balata)、巧克力铁线子胶(massarandubachocolate)、红檀木胶、山榄胶、冠胶、糖胶树胶、杜仲胶、古塔卡太胶(gutta kataiu)、古塔胶、尼日尔杜仲胶、卡斯德拉胶、托帕匡斯麻风树胶(chilte)、芡茨棕树胶(chiquibul)、马来乳胶(gutta hang kang)等,及其混合物。
合成弹性体包括高分子量和低分子量弹性体。有用的高分子量弹性体包括丁二烯-苯乙烯共聚物、聚异戊二烯、聚异丁烯、异丁烯-异戊二烯共聚物、聚乙烯及其组合等等。有用的低分子量弹性体包括聚丁烯、聚丁二烯、聚异丁烯及其组合。适当的胶基糖基础剂还可以包括乙烯基聚合的弹性体(如聚(醋酸乙烯酯)(PVA)、聚乙烯)、乙烯基共聚弹性体(如醋酸乙烯酯和月桂酸乙烯酯的共聚物、醋酸乙烯酯和硬脂酸乙烯酯的共聚物、乙烯和醋酸乙烯酯的共聚物、聚(乙烯醇))及其组合。当被使用时,乙烯基聚合物的数均分子量可以在约3,000至约94,000范围内。乙烯基聚合物如聚(乙烯醇)和聚(醋酸乙烯酯)(当被用于胶基糖基础剂中时,由于区别于被包封的甜味料组合物)可以具有约8,000至约65,000的数均分子量。另外,上述高分子量和低分子量的天然和合成弹性体和橡胶的任意组合可以被用作胶基糖基础剂。基于胶基糖基础剂的重量,聚合物可以以约35至约95重量百分数的量存在。
所采用的胶基糖基础剂的量将取决于各种因素而变化很大,所述因素如所使用的基础剂的类型、期望的胶基糖的稠度和其他用在所述组合物中以制成咀嚼型胶基糖最终产品的组分。一股而言,胶基糖基础剂将以最终咀嚼型胶基糖组合物的约5至约94重量百分数的量存在。在一些实施方案中,所述胶基糖基础剂的量是基于所述咀嚼型胶基糖组合物的总重量的约15至约45重量百分数,具体地,约20至约43重量百分数,更具体地,约30至约40重量百分数。
所述水不溶的胶基糖基础剂部分还可以附加地含有弹性体增塑剂、蜡、软化剂、增量剂和其他可选的成分(如着色料和抗氧化剂)的任意组合。弹性体增塑剂通常还被称为树脂、树脂质化合物(resinous compound)、弹性体溶剂或松香。可以包括于胶基糖基础剂中的添加剂包括以有效量使用的增塑剂、蜡或软化剂以提供各种各样的期望的质地和一致的性质。由于这些成分的低分子量,质地改进剂(texture modifying agent)能够透入(penetrate)胶基糖基础剂的基础结构,使所述胶基糖基础剂成为可塑的且更不粘滞的。
胶基糖基础剂组合物可以包含常规的弹性体增塑剂,以帮助软化所述弹性体基础剂组分,举例来说,萜品烯树脂(例如α-蒎烯或β-蒎烯和/或d-柠檬烯衍生的聚合物),松香或改性松香的甲基、甘油或季戊四醇酯,以及例如氢化的、二聚的或多聚的松香的胶,或包括至少一种前述树脂的组合;部分氢化的木松香或脂松香的季戊四醇酯、木松香或脂松香的季戊四醇酯、木松香的甘油酯、部分二聚的木松香或脂松香的甘油酯、聚合的木松香或脂松香的甘油酯、妥尔油松香的甘油酯、木松香或脂松香的甘油酯;部分氢化的木松香或脂松香;木松香或松香的部分氢化的甲酯等。前述弹性体增塑剂的任意组合可以被用于软化或调整所述弹性体基础剂组分的粘着性。可以以所述胶基糖基础剂的约5至约75重量百分数,具体地,所述胶基糖基础剂的约45至约70重量百分数的量来使用所述弹性体增塑剂。在一些实施方案中,咀嚼型胶基糖组合物还包括胶基糖基础剂软化剂。在一些实施方案中,所述软化剂可以以直至所述胶基糖基础剂的约30重量百分数,具体地,以所述胶基糖基础剂的约3至约20重量百分数。在一些实施方案中,所述软化剂可以以直至所述胶基糖基础剂的约30重量百分数,具体地,以所述胶基糖基础剂的约0.1至约20重量百分数,更具体地,以所述胶基糖基础剂的约0.1至约4重量百分数,再更具体地,以所述胶基糖基础剂的约0.20至约2.5重量百分数,以及更加具体地,以所述胶基糖基础剂的约0.5至约1.7重量百分数的量存在。适当的软化剂包括羊毛脂、棕榈酸、油酸、硬脂酸、脂肪酸、硬脂酸钠、硬脂酸钾、三醋酸甘油酯、甘油卵磷脂(glyceryl lecithin)、单硬脂酸甘油酯、单硬脂酸丙二醇酯、单、二和三甘油酸酯、乙酰化单甘油酯、甘油、卵磷脂、甘油二乙酸酯及其组合物。其他的适当的软化剂包括蜡。蜡(举例来说,天然的和合成的蜡、氢化植物油、石油蜡(例如聚氨酯蜡)、聚乙烯蜡、石蜡、微晶蜡、脂肪蜡(fattywax)、山梨糖醇酐单硬脂酸酯、动物脂、可可脂、丙二醇等)被加入胶基糖基础剂中以获得各种期望的质地和一致的性质。所采用的蜡将具有在大约60摄氏度以下的熔点,并且优选地在大约45至大约55摄氏度的熔点。所述低熔点蜡可以是石蜡。基于所述胶基糖基础剂的总重量,蜡可以以约6至约10重量百分数,具体地,以约7至约9.5重量百分数的量存在于胶基糖基础剂中。除了低熔点蜡,具有更高熔点的蜡可以以基于胶基糖基础剂的重量的直至约5重量百分数的量被用在胶基糖基础剂中。这类高熔点蜡包括蜂蜡、植物蜡、米糠蜡(rice bran wax)、小烛树蜡、巴西棕榈蜡(carnuba wax)、聚乙烯蜡、微晶蜡、石油蜡等,及其混合物。
胶基糖基础剂可以包括有效量的增量剂,如可以充当填充剂和调质剂(textural agent)的矿物辅助剂(mineral adiuvant)。适当的矿物辅助剂包括碳酸钙、碳酸镁、氧化铝、氢氧化铝、硅酸铝、滑石、磷酸三钙、磷酸三钙等,所述矿物辅助剂可以充当填充剂和调质剂。除了被包封的甜味料组合物中的填充剂之外,这些填充剂或辅助剂可以以各种量被用于胶基糖基础剂中。具体地,当被使用时,填充剂的量将以基于胶基糖基础剂的重量的约15至约40重量百分比,具体地,约20至约30重量百分比的量存在。
除水不溶的胶基糖基础剂部分之外,典型的咀嚼型胶基糖组合物包括水可溶的增量部分和一种或更多种调味剂。在一些实施方案中,甜味料是存在于咀嚼型胶基糖组合物的水可溶的增量部分中的。水可溶的增量部分可以包括一种或更多种附加成分,所述附加成分选自由增甜剂、风味料或调味试剂、风味调节剂或增强剂、芳香试剂、凉味剂、暖味剂、着色试剂、口气清新剂、口腔湿润剂、保湿剂、食品级酸、缓冲剂、麻刺剂、泡腾试剂、口腔湿润剂、口腔护理试剂、咽喉护理试剂、药剂、抗氧化剂、防腐剂及其组合组成的组。这些附加成分中的一些可以适合于多于一种目的。举例来说,增甜剂(如蔗糖、山梨糖醇、其他糖醇及其组合)还可以起增量剂的作用。包括至少一种前述附加成分的组合是经常使用的。
在一些实施方案中,除所述被包封的甜味料组合物之外,所述胶基糖组合物包括一种或更多种未被包封的活性成分。附加的活性成分可以是未被包封的活性成分、被包封的活性成分或其混合物。本文所描述的任何活性成分可以被用作附加的活性成分。在一个实施方案中,未被包封的活性成分以基于咀嚼型胶基糖组合物总重量的约0.1至约50重量百分数的量存在。在一个实施方案中,未被包封的活性成分是基于咀嚼型胶基糖组合物的总重量的约0.1至约2.0重量百分数,具体地,咀嚼型胶基糖组合物的约0.25至约1.5重量百分数,更具体地,约0.5至约1.0重量百分数的量存在。在另一个实施方案中,未被包封的活性成分以基于咀嚼型胶基糖组合物的总重量的约9.0至约49.0重量百分数,具体地,咀嚼型胶基糖组合物的约9.0至约39.0重量百分数,更具体地,约10.0至约35.0重量百分数的量存在。
在一些实施方案中,所述咀嚼型胶基糖包括增甜剂,以向所述胶基糖组合物提供甜味。增甜剂可以包括食糖甜味料、无食糖甜味料、高强度甜味料或至少一种前述增甜剂的组合。
食糖甜味料一股包括糖化物。适当的食糖甜味料包括单糖化物、二糖化物和多糖化物,例如,蔗糖(食糖)、右旋糖、麦芽糖、葡聚糖、木糖、核糖、葡萄糖、甘露糖、半乳糖、果糖(左旋糖)、乳糖、转化糖、果寡糖糖浆(fructooligosaccharide syrups)、部分氢化的淀粉、玉米糖浆固形物(如高果糖玉米糖浆),及其混合物。
适当的无食糖增甜剂包括糖醇(或多元醇),例如山梨糖醇、木糖醇、甘露糖醇、半乳糖醇、麦芽糖醇、氢化异麦芽酮糖(异麦芽酮糖醇)、乳糖醇、赤藓糖醇、氢化淀粉水解物、甜菊及其混合物。适当的氢化淀粉水解物包括在授予Verwaerde等人的美国专利号4,279,931中公开的那些氢化淀粉水解物以及包括山梨糖醇、氢化二糖化物、氢化高级(higher)多聚糖化物或其混合物的各种氢化葡萄糖浆和/或粉末。氢化淀粉水解物主要通过玉米糖浆的受控催化氢化来制备。所得的氢化淀粉水解物是单体的、二聚的和多聚的糖化物的混合物。这些不同的糖化物的比例赋予不同的氢化淀粉水解物不同的性质。氢化淀粉水解物的混合物也是有用的,所述氢化淀粉水解物的混合物例如由法国Roquette Freres生产的、以的商品名出售的那些和由美国新泽西州Fair Lawn的Lonza,Inc.、以HYSTAR的商品名出售的那些。
如在本文中使用的,“高强度甜味料”意为具有在每一重量基础上至少为食糖(蔗糖)的甜度100倍的甜度的试剂,具体地在每一重量基础上至少为食糖的甜度500倍的甜度。在一个实施方案中,高强度甜味料在每一重量基础上至少为食糖的甜度1,000倍,更具体地在每一重量基础上至少为食糖的甜度5,000倍。高强度甜味料可以选自于广泛范围的材料,包括水溶性甜味料、水溶性人工甜味料、从天然存在的水溶性甜味料衍生的水溶性甜味料、基于二肽的甜味料以及基于蛋白质的甜味料。包括两种或更多种高强度甜味料的任意组合可以被使用。一种或更多种高强度甜味料还可以与一种或更多种上述的甜味料或增甜剂组合。高强度甜味料可以以各种独特的物理形式被使用(举例来说,本领域公知的那些物理形式)以提供甜味的初始突释(burst)和/或延长的甜味感。不限于此,这样的物理形式包括游离形式(比如,喷雾干燥形式或粉末形式)、珠状形式、被包封的形式,及前述形式的组合。
不限于特定的增甜剂,代表性的类别和例子包括:(1)水溶性的增甜剂,比如二氢查尔酮、莫内林(monellin)、甜菊苷、莱鲍迪苷(rebaudiocides)A、莱鲍迪苷B、莱鲍迪苷C、甘草甜素、二氢核黄素以及糖醇,比如山梨糖醇、甘露糖醇、麦芽糖醇、莫那亭以及L-氨基二羧酸氨基链烯酸酯酰胺,例如在授予Zanno等的美国专利号4,619,834中公开的那些,及其组合;(2)水溶性人工甜味料,比如糖精、可溶的糖精盐,即钠或钙的糖精盐、环磺酸盐、安赛蜜盐,比如3,4-二氢-6-甲基-1,2,3-噁噻嗪-4-酮-2,2-二氧化物的钠盐、铵盐或钙盐、3,4-二氢-6-甲基-1,2,3-噁噻嗪-4-酮-2,2-二氧化物的钾盐(乙酰磺胺酸钾,Acesulfame-K)、糖精的游离酸形式及其组合;(3)基于二肽的甜味料,举例来说,从L-天冬氨酸衍生的甜味料,比如L-天冬氨酰-L-苯丙氨酸甲酯(阿斯巴甜),以及授予Schlatter的美国专利No.3,492,131中描述的材料、L-α-天冬氨酰-N-(2,2,4,4-四甲基-3-硫化三亚甲基)-D-丙氨酰胺水合物(阿力甜)、L-天冬氨酰-L-苯基甘氨酸以及L-天冬氨酰-L-2,5-二氢苯基-甘氨酸的甲酯、L-α-天冬氨酰-L-苯基甘氨酸甲酯、L-α-天冬氨酰-L-2,5-二氢苯基-甘氨酸甲酯、L-天冬氨酰-2,5-二氢-L-苯丙氨酸、L-α-天冬氨酰-2,5-二氢苯丙氨酸甲酯;L-天冬氨酰-L-(1-环己烯)-丙氨酸、N-(N-(3,3-二甲基丁基)-L-α-天冬氨酰)-L-苯丙氨酸1-甲酯(纽甜)或其组合;(4)水溶性甜味料的衍生物,例如甜菊苷、莱鲍迪苷A、莱鲍迪苷B、莱鲍迪苷C、普通食糖(蔗糖)的氯化衍生物,例如氯化脱氧糖衍生物(如例如以已知的产品名称三氯蔗糖的氯化脱氧蔗糖或氯化脱氧半乳蔗糖的衍生物);氯化脱氧蔗糖和氯化脱氧半乳蔗糖的衍生物的实施例包括:1-氯-1′-脱氧蔗糖;4-氯-4-脱氧-α-D-吡喃半乳糖基-α-D-呋喃果糖苷,或4-氯-4-脱氧半乳蔗糖;4-氯-4-脱氧-α-D-吡喃半乳糖基-1-氯-1-脱氧-β-D-果糖-呋喃果糖苷,或4,1′-二氯-4,1′-二脱氧半乳蔗糖;1′,6′-二氯1′,6′-二脱氧蔗糖;1,6-二氯-1,6-二脱氧-β-D-呋喃糖基-4-氯-4-脱氧-α-D-半乳糖苷;4-氯-4-脱氧-α-D-吡喃半乳糖基-1,6-二氯-1,6-二脱氧-β-D-呋喃果糖苷,或4,1′,6′-三氯-4,1′,6′-三脱氧半乳蔗糖;4,6-二氯-4,6-二脱氧-α-D-吡喃半乳糖基-6-氯-6-脱氧-β-D-呋喃果糖苷,或4,6,1′,6′-四氯4,6,1′,6′-四脱氧半乳糖-蔗糖;4,6,1′,6′-四脱氧蔗糖,及其组合;(5)基于蛋白质的甜味料,例如非洲竹芋甜素(thaumaoccous denielli)、索马甜、塔林(talin);罗汉果(Lo han guo)及其组合;以及(6)基于氨基酸的甜味料。
在一些实施方案中,甜味料包括山梨糖醇、甘露糖醇、阿斯巴甜、乙酰磺胺酸钾盐及其组合。甜味料可以取决于甜味的期望水平而以适合的量存在。在一些实施方案中,甜味料以咀嚼型胶基糖组合物的约35至约80重量百分数的量存在。在约35至约80的范围内,所述量可以是约45至约75重量百分数,具体地,所述量可以是约50至约65重量百分数。
在另一个优选的实施方案中,咀嚼型胶基糖还可以包括未被包封的甜味料。合适的未被包封的甜味料包括本文所列举的任何甜味料。在一些实施方案中,未被包封的甜味料包括糖醇、多元醇及其混合物。在一些实施方案中,未被包封的甜味料包括山梨糖醇、甘露糖醇及其混合物。在一个实施方案中,未被包封的活性成分以基于咀嚼型胶基糖组合物的总重量的约5.0至约50重量百分数的量存在。在一个实施方案中,未被包封的甜味料以基于咀嚼型胶基糖组合物总重量的约9.0至约49.0重量百分数的量存在。在一个实施方案中,未被包封的甜味料以基于咀嚼型胶基糖组合物总重量的约9.0至约39.0重量百分数的量存在。在一些实施方案中,未被包封的甜味料以咀嚼型胶基糖组合物的约10.0至约35.0重量百分数的量存在。
在咀嚼型胶基糖产品中,甜味可以来自风味料或调味试剂,和/或来自风味调节剂或增强剂。风味调节剂可以赋予所述风味调节剂自身与另一组分的特征互补或抵消的特征。举例来说,风味物可以通过包括风味调节剂或增强剂,比如香草、香草醛、乙基麦芽酚、糠醛(furfural)、丙酸乙酯、内酯及其组合而被复合为具有附加的甜味特征。取决于所用的芳香的期望强度,风味调节剂可以以咀嚼型胶基糖组合物的约0.01至约30重量百分数的量被使用。优选地,风味调节剂的含量在咀嚼型胶基糖组合物的约0.2至约3重量百分数的范围内。
可以被使用的风味料(也被称为调味物、风味物或调味试剂)包括本领域已知的那些人造的和天然的风味物,例如合成的风味油、天然的调味芳香试剂和/或调味油、得自植物、叶、花、果等的树脂油和提取物,以及包括前述风味料的至少一种的组合。非限制性的代表性风味物包括油,如留兰香油、肉桂油、冬青油(水杨酸甲酯)、椒样薄荷油、丁香油、月桂油、茴香油、桉树油、百里香油、雪松叶油、肉豆蔻的油、多香果、鼠尾草的油、肉豆蔻、苦扁桃仁的油、桂皮油、以及包括柠檬、橙、酸橙、葡萄柚的柑橘油,香草,包括苹果、梨、桃、葡萄、草莓、覆盆子、黑莓、樱桃、李子、菠萝、杏、香蕉、甜瓜、热带果、芒果、山竹果、石榴、木瓜、甜心柠檬等的水果香精,及其组合。具体的风味料是薄荷,如椒样薄荷、留兰香、人工香草、肉桂衍生物,以及各种水果风味物。
人造、天然及合成的水果调味物的实例包括椰子、咖啡、巧克力、香草、柠檬、葡萄柚、橙、酸橙、yazu、酸橘、薄荷醇、甘草、焦糖、蜂蜜、花生、胡桃、腰果、榛子、扁桃仁、菠萝、草莓、树莓、黑莓、热带果、樱桃、肉桂、椒样薄荷、冬青、留兰香、桉树和薄荷、水果香精(如来自苹果、梨、桃、葡萄、蓝莓、草莓、树莓、樱桃、李子、菠萝、杏、香蕉、甜瓜、杏、梅(ume)、樱桃、黑莓、热带果、芒果、山竹果、石榴、木瓜等),及其组合。
其他类型的风味料包括各种醛类和酯类,如乙酸肉桂酯、肉桂醛、柠檬醛二乙缩醛、乙酸二氢香芹酯、甲酸丁子香酚酯、对-甲基茴香醚(p-methylamisol)、乙醛(苹果);苯甲醛(樱桃,扁桃仁);茴香醛(甘草,茴香);肉桂醛(肉桂);柠檬醛,即α-柠檬醛(柠檬,酸橙);橙花醛,即β-柠檬醛(柠檬,酸橙);癸醛(橙,柠檬);乙基香草醛(香草,奶油);向阳植物,即胡椒醛(香草,奶油);香草醛(香草,奶油);α-戊基肉桂醛(香辛的果味风味物);丁醛(黄油,干酪);戊醛(黄油,干酪);香茅醛(改性产物,多种类型);癸醛(柑橘属水果);C-8醛(柑橘属水果);C-9醛(柑橘属水果);C-12醛(柑橘属水果);2-乙基丁醛(浆果类水果);已烯醛,即反-2(浆果类水果);甲基苯甲醛(樱桃,扁桃仁);藜芦醛(香草);2,6-二甲基-5-庚烯醛,即甜瓜醛(甜瓜);2,6-二甲基辛醛(绿色果品);2-十二烯醛(柑橘属,橘子)及其组合。
其他能够操控其释放特性的潜在风味物包括牛奶风味物、黄油风味物、干酪风味物、奶油风味物、酸奶风味物、香草风味物、茶或咖啡风味物(如绿茶风味物、乌龙茶风味物)、可可风味物、巧克力风味物、薄荷风味物(如椒样薄荷风味物、留兰香风味物与日本薄荷风味物)、辛辣风味物(如阿魏风味物、印度藏茴香(aiowan)风味物、大茴香风味物、当归风味物、茴香风味物、多香果风味物、肉桂风味物、甘菊风味物、芥末风味物、小豆蔻风味物、香菜风味物、孜然风味物、丁香风味物、胡椒风味物、芫荽风味物、黄樟风味物、香薄荷风味物、花椒风味物、紫苏风味物、杜松子风味物、生姜风味物、八角风味物、辣根风味物、百里香风味物、龙蒿风味物、莳萝风味物、辣椒风味物、肉豆蔻风味物、罗勒风味物、牛至菜风味物、迷迭香风味物、月桂叶风味物和山葵风味物)、酒类风味物(例如果酒味物、威士忌风味物、白兰地风味物、朗姆酒风味物、杜松子酒风味物和利口酒风味物)、花卉和蔬菜风味物(如洋葱风味物、大蒜风味物、卷心菜风味物、胡萝卜风味物、芹菜风味物、蘑菇风味物和番茄风味物)。常用的调味物包括薄荷类,如以单独或混合物的形式采用的椒样薄荷、薄荷醇、留兰香、人工香草、肉桂衍生物和各种水果风味物。风味物还可以提供口气清新性质,尤其是薄荷风味物与凉味剂组合使用时。在一些实施方案中,所述组合物还可以包括果汁。
调味试剂可以以许多独特的物理形式被使用。这样的物理形式包括液体和/或干燥形式。在一些实施方案中,调味试剂可以是游离(未被包封的)形式,喷雾干燥形式、冻干形式、粉末状形式、珠状的形式、被包封的形式、片状、块状,及其混合物。当采用喷雾干燥形式时,可以使用适合的干燥手段(如喷雾干燥液体)。可替换地,调味试剂可以被吸收到水溶性材料(例如纤维素、淀粉、食糖、麦芽糖糊精、阿拉伯树胶等)上,或者可以被包封。在再其他的实施方案中,调味试剂可以被吸收到硅石、沸石等等上。调味物的粒径可以小于3毫米,小于2毫米或优选地小于1毫米,所述粒径按照颗粒的最长尺寸计算。天然调味试剂可以具有约3微米至约2毫米,具体地,约4微米至约1毫米的粒径。取决于所用的芳香的期望强度,可以以胶基糖组合物的约0.01至约30重量百分数的量使用风味料。优选地,风味料的含量在胶基糖组合物的约0.2至约3重量百分数的范围内。
风味增强剂是强化、补充、修饰或增进原始材料的口味或芳香感受而不引入所述风味增强剂自身的特征性口味或芳香感受的材料。在一些实施方案中,可以包括设计为强化、补充、修饰或增进风味、甜味、酸味、鲜味(umami)、淳厚味(kokumi)、咸味或其组合的感受的风味增强剂。取决于所用的芳香的期望强度,风味增强剂可以以胶基糖组合物的约0.01至约30重量百分数的量被使用。优选地,风味增强剂的含量在胶基糖组合物的约0.2至约3重量百分数的范围内。示例的风味调节剂或增强剂包括甘草酸单铵盐、甘草的甘草酸盐、枳实提取物、alapyridaine、alapyridaine(N-(1-羧乙基)-6-(羟甲基)吡啶鎓-3-醇)内盐、奇果蛋白、仙茅蛋白、strogin、马槟榔甜蛋白、匙羹藤酸、洋蓟酸、glupyridaine、吡啶鎓-甜菜碱化合物、纽甜、索马甜、新橙皮苷二氢查耳酮、塔格糖、海藻糖、麦芽醇、乙基麦芽醇、香草提取物、香荚兰油树脂、香草醛、甜菜提取物(醇提取物)、甘蔗叶香精(醇提取物)、响应G-蛋白耦合受体(T2Rs和T1Rs)的化合物及其组合。在一些实施方案中,风味调节剂或增强剂选自糖酸、氯化钠、氯化钾、酸式硫酸钠及其组合。在其他的实施方案中,风味调节剂或增强剂选自谷氨酸盐(比如谷氨酸单钠盐和谷氨酸单钾盐)、水解植物蛋白、水解动物蛋白、酵母提取物及其组合。更多例子包括腺苷一磷酸(AMP)、谷胱甘肽、以及核苷酸(比如肌苷单磷酸、肌苷酸二钠、黄苷单磷酸、鸟苷单磷酸)及其组合。赋予淳厚味的风味增强剂组合物的更多例子也被包括在授予Kuroda等人的美国专利号5,679,397中。
本文中使用的风味料、风味调节剂和风味增强剂的量可以是服从于如最终可食产品组合物的种类、单个的风味物、所采用的糖食基础以及期望的风味强度这样的因素的优选的问题。因此,为了在最终产品中得到期望的结果,调味剂的量可以变化,而这样的变化是在本领域技术人员能力之内,无需过量实验。
在一些实施方案中,咀嚼型胶基糖可以含有芳香试剂和/或调味试剂,所述芳香试剂和或调味试剂包括天然和合成调味物,例如天然植物组分、调味芳香品和/或油、精油、香精、提取物、粉末、食品级酸、油树脂、源自植物、叶、花、果实等等的提取物以及其组合。调味物可以是液体或粉末形式的。
在一些实施方案中,咀嚼型胶基糖含有芳香试剂,所述芳香试剂包括天然的和合成的调味物,例如天然植物组分、调味芳香品和/或油、精油、香精、提取物、粉末、食品级酸、油树脂、源自植物、叶、花、果实等等的提取物,及其组合。芳香试剂可以是液体或粉末形式的。在一些实施方案中,被包封的甜味料组合物还含有调味物,本文所描述的任何调味物都是适合使用的。根据所使用的芳香物和/或风味物的期望的强度,可以以胶基糖组合物的约0.01至约30重量百分比的量使用芳香试剂和/或风味物。优选地,芳香物和/或风味物的含量在胶基糖组合物的约0.2至约4重量百分数的范围内。
在一些实施方案中,咀嚼型胶基糖还可以向食用者递送多重、独特的风味以导致风味改变的胶基糖组合物。在一个实施方案中,咀嚼型胶基糖组合物包含如本文所描述的聚(醋酸乙烯酯)和脂肪酸盐包封的甜味料组合物,并且还包含至少第一风味组合物和第二风味组合物,其中当咀嚼型胶基糖组合物被咀嚼时,所述第一风味组合物从咀嚼型胶基糖开始释放,而包括被包封的甜味料组合物的所述第二风味组合物在第一风味组合物已经开始释放之后开始释放。在另一个实施方案中,咀嚼型胶基糖包括第三风味组合物,所述第三风味组合物在第二风味组合物之后开始释放。
在其他实施方案中,咀嚼型胶基糖组合物递送多重、独特的风味,举例来说,如甜味风味、酸味风味、水果风味、薄荷风味等等,包括本文所公开的任意调味物和/或可感觉物质。甜味风味物和酸味风味物可以以任何顺序次序或组合被释放。举例来说,在胶基糖组合物的一个实施方案中,第一风味组合物是甜味风味物,而第二风味物是酸味风味物。在另一个实施方案中,第一风味组合物是甜味风味物,第二风味组合物是酸味风味物,并且第三风味组合物是甜味风味物。
在一些实施方案中,第一风味组合物在咀嚼开始后释放持续约5分钟至约7分钟,而第二风味组合物在咀嚼开始后释放持续约8分钟至约10分钟。在其他实施方案中,第一风味组合物在咀嚼开始后释放持续约5分钟至约7分钟,第二风味组合物在咀嚼开始后释放持续约8分钟至约10分钟,而第三风味组合物在咀嚼开始后释放持续约10分钟至约30分钟。在额外的实施方案中,第一风味组合物在咀嚼开始后释放持续约6分钟至约7分钟,第二风味组合物在咀嚼开始后释放持续约7分钟至约12分钟,而第三风味组合物在咀嚼开始后释放持续约12分钟至约30分钟。
咀嚼型胶基糖还可以包括凉味剂和暖味剂。凉味剂(也被称为冷却剂(coolant))是在口腔中、鼻腔中或皮肤上提供清凉或清新效果的添加剂。如本文所使用的,基于薄荷基的冷却剂包括薄荷醇和薄荷醇衍生物。薄荷醇(也被称为2-(2-丙基)-5-甲基-1-环己醇)是以人造形式或以来自如椒样薄荷油的来源的天然形式可获得的。薄荷醇衍生物包括基于薄荷基酯和基于薄荷基甲酰胺的凉味化合物,如薄荷基甲酰胺、N-乙基-p-薄荷烷甲酰胺、单薄荷基琥珀酸酯、甲基琥珀酸单薄荷酯、戊二酸单薄荷酯、2-吡咯烷酮-5-羧酸薄荷酯、3-甲基马来酸单薄荷酯、醋酸薄荷酯、乳酸薄荷酯、水杨酸薄荷酯、2-异丙基-5-甲基环己醇(2-isopropanyl-5-methylcyclohexano1)、3-L-薄荷氧基丙烷-1,2-二醇、薄荷烷、薄荷酮、薄荷酮缩酮(menthone ketals)、薄荷酮甘油缩酮(menthone glycerol ketals)、薄荷基戊二酸酯、N-乙基-p-薄荷烷-3-羧酰胺(WS-3)及其组合。额外的基于薄荷基的冷却剂(具体地为薄荷基甲酰胺)在授予Bardsley等的美国专利号7,923,577中被描述。
举例来说,可以与基于薄荷基的冷却剂组合使用或在缺少基于薄荷基的冷却剂的情况下使用的其他凉味剂包括2-巯基-环-癸酮、具有2至6个碳原子的羟基羧酸、木糖醇、赤藓糖醇、α-二甲基琥珀酸、乳酸甲酯、无环甲酰胺类(如N-2,3-三甲基-2-异丙基丁酰胺)及其组合。额外的凉味剂包括在Kazimierski等的美国专利申请公开号US2011/0070171A1和US2011/0070329A1中描述的1-叔丁基环己烷甲酰胺(1-tert-butylcyclohexanecarboxamides)。
包括主要凉味化合物、次要凉味化合物和可摄取的非极性溶剂的凉味组合物在Furrer等的美国专利申请公开号US2011/0091531A1中被描述。凉味剂可以取决于期望的凉味强度水平而以适合的量存在。在一些实施方案中,凉味剂以咀嚼型胶基糖组合物的约0.01至约1.5重量百分数的量存在。在约0.01至约1.5重量百分数的范围内,所述凉味剂可以是约0.05至约1.25重量百分数,具体地,所述凉味剂可以是约0.1至1重量百分数。
暖味剂可以选自广泛种类的已知用来向使用者提供温热的感觉信号的化合物。这些化合物给予感受到的温暖的感觉(特别是在口腔中),并且常常增进风味物、甜味料和其他器官感觉组分的感受。包括在有用的暖味化合物中的为香兰醇正丁醚(TK-1000,由日本东京Takasago Perfumary Company Limited供应)、香兰醇正丙醚、香兰醇异丙醚、香兰醇异丁醚、香兰醇-n-氨基醚、香兰醇异戊醚、香兰醇正已醚、香兰醇甲醚、香兰醇乙醚、姜醇、姜烯酚、姜酮酚、姜油酮、辣椒碱、二氢辣椒碱、降二氢辣椒碱、高辣椒碱、高二氢辣椒碱、乙醇、异丙醇、异戊醇、苯甲醇、甘油及其组合。暖味剂可以取决于期望的暖味强度水平而以适合的量存在。在一些实施方案中,暖味剂以咀嚼型胶基糖组合物的约0.01至约1.5重量百分数的量存在。在约0.01至约1.5重量百分数的范围内,所述暖味剂可以是约0.05至约1.25重量百分数,具体地,所述暖味剂可以是约0.1至1重量百分数。
在一些实施方案中,可以提供麻刺感觉。麻刺剂包括金纽扣(iambu)和从例如金纽扣或山椒素的材料中提取的烷酰胺。麻刺剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,麻刺剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述麻刺剂可以是约0.05至约1.25重量百分数;具体地,所述麻刺剂可以是约0.1至1重量百分数。
另外,感觉可以由泡腾造成。这种泡腾是通过将碱性材料和酸性材料组合而造成的。在一些实施方案中,碱性材料可以包括碱金属碳酸盐、碱金属碳酸氢盐、碱土金属碳酸盐、碱土金属碳酸氢盐及其组合。在一些实施方案中,酸性材料可以包括醋酸、己二酸、抗坏血酸、丁酸、柠檬酸、甲酸、富马酸、葡糖酸、乳酸、磷酸、苹果酸、草酸、琥珀酸、酒石酸及其组合。泡腾剂可以取决于期望的强度水平以合适的量存在。在一些实施方案中,泡腾剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述泡腾剂可以是约0.05至约1.25重量百分数;具体地,泡腾剂可以是约0.1至1重量百分数。
可以以有效产生食品的期望的颜色的量使用着色试剂(着色剂、着色物)。适合的着色试剂包括颜料,所述颜料可以以咀嚼型胶基糖组合物的高至约6重量百分比的量被并入。举例来说,二氧化钛可以以咀嚼型胶基糖组合物重量的高至约2重量百分比,且具体地小于约1重量百分比的量被并入。适合的着色试剂也包括天然食品色素和适合用于食品、药物和化妆品应用的染料。
适合的色素包括胭脂树橙提取物(E160b)、胭脂树橙、降胭脂树素、虾青素(astaxanthin)、脱水甜菜(甜菜粉)、甜菜红/甜菜苷(E162)、群青蓝、斑蝥黄(E161g)、隐黄质(E161c)、玉红黄质(E161d)、紫黄质(violanxanthin,E161e)、紫杉紫素(E161f)、焦糖(E150(a-d))、β-阿朴-8′-胡萝卜醛(E160e)、β-胡萝卜素(E160a)、α-胡萝卜素、γ-胡萝卜素、β-阿朴-8-胡萝卜素醛乙酯(E160f)、毛莨黄素(E161a)、黄体素(E161b)、胭脂虫提取物(E120);胭脂红(E132)、酸性淡红/偶氮玉红(E122)、叶绿素铜钠(E141)、叶绿素(E140)、烤制的部分脱脂的熟棉籽粉、葡萄糖酸亚铁、乳酸亚铁、葡萄色提取物(grape color extract)、葡萄果皮提取物(葡萄花青素)、花青素(E163)、血色球菌藻粉、合成铁氧化物、铁氧化物和氢氧化物(E172)、果汁、蔬菜汁、干藻粉、万寿菊(阿兹特克万寿菊)粉和提取物、胡萝卜油、玉米胚乳油、红辣椒、红辣椒油树脂、法夫红酵母、核黄素(E101)、藏红花素、二氧化钛、姜黄(E100)、姜黄油树脂(turmericoleoresin)、苋菜红(E123)、辣椒红色素/辣椒玉红素(E160c)、番茄红素(E160d)、FD&C蓝1号、FD&C蓝2号、FD&C绿3号、FD&C红3号、FD&C红40号、FD&C黄5号和FD&C黄6号、酒石黄(E102)、喹啉黄(E104)、日落黄(E110)、丽春红(E124)、赤藓红(E127)、专利蓝V(E131)、二氧化钛(E171)、铝(E173)、银(E174)、金(E175)、颜料玉红/利索尔宝红BK(E180)、碳酸钙(E170)、炭黑(E153)、黑PN/亮黑BN(E151)、绿S/酸煌绿BS(E142)、FD&C铝色淀及其组合。
可以被用于咀嚼型胶基糖的示例的口气清新剂包括柠檬酸锌、醋酸锌、氟化锌、硫酸锌铵、溴化锌、碘化锌、氯化锌、硝酸锌、氟硅酸锌、葡萄糖酸锌、酒石酸锌、琥珀酸锌、甲酸锌、铬酸锌、苯酚磺酸锌、连二硫酸锌、硫酸锌、硝酸银、水杨酸锌、甘油磷酸锌、硝酸铜、叶绿素、叶绿素铜、叶绿酸、氢化棉籽油、二氧化氯、β-环糊精、沸石、硅基材料、碳基材料、例如漆酶的酶,或包括前述口气清新剂中的至少一种的混合物。口气清新剂可以包括精油以及各种醛和醇。作为口气清新剂使用的精油可以包括留兰香、椒样薄荷、冬青、黄樟、叶绿素、柠檬醛、香叶醇、小豆蔻、丁香、鼠尾草、香芹酚、桉树、小豆蔻、厚朴提取物、马郁兰、肉桂、柠檬、酸橙、葡萄柚、橙或其组合的油。可以比如肉桂醛和水杨醛的醛被使用。另外,例如薄荷醇、香芹酮、iso-garrigol以及茴香脑的化学物质可以起口气清新剂的作用。口气清新剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,口气清新剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述口气清新剂可以是约0.05至约1.25重量百分数;具体地,所述口气清新剂可以是约0.1至1重量百分数。
示例的口腔湿润剂包括唾液刺激剂,比如包括醋酸、己二酸、抗坏血酸、丁酸、柠檬酸、甲酸、富马酸、葡糖酸、乳酸、磷酸、苹果酸、草酸、琥珀酸以及酒石酸的酸和盐。口腔湿润剂可以包括与水化合并且可以附着在口腔表面以提供口腔湿润感觉的水状胶体材料。水状胶体材料可以包括天然存在的材料,例如植物分泌液、种籽胶和海藻提取物,或者水状胶体材料可以是化学改性的材料,比如纤维素、淀粉或天然树胶衍生物。此外,水状胶体材料可以包括果胶、阿拉伯树胶、阿拉伯胶、海藻酸盐、琼脂、角叉菜胶、瓜尔胶、黄原胶、洋槐豆胶、明胶、结冷胶(gellan gum)、半乳甘露聚糖、黄芪胶、刺梧桐树胶、可得然胶(curdlan)、魔芋胶、壳聚糖、木葡聚糖、β-葡聚糖、帚叉藻胶(furcellaran)、印度树胶(gum ghatti)、围涎树胶(tamarin)和细菌胶。口腔湿润剂可以包括改性的天然树胶比如海藻酸丙二醇酯、羧甲基洋槐豆胶、低甲氧基果胶或其组合。改性纤维素可以被包括,比如微晶纤维素、羧甲基纤维素(CMC)、甲基纤维素(MC)、羟丙基甲基纤维素(HPMC)、羟丙基纤维素(HPC)或其组合。口腔湿润剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,口腔湿润剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述口腔湿润剂可以是约0.05至约1.25重量百分数;具体地,所述口腔湿润剂可以是约0.1至1重量百分数。
相似地,可以包括能够提供生津(mouth hydration)感受的保湿剂。这样的保湿剂可以包括甘油、山梨糖醇、聚乙二醇、赤藓糖醇、木糖醇或其组合。另外,在一些实施方案中,脂肪能够提供口腔湿润的感受。这样的脂肪可以包括中链的甘油三酯、植物油、鱼油、矿物油或其组合。保湿剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,保湿剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述保湿剂可以是约0.05至约1.25重量百分数;具体地,所述保湿剂可以是约0.1至1重量百分数。
适合的食品级酸包括乙酸、柠檬酸、富马酸、盐酸、乳酸和硝酸以及柠檬酸钠、碳酸氢钠、碳酸钠、磷酸钠或磷酸钾、氧化镁、偏磷酸钾、醋酸钠及其组合。酸化剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,酸化剂以咀嚼型胶基糖组合物的约0.1至约3重量百分数的量存在。在约0.1至约3重量百分数的范围内,所述酸化剂可以是约0.5至约2.5重量百分数;具体地,所述保湿剂可以是约0.75至2重量百分数。
在优选的实施方案中,咀嚼型胶基糖还可以包括未被包封的食品级酸。举例来说,合适的未被包封的食品级酸包括脂肪酸、抗坏血酸、天冬氨酸、苯甲酸、柠檬酸、富马酸、谷氨酸、马来酸、苹果酸、草酸、磷酸、山梨酸、琥珀酸、酒石酸及其混合物。在一些实施方案中,未被包封的酸包括柠檬酸、苹果酸及其混合物。在一个实施方案中,未被包封的食品级酸是以基于咀嚼型胶基糖组合物总重量的约0.1至约2.0重量百分数的量存在的。在一个实施方案中,未被包封的食品级酸是以基于咀嚼型胶基糖组合物总重量的约0.1至约2.0重量百分数的量存在的。在一些实施方案中,未被包封的食品级酸是以咀嚼型胶基糖组合物的约0.25至约1.5重量百分数,更具体地,约0.5至约1.0重量百分数的量存在的。
示例的缓冲剂包括碳酸氢钠、磷酸钠、氢氧化钠、氢氧化铵、氢氧化钾、锡酸钠、三乙醇胺、柠檬酸、盐酸、柠檬酸钠及其组合。缓冲剂可以取决于期望的强度水平而以适合的量存在。在一些实施方案中,缓冲剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述缓冲剂可以是约0.05至约1.25重量百分数;具体地,所述缓冲剂可以是约0.1至1重量百分数。
适合的口腔护理剂包括口气清新剂、牙齿增白剂、抗微生物剂、牙齿矿化剂、龋齿抑制剂、局部麻醉剂、粘液保护剂、渍斑脱除剂、口腔清洁剂、漂白剂、脱敏剂、牙科再矿化剂、抗菌剂、抗龋剂、渍斑酸缓冲剂、表面活性剂、抗牙石剂及其组合。这样的成分的实施例包括水解剂(包括蛋白水解酶)、摩擦剂(如水合硅石、碳酸钙、碳酸氢钠和氧化铝)、其他活性的除渍组分例如表面活性试剂,包括阴离子表面活性剂,如硬脂酸钠、棕榈酸钠、硫酸化油酸丁酯、油酸钠、富马酸的盐、甘油、羟基化卵磷脂、月桂基硫酸钠,以及螯合剂,如聚磷酸盐,其典型地作为牙垢控制成分。牙科护理成分还可以包括焦磷酸四钠、碳酸氢钠、酸式焦磷酸钠、三聚磷酸钠、木糖醇、六偏磷酸钠,及其组合物。
此外,适当的口腔护理剂包括过氧化物,例如过氧化脲、过氧化钙、过氧化镁、过氧化钠、过氧化氢和过氧二磷酸。在一些实施方案中,包括硝酸钾和柠檬酸钾。其他的实施例可以包括酪蛋白糖巨肽、钙酪蛋白胨-磷酸钙、酪蛋白磷酸肽、酪蛋白磷酸肽-无定形磷酸钙(CPP-ACP)和无定形磷酸钙。再另外的实施例可以包括木瓜蛋白酶、磷虾酶(krillase)、胃蛋白酶、胰蛋白酶、溶菌酶、葡聚糖酶、变构酶、糖化酶、淀粉酶、葡萄糖氧化酶,及其组合。
适当的口腔护理剂包括达到增加的预防疾病作用并使口腔护理成分在化妆品上更可接受的表面活性剂。用作口腔护理剂的表面活性剂包括赋予组合物清洁及起泡性质的清洁材料。适当的表面活性剂包括硬脂酸钠、蓖麻油酸钠、月桂基硫酸钠、较高级脂肪酸单甘油酯基单硫酸酯的水溶性盐(例如单硫酸化氢化椰子油脂肪酸的单甘油酯的钠盐),较高级烷基硫酸盐例如月桂基硫酸钠,烷基芳基磺酸盐例如十二烷基苯磺酸钠,磺基乙酸较高级烷基酯、月桂基磺基乙酸钠、1,2-二羟基丙烷磺酸盐的较高级脂肪酸酯和充分饱和的较低级脂肪族氨基羧酸的较高级脂肪酰胺化合物,例如那些在脂肪酸、烷基或酰基等中具有12到16个碳原子的化合物。最后提到的酰胺的实施例是N-月桂酰肌氨酸,以及N-月桂酰、N-肉豆蔻酰,或N-棕榈酰肌氨酸的钠、钾和乙醇胺盐。
除了表面活性剂,口腔护理成分可包括抗菌试剂,例如,三氯生、氯己定、柠檬酸锌、硝酸银、铜、柠檬烯和西吡氯铵及其组合。
抗龋剂包括氟化物离子,例如氟化钠、氟化钾、氟硅酸钠、氟硅酸铵、氟化钾、单氟磷酸钠、氟化亚锡、氟化亚锡钾、六氟锡酸钠、氯氟化亚锡及其组合。
口腔护理剂的进一步的实施例被包括在授予Reynolds的美国专利号5,227,154,授予Greenberg的美国专利号5,378,131和授予Holme等的美国专利号6,685,916中。口腔护理剂可以取决于期望的护理水平而以适合的量存在。在一些实施方案中,口腔护理剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述口腔护理剂可以是约0.05至约1.25重量百分数;具体地,所述口腔护理剂可以是约0.1至1重量百分数。
咽喉护理或咽喉舒缓成分包括镇痛剂、抗组胺剂、麻醉剂、缓和剂、粘液溶解剂、祛痰剂、止咳药、防腐剂及其组合。在一些实施方案中,咽喉舒缓剂比如蜂蜜、蜂胶、芦荟、甘油、薄荷醇或其组合被采用。咽喉护理剂可以取决于期望的护理水平而以适合的量存在。在一些实施方案中,咽喉护理剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述咽喉护理剂可以是约0.05至约1.25重量百分数;具体地,所述咽喉护理剂可以是约0.1至1重量百分数。
药物可以被包括在咀嚼型胶基糖产品中。非限制性说明性类别和具体实例包括抗组胺剂、解充血剂(拟交感神经药)、止咳剂(咳嗽抑制剂)、祛痰剂、麻醉剂、镇痛剂、缓和剂、抗菌剂、抗病毒剂、消炎剂、抗酸剂、抗真菌剂、化疗药物、利尿剂、精神药剂、顺势治疗剂、抗胆碱剂、咽喉舒缓剂、抗呕吐剂、心血管药剂、各种生物碱、轻泻剂、食欲抑制剂、ACE-抑制剂、抗哮喘剂、抗高胆固醇血症剂(anti-cholesterolemics)、抗抑郁剂、抗腹泻制剂、抗高血压药、抗脂质剂、痤疮药、氨基酸制剂、抗高尿酸血症药(anti-uricemic drug)、合成代谢制剂、食欲刺激剂、骨代谢调节剂、避孕药、子宫内膜异位控制剂(endometriosis management agent)、酶、勃起障碍治疗剂(如柠檬酸西地那非)、致育剂、肠胃药剂、顺势治疗药、激素、运动病治疗剂、肌肉松弛剂、骨质疏松制剂、催产素、副交感神经阻断剂、拟副交感神经剂、前列腺素、呼吸药剂、镇静剂、戒烟辅助剂(如溴隐定或尼古丁)、震颤药剂、尿路药剂、抗溃疡剂、止吐剂、高和低血糖症药剂、甲状腺和抗甲状腺制剂、子宫弛缓剂(terine relaxant)、红血球生成药、黏液溶解剂、DNA和基因修正药、以及包括营养素、微量营养素、维生素和辅酶的营养补充剂。除非特别另外说明,药物的药学上可接受的盐和前体药物也被包括。这些药物的一些可以起到多于一种的用途。可以使用上述种类的可选的药物的组合。对抗相同的或不同的症状具有活性的两种或更多种药物可以被组合在一起使用。
用于对咳嗽、或感冒或流感症状的治疗的药物包括单独或组合的元素、化合物或材料,其已被用于,或已被示出为对于与咳嗽、或感冒或流感通常相关联的至少一种症状的改善有用。应当被理解的是,“用于对咳嗽、或感冒或流感症状的治疗的药物”包括对由其他来源产生的类似感冒或类似流感的症状(例如过敏、不利的环境条件等等)的治疗也有用的药物。本文中使用的感冒、类似感冒、流感和类似流感的症状包括咳嗽、鼻炎、鼻塞、上呼吸道感染、过敏性鼻炎、耳炎、鼻窦炎、打喷嚏以及不适、疼痛、发烧和与感冒、流感、过敏、不利环境条件等等相关联的全身不适。
用于咳嗽、或感冒或流感症状的治疗的药物的一股类别的实施例包括抗组胺剂、解充血剂(拟交感神经药)、止咳剂(咳嗽抑制剂)、消炎剂、顺势治疗剂、祛痰剂、麻醉剂、缓和剂、镇痛剂、抗胆碱剂、咽喉舒缓剂、抗菌剂以及抗病毒剂。这些药物的一些可以起到多于一种的用途。除非特别另外说明,所述药物的药学上可接受的盐和前体药物也被包括。对抗感冒或咳嗽的相同的或不同的症状具有活性的两种或更多种药物可以被组合在一起使用。
示例性的抗组胺剂包括阿扎他定、溴苯海拉明、溴苯那敏、马来酸溴苯那敏、卡比沙明、马来酸卡比沙明、西米替丁、氯苯那敏、马来酸氯苯那敏、右氯苯那敏、苯海拉明、盐酸苯海拉明、多西拉敏、苯茚胺、非尼拉敏、苯托沙敏、美吡拉敏、异丙嗪、曲普利啶、氯雷他定、雷尼替丁、氯环嗪、特非那定、富马酸氯马斯汀、茶苯海明、马来酸吡拉明(prilamine maleate)、盐酸曲吡那敏、柠檬酸曲吡那敏、双羟萘酸羟嗪、盐酸羟嗪、乳酸苯甲嗪、盐酸苯甲嗪、盐酸氯苯甲嗪、阿伐斯汀、盐酸西替利嗪、阿司咪唑、盐酸左卡巴斯汀、西替利嗪(cetirzine)及其组合。
示例性的解充血剂包括如萘磺酸左丙氧芬、那可丁、咳必清、咳美芬、氯苯达诺、盐酸伪麻黄碱、去氧肾上腺素、苯丙醇胺、苯海拉明、海罂粟碱、福尔可定、苯佐那酯、麻黄素、肾上腺素(ephinephrine)、左旋脱氧麻黄碱(1evodesoxyephedrine)、羟甲唑啉、萘甲唑啉、六氢脱氧麻黄硷(propylhexedrine)、赛洛唑啉及其组合的试剂。
止咳剂帮助缓解咳嗽。止咳剂的实例包括可待因、双氢可待因、氢可酮以及氢吗啡酮、咳必清、咳美芬、重酒石酸氢可酮、chlorphedianol、诺斯卡品(noscarpine)、右美沙芬及其组合。
祛痰剂包括愈创甘油醚、八角、血根草、款冬、接骨木花、金印、胶草属草、牛膝草、兜藓、毛蕊花、远志草、金钟柏、百里香、马鞭草、愈创木酚甘油醚、水合萜二醇、N-乙酰半胱氨酸、溴己新、氨溴索、多米奥醇、3-碘-1,2-丙二醇以及野樱桃、氯化铵、碘化钙、碘化甘油、愈创木酚磺酸钾、碘化钾、柠檬酸钠及其组合。
麻醉剂包括依托咪酯、氯胺酮、异丙酚以及苯二氮类(benodiazapines)(例如,利眠宁、安定、clorezepate、哈拉西泮、氟西泮、夸西泮、艾司唑仑、三唑仑、阿普唑仑(alprozolm)、咪达唑仑、羟基安定、奥沙西泮、劳拉西泮)、苯佐卡因、达克罗宁、布比卡因、依替卡因、利多卡因、甲哌卡因、promoxine、丙胺卡因、普鲁卡因、丙美卡因(proparcaine)、罗哌卡因、丁卡因及其组合。其它有用的试剂可以包括异戊巴比妥(amobartital)、阿普比妥、仲丁巴比妥、布他比妥甲苯比妥、美索比妥、戊巴比妥、苯巴比妥、司可巴比妥、硫喷妥、聚乙醛(paral)、水合氯醛、乙氯维诺、clutethimide、methprylon、炔乙蚁胺、甲丙氨酯及其组合。
镇痛剂包括阿片类药物,如吗啡、mepidine、芬太尼(dentanyl)、舒芬太尼(sufentranil)、阿芬太尼、阿司匹林、水杨酰胺、水杨酸钠、对乙酰氨基酚、布洛芬、吲哚美辛、萘普生、atrin、isocome、midrin、axotal、firinal、对乙酰氨基酚和布他比妥制剂(phrenilin)、麦角和麦角衍生物(酒石酸麦角胺和卡啡因合剂(wigraine)、加非葛、ergostat、酒石酸麦角胺(ergomar)、双氢麦角胺)、舒马曲坦及其组合。
抗胆碱剂包括后马托品、阿托品、莨菪碱溴化氢、L-莨菪碱、L-莨菪生物碱、颠茄生物碱的酊剂、后马托品溴化氢、后马托品溴甲烷、甲基东莨菪碱、辛托品、辛托品与苯巴比妥、clindinium、胃长宁、hexocyclim、异丙胺、肠宝(mepenzolate)、乙胺太林、羟苄利明、普鲁本辛、曲地铵、双环胺、东莨菪碱、阿托品、双环胺、黄酮哌酯、异丙托铵、奥昔布宁、哌仑西平、噻托溴铵、托特罗定、托吡卡胺、咪噻吩、阿曲库铵、多撒库铵、米库氯铵、泮库溴铵、筒箭毒碱、维库溴铵、氯化琥珀胆碱及其组合。
缓和剂包括款冬、聚合草、玉米须、偃麦草、亚麻籽、爱尔兰藓、兜藓、甘草、锦葵、药属葵、毛蕊花、燕麦片、斗篷草、滑榆(slippery elm)及其组合。
抗菌剂包括在氨基糖苷类、头孢菌素类、大环内酯类、青霉素类、喹诺酮类、磺胺类以及四环素类的抗生素类别内的那些试剂。具体的示例性抗生素试剂包括萘夫西林(naficillin)、苯唑西林、万古霉素、克林霉素、红霉素、甲氧苄啶-磺胺甲恶唑、利福平、环丙沙星、广谱青霉素、阿莫西林、庆大霉素、ceftriazoxone、头孢噻肟、氯霉素、克拉维酸(clavunate)、舒巴坦、丙磺舒、强力霉素、壮观霉素、头孢克肟、青霉素G、米诺环素、β-内酰胺酶抑制剂;美洛西林(meziocillin)、哌拉西林、氨曲南、诺氟沙星、甲氧苄啶、头孢他啶、氨苯砜、新霉素、阿奇霉素、克拉霉素、阿莫西林、环丙沙星以及万古霉素。
抗病毒剂特定地或一股地调整病毒的生物活性,所述病毒例如小核糖核酸病毒、流感病毒、疱疹病毒、单纯疱疹、带状疱疹、肠道病毒、水痘病毒和鼻病毒,这些病毒与普通感冒相关联。示例性的抗病毒剂包括阿昔洛韦、三氟尿苷、碘苷(idoxorudine)、膦甲酸、更昔洛韦、齐多夫定、双脱氧胞苷、双脱氧肌苷、双嘧达莫、司他夫定、西多福韦、泛昔洛韦、伐昔洛韦、缬更昔洛韦、阿昔洛韦、地达诺新、扎西他滨、rifimantadine、沙奎那韦、茚地那韦、利托那韦、三氮唑核苷、奈非那韦、阿德福韦、奈韦拉平、地拉韦啶、依法韦仑、阿巴卡韦、金刚烷胺、恩曲他滨、恩替卡韦、替诺福韦、扎那米韦、奥司他韦、ICI130,685、impulsin、普可那利、喷昔洛韦、阿糖腺苷、细胞因子及其组合。
消炎剂包括水杨酸衍生物(包括阿司匹林)、对氨基苯酚衍生物(包括对乙酰氨基酚、吲哚)以及茚乙酸类(包括吲哚美辛、舒林酸和依托度酸(etodalac))、异芳基乙酸类(包括托美丁双氯芬酸和酮咯酸)、芳基丙酸衍生物(包括布洛芬、萘普生、酮洛芬、非诺洛芬(fenopren)、酮咯酸(ketorlac)、卡洛芬、恶丙嗪)、邻氨基苯甲酸类(包括甲芬那酸、甲氯芬那酸)、以及烯醇酸类(包括吡罗昔康、替诺昔康、苯基丁氮酮和oxyphenthatrazone)。
抗酸剂包括西米替丁、雷尼替丁、尼扎替丁、法莫替丁、奥美拉唑、铋抗酸剂、甲硝唑抗酸剂、四环素抗酸剂、克拉霉素抗酸剂、铝、镁的氢氧化物、碳酸氢钠、碳酸氢钙以及其它碳酸盐、硅酸盐、磷酸盐及其组合。
举例来说,抗真菌剂包括酮康唑、氟康唑、制霉菌素、伊曲康唑、克霉唑(clomitrazole)、纳他霉素、益康唑、异康唑、奥昔康唑、噻苯咪唑、噻康唑(tiaconazole)、伏立康唑、特比萘芬、阿莫罗芬、micfungin、两性霉素B及其组合。
化疗试剂包括顺铂(CDDP)、甲基苄肼、氮芥、环磷酰胺、喜树碱、异环磷酰胺、美法仑、苯丁酸氮芥、白消安(bisulfan)、亚硝基脲(nitrosurea)、更生霉素、道诺霉素、阿霉素、博来霉素、普卡霉素(plicomycin)、丝裂霉素、依托泊苷(VPl6)、它莫昔芬、紫杉酚、反铂(transplatinum)、5-氟尿嘧啶、新长春碱、长春碱和甲氨蝶呤及其类似物或衍生物变体,及其组合。
利尿剂包括但不限于乙酰唑胺、双氯非那胺、醋甲唑胺、呋塞米、布美他尼、ethacrynicacid torseimde、阿佐塞米、莫唑胺、吡咯他尼、曲帕胺、苄氟噻嗪、苄噻嗪、氯噻嗪、氢氯噻嗪、氢氟甲噻、甲氯噻嗪、泊利噻嗪、三氯噻嗪、吲达帕胺、美托拉宗、喹乙宗、阿米洛利、氨苯蝶啶、安体舒通(sprionolactone)、坎利酮、坎利酸钾及其组合。
精神药剂包括氯丙嗪、美索达嗪、硫醚嗪、millazine、廷德尔、盐酸氟奋乃静、氟奋乃静、奋乃静、三氟拉嗪、三氟拉嗪片剂(suprazine)、泰尔登、纳文、氯氮平、氟哌啶醇、halperon、克赛平(loxitane)、盐酸吗啉吲酮、哌迷清、维思通、阿普唑仑、利眠宁(chlordiaepoxide)、氯硝西泮(clonezepam)、clorezepate、安定、哈拉西泮、劳拉西泮、奥沙西泮、普拉西泮、丁螺环酮、盐酸阿密替林(elvavil)、氯米帕明、多虑平、多塞平、盐酸丙咪嗪、曲米帕明、阿莫沙平、地昔帕明、地昔帕明胶囊(pertofrane)、马普替林、去甲替林、普罗替林、百忧解、氟伏沙明、帕罗西汀、左洛复、文拉法辛、安非他酮缓释片剂(welibutrin)、奈法唑酮、曲唑酮、苯乙肼、反苯环丙胺、咪多吡及其组合。
食欲抑制剂包括苄非他明、安非拉酮、马吲哚、苯甲曲秦、芬特明、蝴蝶亚、麻黄和咖啡因。额外的食欲抑制剂在商业上是以下面的商品名:芬特明盐酸盐(Adipex)、酒石酸苯甲曲秦缓释胶囊剂(Adipost)、苯甲曲秦三层片剂(Bontril PDM)、苯甲曲秦缓释剂(Bontril Slow Release)、盐酸苄非他明(Didrex)、盐酸芬特明(Fastin)、芬特明(Ionamin)、马扎诺(Mazanor)、Melfiat、盐酸芬特明胶囊剂(Obenix)、Phendiet、Phendiet-105、Phentercot、Phentride、Plegine、Prelu-2、Pro-Fast、PT105、马吲哚片剂(Sanorex)、盐酸安非拉酮片剂(Tenuate)、马吲哚片剂(Sanorex)、盐酸安非拉酮片剂(Tenuate)、Tenuate Dospan、盐酸安非拉酮制剂(Tepanil Ten-Tab)、Teramine、盐酸芬特明缓释胶囊剂(Zantryl)及其组合。
营养素和微量营养素包括草本剂和植物剂,例如芦荟、覆盆子、血根草、金盏花、甜椒、洋甘菊、猫爪草、紫锥花、大蒜、姜、银杏、白毛莨、各种人参、绿茶、金印、瓜拉那、卡瓦根、叶黄素、荨麻、西番莲、迷迭香、锯棕榈、圣约翰草、百里香、缬草及其组合。还包括的是矿物补充剂,例如钙、铜、碘、铁、镁、锰、钼、磷、锌、硒及其组合。可以添加的其他营养素包括果寡糖、葡萄糖胺、葡萄籽提取物、可乐果提取物、瓜拉那、麻黄、菊粉、植物甾醇、植物化学物质、儿茶素、表儿茶素、表儿茶素没食子酸酯、表没食子儿茶素、表没食子儿茶素没食子酸酯、异黄酮、卵磷脂、番茄红素、低聚果糖、多酚类、黄酮类、黄烷醇、黄酮醇和车前草,以及减肥试剂,例如吡啶甲酸铬和苯丙醇胺。维生素和辅酶包括水溶性或脂溶性维生素,例如硫胺素、核黄素、烟酸、吡哆醇、泛酸、生物素、叶酸、黄素、胆碱、肌醇以及对氨基苯甲酸、肉毒碱、维生素C、维生素D及其类似物、维生素A以及类胡萝卜素、视黄酸、维生素E、维生素K、维生素B6、维生素B12及其组合。可以使用包括前述营养素的至少一种的组合。
可以使用的具体的可选的、附加的药物包括咖啡因、西米替丁,雷尼替丁,法莫替丁,奥美拉唑,达克罗宁,尼古丁及其组合。
药物可以取决于用于期望目的的适合的剂量水平而以适合的量存在。在一些实施方案中,药物以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述药物可以是约0.05至约1.25重量百分数;具体地,所述药物可以是约0.1至1重量百分数。
抗氧化剂包括天然的和人工的抗氧化剂(如β-胡萝卜素)、酸化剂(例如维生素C、没食子酸丙酯、丁基羟基茴香醚、二丁基羟基甲苯、维生素E、鼠尾草酸、迷迭香酚、迷迭香二酚)等等。抗氧化剂可以取决于期望的目的而以适合的量存在。在一些实施方案中,抗氧化剂以咀嚼型胶基糖组合物的约0.01至约2重量百分数的量存在。在约0.01至约2重量百分数的范围内,所述抗氧化剂可以是约0.05至约1.25重量百分数;具体地,所述抗氧化剂可以是约0.1至1重量百分数。
防腐剂包括改进咀嚼型胶基糖产品的货架期的任何天然的和合成的防腐剂。适合的防腐剂包括丙酸、苯甲酸和山梨酸。
适合使用的附加增量剂(载体、延展剂)包括甜味剂,例如单糖化物、二糖化物、多糖化物、糖醇、葡聚糖、麦芽糊精及其组合;以及矿物质,例如碳酸钙,滑石、二氧化钛、磷酸二钙、硅石及其组合。可以以直至咀嚼型胶基糖组合物的约90重量百分数,具体地,以咀嚼型胶基糖组合物的约40至约70重量百分数,更具体地,以咀嚼型胶基糖组合物的约50至约65重量百分数的量使用增量剂。
适合的乳化剂包括蒸馏单甘酯、单甘酯和双甘酯的醋酸酯、单甘酯和双甘酯的柠檬酸酯、单甘酯和双甘酯的乳酸酯、脂肪酸的单甘酯和双甘酯及聚甘油酯、鲸蜡硬脂醇-20、聚甘油蓖麻醇酯、脂肪酸的丙二醇酯、月桂酸聚甘油酯、椰油酸甘油酯、阿拉伯树胶、阿拉伯胶、脱水山梨糖醇单硬脂酸酯、脱水山梨糖醇三硬脂酸酯、脱水山梨糖醇单月桂酸酯、脱水山梨糖醇单油酸酯、硬脂酰乳酸钠、硬脂酰乳酸钙、单甘酯和双甘酯的二乙酰酒石酸酯、辛癸酸甘油酯/中链三甘油酯、二油酸甘油酯、油酸甘油酯、脂肪酸的甘油乳酯、棕榈酸甘油乳酯、硬脂酸甘油酯、月桂酸甘油酯、二月桂酸甘油酯、单蓖麻油酸甘油酯、单硬脂酸三甘油酯、二硬脂酸六甘油酯、单硬脂酸十甘油酯、二棕榈酸十甘油酯、单油酸十甘油酯、六油酸聚甘油10酯、中链三甘油酯、辛酸/癸酸三甘油酯、单硬脂酸丙二醇酯、聚山梨醇酯20、聚山梨醇酯40、聚山梨醇酯60、聚山梨醇酯80、聚山梨醇酯65、二硬脂酸六甘油酯、单硬脂酸三甘油酯、以商品名TWEEN销售的聚(氧乙烯)山梨醇酐脂肪酸酯、以商品名SPAN销售的山梨醇酐脂肪酸酯、硬脂酰乳酸酯、硬脂酰-2-乳酸钙、硬脂酰-2-乳酸钠卵磷脂、磷脂酸铵、脂肪酸的蔗糖酯、蔗糖甘油酯、脂肪酸的丙基-1,2-二醇酯以及包括前述至少一种的组合。
适当的增稠剂包括纤维素醚(例如,羟基乙基纤维素、羟丙基甲基纤维素或羟丙基纤维素)、甲基纤维素、羧甲基纤维素及其组合。作为增稠剂的有用的附加的聚合物包括以商品名CARBOMER出售的丙烯酸聚合物和共聚物;聚(乙烯基吡咯烷酮);聚乙烯醇;海藻酸钠;聚乙二醇;天然树胶如黄原胶、黄芪胶、瓜尔胶、阿拉伯胶(acacia gum)、阿拉伯树胶、水可分散的(water-dispersible)聚丙烯酸酯(如聚(丙烯酸));甲基丙烯酸甲酯共聚物;羧乙烯基共聚物(carboxyvinyl copolymers);及其组合。
咀嚼型胶基糖组合物的每种组分的相对量将取决于组分的特性以及期望的风味,并且是本领域普通技术人员容易地确定的。
本文公开的胶基糖组合物可以被包覆或未被包覆,并且可以是厚片、棒、小丸、球等形式。不同形式的胶基糖组合物的组成将是相似的,但可以在成分的比例方面有变化。举例来说,被包覆的胶基糖组合物可以包含较低百分数的软化剂。小丸和球可以具有咀嚼型胶基糖芯,所述咀嚼型胶基糖芯已被包覆以食糖溶液或者无食糖的溶液,以产生硬壳。厚片和棒通常被配制为质地上软于咀嚼型胶基糖芯。在一些情况中,羟基脂肪酸盐或其他表面活性剂活性物可以对胶基糖基础剂有软化效果。为了调整所述表面活性剂活性物在所述胶基糖基础剂上所能产生的任何潜在的不期望的软化效果,将厚片或棒状胶基糖配制为具有较之通常更坚硬的质地是有益的(即,使用比典型所采用的更少的常规软化剂)。
中心填充的胶基糖是另一种常见的胶基糖形式。胶基糖部分具有上文所描述的类似的组成和制造方式。然而,中心填充物典型地是水性液体或凝胶,所述水性液体或凝胶是在加工期间被注入所述胶基糖的中心的。可选地,被包封的甜味料组合物可以在填充物制造期间被加入所述中心填充物中、被直接加入总胶基糖组合物的咀嚼型胶基糖部分中或加入中心填充物和咀嚼型胶基糖部分两者中。所述中心填充的胶基糖还可以被可选地包覆,并且可以以各种形式来制备,如以棒棒糖的形式。
本公开还包括制备被包封的甜味料组合物以及含有所述被包封的甜味料组合物的咀嚼型胶基糖的方法。一些实施方案包括用于制备包括咀嚼型胶基糖组合物和吹泡型胶基糖组合物两者的胶基糖组合物的方法。这些咀嚼型胶基糖组合物可以使用本领域技术人员已知的任何标准的技术和设备来制备。依照一些实施方案有用的装置包括在咀嚼型胶基糖制造领域公知的混合和加热装置,因此,具体装置的选自对于本领域技术人员是显而易见的。
在一个实施方案中,制备被包封的甜味料组合物的方法包括将聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料熔融共混以形成被包封的甜味料组合物的步骤。在一些实施方案中,被用来形成被包封的甜味料组合物的甜味料在25℃和一个大气压下是固体,并且具有如本文先前所描述的粒径。在一些实施方案中,将聚(醋酸乙烯酯)、脂肪酸盐和食品级酸熔融共混是在约80至约120摄氏度的温度下,更具体地,在约90至约110摄氏度的温度下进行的。在优选的实施方案中,将聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料熔融共混包括将脂肪酸盐与熔融的聚(醋酸乙烯酯)共混,以及然后将填充剂和甜味料与熔融共混的聚(醋酸乙烯酯)和脂肪酸盐熔融共混以形成被包封的甜味料组合物的步骤。
一旦被包封的甜味料组合物形成,可以冷却和研磨所述被包封的甜味料组合物以形成具有约50至约800微米,具体地,约100至约600微米,更具体地,约250至约420微米的数均粒径的颗粒。在其他实施方案中,被包封的甜味料组合物可以通过研磨、筛分、筛选、切割、粉碎、压缩、碾磨等等而被加工成为颗粒。一旦被包封的甜味料组合物被加工成为期望的粒径,可以将所述被包封的甜味料组合物储存在凉爽干燥的地方,如低湿度和温度低于约35℃的密封容器中。
可以通过熔融共混胶基糖基础剂和被包封的甜味料组合物的步骤来将所述被包封的甜味料组合物进一步加入咀嚼型胶基糖组合物中以形成咀嚼型胶基糖组合物。优选的实施方案包括将胶基糖基础剂、甜味料和被包封的甜味料组合物共混以形成咀嚼型胶基糖组合物的步骤。在另一优选的实施方案中,将胶基糖基础剂、甜味料和被包封的甜味料组合物共混的步骤还包括将胶基糖基础剂、甜味料和被包封的甜味料组合物与未被包封的食品级酸共混的步骤。
此外,将聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料共混的步骤包括用每千克被包封的甜味料组合物约70至约350千焦的混合能熔融共混。在一些实施方案中,混合能是每千克约100至约300千焦,具体地,每千克约150至约250千焦。用于熔融共混的混合能是通过用处理的熔融物质量除驱动熔融混合元件(例如,双螺杆挤出机的螺杆)所消耗的能量来计算的。举例来说,如果在熔融共混l千克被包封的甜味料组合物的过程中需要100千焦的能量来驱动双螺杆挤出机的螺杆,则混合能是100千焦/l千克=100千焦/千克。
在一个示例的过程中,胶基糖基础剂被加热到足够高的温度以在没有对胶基糖基础剂的物理和化学构成不利的影响的情况下软化胶基糖基础剂,所述温度根据所使用的胶基糖基础剂的组成而变化,并且是本领域技术人员无需过度实验就能容易地确定的。举例来说,恰好在与基础剂剩下的成分(比如增塑剂、填充剂、增量剂或甜味料、软化剂和着色试剂)递增地掺和以塑化共混物以及调节基础剂和风味增强组合物(作为与其它添加剂一起或单独的浓缩物)的硬度、粘弹性和可成形性之前,胶基糖基础剂可以被熔融到约60℃至约160℃,或者熔融到约150℃至约175℃,持续足以使基础剂熔融的一段时间,例如约三十分钟。继续混合直至得到胶基糖组合物的均匀混合物。允许将产生的咀嚼型胶基糖组合物冷却。此后,所述胶基糖组合物混合物可以被确定尺寸和形成为期望的胶基糖形状,即,棒、厚片、小丸、球等等。在将所述咀嚼型胶基糖包装之前,可以将被确定尺寸的咀嚼型胶基糖调理约一天至约一周。
在一个优选的实施方案中,制备咀嚼型胶基糖组合物的方法包括将聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料熔融共混以形成被包封的甜味料组合物。然后将胶基糖基础剂和所述被包封的甜味料组合物熔融共混以形成咀嚼型胶基糖组合物,其中所述被包封的甜味料组合物包括基于被包封的甜味料组合物总重量的约2至约20重量百分数的量的脂肪酸盐、约2至约20重量百分数的量的填充剂、甜味料和聚(醋酸乙烯酯)。在一些实施方案中,脂肪酸盐包括硬脂酸钙或硬脂酸镁;填充剂包括滑石;甜味料包括罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸或其组合;在所述熔融共混聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料的步骤之前,所述甜味料具有约50至约100微米的数均粒径;所述被包封的甜味料组合物包括重量比为约1∶0.25至约1∶25的脂肪酸盐和甜味料,重量比为1∶1.75至约1∶45的脂肪酸盐和聚(醋酸乙烯酯),重量比为约1∶0.7至约1∶18的甜味料和聚(醋酸乙烯酯);并且其中咀嚼型胶基糖组合物包括约0.25至约11重量百分数的所述被包封的甜味料组合物。在一些实施方案中,所述方法还包括在约90至约120摄氏度的温度下将聚(醋酸乙烯酯)、脂肪酸盐、填充剂和甜味料熔融共混,研磨所述被包封的甜味料组合物以形成具有小于或等于420微米的数均粒径的颗粒,以及将胶基糖基础剂和被包封的甜味料组合物与未被包封的甜味料、未被包封的食品级酸或其组合熔融共混的步骤。
在一些实施方案中,胶基糖块可以被包覆以水性包衣组合物,所述水性包衣组合物可以以本领域已知的任何方法施加。包衣组合物可以以总咀嚼型胶基糖块的约10至约50重量百分数的量存在。在约10至约50重量百分数的范围内,所述包衣组合物的量可以是以总咀嚼型胶基糖块的约20至约40重量百分数,具体地约25至35重量百分数。
外包衣可以是硬的或酥脆的。在一些实施方案中,外包衣包括山梨糖醇、麦芽糖醇、木糖醇、异麦芽酮糖醇或其他可结晶的多元醇;也可以使用蔗糖。还可以加入风味料以获得独特的产品特性。
如果存在包衣,所述包衣可以包括几个不透明层,以便所述咀嚼型胶基糖组合物通过包衣本身不可见,所述包衣可以为了美学、质地和保护的目的可选地被另外的一个或更多个透明层覆盖。所述外包衣也可以包含少量的水和阿拉伯树胶。所述包衣可以进一步被蜡包覆。所述包衣可以以通过连续地施用包衣溶液,同时在每层包衣之间进行干燥的常规的方式来施用。虽然可以添加其他着色料,随着包衣的干燥,其通常变得不透明并且通常为白色。多元醇包衣可以进一步被蜡包覆。所述包衣可以进一步包括彩色的薄片或斑点。
如果所述组合物包括包衣,可能的是一种或更多种上述活性成分可以遍及包衣而被分散。如果一种或更多种所述活性成分在单相组合物中与另一种活性成分不相容,这可以是优选的。
如果胶基糖产品是中心填充的胶基糖,所述包衣可以被配制为帮助提高所述胶基糖块的稳定性并且防止所述液体填充物的泄漏。在一些实施方案中,所述包衣可以包括明胶组合物。所述明胶组合物可以以40重量百分数的溶液被添加,并且可以以所述包衣组合物的约5至约10重量百分数存在于所述包衣组合物中,并且更具体地,包衣溶液的约7至约8重量百分数。所述明胶的凝胶强度可以是约130勃鲁姆(bloom)至约250勃鲁姆。
添加剂(例如生理性冷却剂、咽喉舒缓剂、香辛料、暖味剂、口腔护理试剂、药剂、维生素、咖啡因和常规添加剂)可以被包括于咀嚼型胶基糖组合物的任意或所有部分。可以以足以达到其预期效果的量使用这类组分。
通过下面的实施例,进一步说明前述的和其他的实施方案,所述实施例并不意图限定权利要求书的有效范围。除非另有说明,实施例中和贯穿说明书和权利要求书的所有份数和百分比是按照最终组合物的重量。
实施例1和比较实施例1
实施例1阐明了被包封的甜味料组合物的制备,所述被包封的甜味料组合物包括质地改进剂(如硬脂酸镁和其他质地改进剂)和填充剂(如滑石和其他填充剂)。组成被总结在表1中,其中组分含量是以基于所述被包封的甜味料组合物的总重量的重量百分数来表达的。聚(醋酸乙烯酯)具有约100,000的重均分子量,并且作为B100从WackerBiosolutions获得。罗汉果是作为从BioVittoria有限公司(BioVittoria Ltd)获得的。甜味料罗汉果是以具有约38微米的数均粒径的粉末形式获得的。在表1的实施例1中,硬脂酸镁是作为从Mallinckrodt化学品公司(Mallinckrodt Chemicals,Inc)获得的,并且滑石是作为Imperial700FCC(滑石)从Luzenac America获得的。在表1的比较实施例1中,单硬脂酸甘油酯是作为MS从Lonza Group Ltd获得的,并且氢化油是氢化棉籽油和氢化棕榈油的共混物,所述氢化油共混物具有约71℃的熔点,是作为氢化植物油(Hydrogenated Vegetable Oil)从Stratas Foods获得。挤出机是Brabender锥形双螺杆挤出机,所述挤出机具有43.2毫米(加料端)至29毫米(出料端)的内径,以及36厘米的筒(barrel)长,在90℃的筒温度下操作。
为了制备被包封的甜味料组合物,聚(醋酸乙烯酯)与任意质地改进剂被熔融共混,然后加入甜味料。冷却挤出物,然后研磨并筛分挤出物至小于420微米的数均粒径。在用来形成胶基糖组合物之前,将粉末状的被包封的甜味料组合物储存于低湿度和低于35℃的温度下的密封容器中。
表1
*平均分子量=100,000
图1是针对实施例1和比较实施例1的甜味料包封物的溶解属性示出了甜味料释放的百分数(%)对时间(小时:分钟:秒)的标绘图。针对比较实施例1的溶解属性并未通过实验获得。针对比较实施例1的数据是基于被包封于聚(醋酸乙烯酯)、单硬脂酸甘油酯和氢化油的组合中的其他活性物的释放属性计算的,并且是由实施例1的溶解属性外推的,实施例1的溶解属性是通过实验获得的。
实施例2A、2B和3以及比较实施例2A、2B和3
实施例2A、2B和3阐述了被包封的甜味料组合物的制备,所述被包封的甜味料组合物包括加工助剂/质地改进剂,例如硬脂酸镁和硬脂酸钙。这些实施例阐述了与具有高分子量的聚醋酸(乙烯)酯结合使用加工助剂/质地改进剂的优势。实施例2A、2A和3以及比较实施例2A、2B和3被总结在表2中,其中组分的量是以基于所述被包封的甜味料组合物的总重量的重量百分数来表达的。高分子量的聚(醋酸乙烯酯)具有约100,000的重均分子量,并且作为B100从Wacker Biosolutions获得。低分子量聚(醋酸乙烯酯)具有约35,000的重均分子量,并且作为B17从Wacker Biosolutions获得。甜味料阿斯巴甜-乙酰磺胺酸是作为从The Nutrasweet Company获得的,并且三氯蔗糖是作为Sucralose从Tate&Lyle获得的。甜味料阿斯巴甜-乙酰磺胺酸和三氯蔗糖是以分别具有约81和约10微米的数均粒径的粉末形式获得。在表2的实施例2A和3中,硬脂酸镁是作为从Mallinckrodt Chemicals,Inc获得的。在表2的实施例2B中,硬脂酸钙是作为Kosher Passover Food Grade从Mallinckrodt Chemicals,Inc获得的。在表2的比较实施例2A中,低分子量聚(醋酸乙烯酯)具有约35,000的重均分子量,并且作为Vinnapas B17从Wacker Biosolutions获得。挤出机是Brabender锥形双螺杆挤出机,所述挤出机具有43.2毫米(加料端)至29毫米(出料端)的内径,以及36厘米的筒(barrel)长。
为了制备被包封的甜味料组合物,聚(醋酸乙烯酯)与和不与任意质地改进剂被熔融共混,然后加入甜味料。冷却挤出物,然后研磨并筛分挤出物至小于420微米的数均粒径。在用来形成胶基糖组合物之前,将粉末状的被包封的甜味料组合物储存于低湿度和低于35℃的温度下的密封容器中。
实施例2A、2B和3阐述了由用高分子量聚醋酸(乙烯)酯和任何质地改进剂的组合包封甜味料提供的加工稳定性的增加。呈现在表2中的结果示出了当经由高温挤出过程使三氯蔗糖或阿斯巴甜-乙酰磺胺酸的任一个包封于具有约100,000的数均分子量的聚醋酸(乙烯)酯和硬脂酸镁的组合中时,获得的被包封的甜味料组合物在颜色上保持白色。挤出物颜色没有变暗表明甜味料在挤出过程期间保持稳定,并且抵抗加工期间的热降解。因此,质地改进剂(如硬脂酸镁或硬脂酸钙)的添加导致了经由高温挤出过程生产被包封于高分子量聚(醋酸乙烯酯)中的甜味料的能力。这导致了稳定的甜味料组合物,正如实施例2A和2B中示出的,所述甜味料组合物与在80或85摄氏度的低挤出温度下被包封于低分子量聚醋酸(乙烯)酯中的甜味料一样稳定。具有使用高温挤出过程而包封于具有约100,000的数均分子量的聚醋酸(乙烯)酯与硬脂酸镁中的阿斯巴甜-乙酰磺胺酸的实施例3即使在相对高的挤出温度(110℃)下,也显示了稳定性。相比之下,分别是使用高温挤出加工而包封于具有约100,000的数均分子量的聚醋酸(乙烯)酯而没有任何硬脂酸镁中的三氯蔗糖和阿斯巴甜-乙酰磺胺酸的比较实施例2B和3显示了所获得的被包封的甜味料组合物不符合期望的变暗,这指示了甜味料是不稳定的,并且在110摄氏度下被挤出时热降解。
当将阿斯巴甜-乙酰磺胺酸包封于聚(醋酸乙烯酯)中时,包封基体在加工期间变黄。阿斯巴甜-乙酰磺胺酸的酸性本性催化了聚(醋酸乙烯酯)的热分解。这导致醋酸的释放并引导聚合物骨架内部的共轭区的形成。聚合物骨架的共轭导致黄色。
此外,相较于其他高强度甜味料(如阿斯巴甜、乙酰磺胺酸K和三氯蔗糖),阿斯巴甜-乙酰磺胺酸是酸性的。这是通过形成两个单独的溶液然后测量所获得的溶液的pH阐明的,所述两个单独的溶液是通过溶解阿斯巴甜-乙酰磺胺酸于水中和通过溶解游离的阿斯巴甜于水中形成的。所述阿斯巴甜-乙酰磺胺酸溶液的pH是约2.5,相比之下,所述阿斯巴甜溶液具有约6的pH。
聚(醋酸乙烯酯)的热降解开始于约140至约160摄氏度。然而,在酸催化剂(例如,阿斯巴甜-乙酰磺胺酸)的存在下,该分解可以在较低的温度(即,在挤出温度下)下发生。聚(醋酸乙烯酯)分解过程通过醋酸从聚合物链末端的增加的损失来进行,导致聚(醋酸乙烯酯)上不饱和的聚合物骨架的部分形成,导致在微黄色至褐色的范围的颜色变化。由于分解的副产物是酸(即,醋酸),分解可以以自催化的方式进行。以下示出所述分解反应的一个实例:
硬脂酸盐以两种方式发挥作用,以防止包封材料的热分解。第一,硬脂酸盐在挤出期间充当加工助剂,其中所述硬脂酸盐降低了聚合物的熔体粘度,并且为聚合物熔体提供润滑。这允许挤出过程在较低温度下进行。在某些例子中,该较低温度是防止热分解开始所需的全部条件。第二,硬脂酸盐的另一个作用是充当酸清除剂,从而通过在醋酸形成时将其中和来防止热分解一旦开始就以自催化的方式进行。硬脂酸盐还用来中和其他酸性副产物,如在使用其他甜味料时可能存在或形成的各种酸。
实施例4和比较实施例4
这些实施例阐明了使用被包封的甜味料组合物的咀嚼型胶基糖的制备。实施例4咀嚼型胶基糖组合物并入了实施例1的发明性的被包封的甜味料组合物。比较实施例4咀嚼型胶基糖组合物并入了比较实施例1的作比较的被包封的甜味料组合物。咀嚼型胶基糖组合物被总结在表3中,其中组分含量是以基于咀嚼型胶基糖组合物总重量的重量百分数表达的。
为了制备所述组合物,在98摄氏度下在混合器中将胶基糖基础剂熔融。然后将表3中所示的剩下成分和被包封的甜味料组合物加入包含熔融的胶基糖基础剂的混合器,并且合并以分散所述成分。将产生的咀嚼型胶基糖混合物冷却,并且然后加工成为期望的咀嚼型胶基糖形状。在包装咀嚼型胶基糖之前,将咀嚼型胶基糖在14摄氏度和25相对湿度百分数下调理约一周。
表3
感官评价测试小组评估了实施例4和比较实施例4的咀嚼型胶基糖以确定硬度和甜度作为咀嚼时间的函数。图2是针对(a)比较实施例4和(b)实施例4的咀嚼型胶基糖示出了胶基糖硬度关于咀嚼时间(分钟)的函数的条形图,比较实施例4的咀嚼型胶基糖是包含用单独的聚(醋酸乙烯酯)包封的甜味料的咀嚼型胶基糖,实施例4的咀嚼型胶基糖是用聚(醋酸乙烯酯)、脂肪酸盐和填充剂包封的甜味料的咀嚼型胶基糖。图2显示了相比于具有没有被加入其中的脂肪酸盐的被包封的甜味料的咀嚼型胶基糖,包含具有被加入其中的脂肪酸盐的被包封的甜味料组合物的咀嚼型胶基糖从约4至约6分钟向前展现柔软质地。
图3是针对(a)比较实施例4和(b)实施例4的咀嚼型胶基糖的胶基糖甜味关于咀嚼时间(分钟)的函数的条形图,比较实施例4的咀嚼型胶基糖是包含用单独的聚(醋酸乙烯酯)包封的甜味料的咀嚼型胶基糖,实施例4的咀嚼型胶基糖是用聚(醋酸乙烯酯)、脂肪酸盐和填充剂包封的甜味料的咀嚼型胶基糖。图3显示,相较于具有没有被加入其中的脂肪酸盐的被包封的甜味料的咀嚼型胶基糖,包含具有被加入其中的脂肪酸盐的被包封的甜味料组合物的咀嚼型胶基糖在甜味料的释放速度上展现了最小限度的改变。这导致了咀嚼型胶基糖具有改进的柔软质地而不更改或改变正如最终使用者(end-user)咀嚼期间所体验的甜味强度。
这个书面描述使用实施例来公开本发明(包括最佳实施方式),并且还使得任何本领域技术人员能够实施和使用本发明。本发明的可专利范围由权利要求书限定,并且可以包括本领域技术人员想到的其他实施例。如果这样的其他实施例具有不异于本权利要求书的字面语言结构要素,或者如果它们包括具有与本权利要求书的字面语言非实质不同的等同的结构要素,则它们意图在权利要求书的范围内。
所有引用的专利、专利申请以及其他参考通过引用被整体并入本文。然而,如果本申请中的术语与并入的参考抵触或冲突,来自本申请的术语优先于来自并入的参考的相冲突的术语。
所有在本文中公开的范围包括端点,并且端点与彼此独立地结合。
无论被用于前言(preamble)或权利要求的主体中,如本文所使用的,与“包括(including)”、“包含(containing)”或“以……为特征(characterized by)”同义的过渡词“包括(comprising)”(还有“包括(comprises)”等)是包括性或开放式的,并且不排除额外的、未陈述的要素或方法步骤。
除非在本文中另外指明或由上下文清楚地抵触,术语“a”、“an”、“the”以及类似指示物的在描述的发明的上下文中(具体地在所附权利要求书的上下文中)的使用要被解释为覆盖单数和复数二者。另外,还应该注意的是,本文中术语“第一”、“第二”等等不表示任何顺序、数量或重要性,而是用于区别一个要素和另一个要素。与数量结合使用的修饰语“约”包括陈述的值,并且具有由上下文指示的含义(例如,其包括与特定数量的测量相关联的误差度)。
Claims (84)
1.一种被包封的甜味料组合物,所述被包封的甜味料组合物包括:
包封材料,所述包封材料包括
聚(醋酸乙烯酯),
约2至约20重量百分数的脂肪酸盐,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组,和
约2至约20重量百分数的填充剂;和
甜味料,
其中所述包封材料至少部分地包封所述甜味料,并且其中所有重量百分数是基于所述被包封的甜味料组合物的总重量。
2.如权利要求1所述的被包封的甜味料组合物,其中所述聚(醋酸乙烯酯)具有至少75,000原子质量单位的重均分子量。
3.如权利要求1或2所述的被包封的甜味料组合物,其中所述脂肪酸盐选自由碱金属硬脂酸盐、碱土金属硬脂酸盐、碱金属蓖麻油酸盐及其组合组成的组。
4.如权利要求1-3之任一项所述的被包封的甜味料组合物,其中所述脂肪酸盐包括碱土金属硬脂酸盐。
5.如权利要求1-3之任一项所述的被包封的甜味料组合物,其中所述脂肪酸盐选自由C16-C36脂肪族羧酸的钠盐、C16-C36脂肪族羧酸的钾盐、C16-C36脂肪族羧酸的钙盐、C16-C36脂肪族羧酸的镁盐及其组合组成的组。
6.如权利要求1-3之任一项或权利要求4所述的被包封的甜味料组合物,其中所述脂肪酸盐包括硬脂酸钠、硬脂酸钾、硬脂酸镁、硬脂酸钙、蓖麻油酸钠及其组合。
7.如权利要求1-6之任一项所述的被包封的甜味料组合物,其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙及其组合。
8.如权利要求1-7之任一项所述的被包封的甜味料组合物,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
9.如权利要求1-8之任一项所述的被包封的甜味料组合物,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
10.如权利要求1-9之任一项所述的被包封的甜味料组合物,其中所述填充剂选自由滑石、碳酸钙、磷酸二钙、硅石及其组合组成的组。
11.如权利要求1-10之任一项所述的被包封的甜味料组合物,其中所述填充剂包括滑石。
12.如权利要求1-11之任一项所述的被包封的甜味料组合物,包括约35至约90重量百分数的聚醋酸(乙烯)酯。
13.如权利要求1-12之任一项所述的被包封的甜味料组合物,包括约5至约50重量百分数的甜味料。
14.如权利要求1-13之任一项所述的被包封的甜味料组合物,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25。
15.如权利要求1-14之任一项所述的被包封的甜味料组合物,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45。
16.如权利要求1-15之任一项所述的被包封的甜味料组合物,其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18。
17.如权利要求1-16之任一项所述的被包封的甜味料组合物,其中所述被包封的甜味料组合物具有约50至约800微米的数均颗粒。
18.如权利要求1-17之任一项所述的被包封的甜味料组合物,
其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙或其组合;
其中所述填充剂包括滑石;
其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45;
其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18;并且
其中所述被包封的甜味料组合物具有小于或等于约420微米的数均粒径。
19.一种咀嚼型胶基糖组合物,所述咀嚼型胶基糖组合物包括:
胶基糖基础剂,
未被包封的甜味料,和
被包封的甜味料组合物,所述被包封的甜味料组合物包括
包封材料,所述包封材料包括
聚(醋酸乙烯酯),
基于所述被包封的甜味料组合物的总重量的约2至约20重量百分数的脂肪酸盐,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组,和
基于所述被包封的甜味料组合物的总重量的约2至约20重量百分数的填充剂;和
甜味料,
其中所述包封材料至少部分地包封所述甜味料组合物。
20.如权利要求19所述的咀嚼型胶基糖组合物,其中所述聚(醋酸乙烯酯)具有至少75,000原子质量单位的重均分子量。
21.如权利要求19或20所述的咀嚼型胶基糖组合物,其中所述脂肪酸盐选自由碱土金属硬脂酸盐、碱金属硬脂酸盐、碱金属蓖麻油酸盐及其组合组成的组。
22.如权利要求19-21之任一项所述的咀嚼型胶基糖组合物,其中所述脂肪酸盐包括碱土金属硬脂酸盐。
23.如权利要求19-22之任一项所述的咀嚼型胶基糖组合物,其中所述脂肪酸盐选自由C16-C36脂肪族羧酸的钠盐、C16-C36脂肪族羧酸的钾盐、C16-C36脂肪族羧酸的钙盐、C16-C36脂肪族羧酸的镁盐及其组合组成的组。
24.如权利要求19-21之任一项或权利要求23所述的咀嚼型胶基糖组合物,其中所述脂肪酸盐包括硬脂酸钠、硬脂酸钾、硬脂酸镁、硬脂酸钙、蓖麻油酸钠或其组合。
25.如权利要求19-24之任一项所述的咀嚼型胶基糖组合物,其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙及其组合。
26.如权利要求19-25之任一项所述的咀嚼型胶基糖组合物,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
27.如权利要求19-26之任一项所述的咀嚼型胶基糖组合物,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
28.如权利要求19-27之任一项所述的咀嚼型胶基糖组合物,其中所述填充剂选自由滑石、碳酸钙、磷酸二钙、硅石及其组合组成的组。
29.如权利要求19-28之任一项所述的咀嚼型胶基糖组合物,其中所述填充剂包括滑石。
30.如权利要求19-29之任一项所述的咀嚼型胶基糖组合物,包括约35至约90重量百分数的聚醋酸(乙烯)酯。
31.如权利要求19-30之任一项所述的咀嚼型胶基糖组合物,包括约5至约50重量百分数的甜味料。
32.如权利要求19-31之任一项所述的咀嚼型胶基糖组合物,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25。
33.如权利要求19-32之任一项所述的咀嚼型胶基糖组合物,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45。
34.如权利要求19-33之任一项所述的咀嚼型胶基糖组合物,其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18。
35.如权利要求19-34之任一项所述的咀嚼型胶基糖组合物,包括约0.25至约11重量百分数的所述被包封的甜味料组合物。
36.如权利要求19-35之任一项所述的咀嚼型胶基糖组合物,还包括未被包封的甜味料、未被包封的食品级酸或其组合。
37.如权利要求19-36之任一项所述的咀嚼型胶基糖组合物,其中所述被包封的甜味料组合物具有约50至约800微米的数均颗粒。
38.如权利要求19-37之任一项所述的咀嚼型胶基糖组合物,
其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙或其组合;
其中所述填充剂包括滑石;
其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45;
其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18;
其中所述咀嚼型胶基糖包括约0.25至约11重量百分数的所述被包封的甜味料组合物;并且
其中所述被包封的甜味料组合物具有小于或等于约420微米的数均粒径。
39.如权利要求19-38之任一项所述的咀嚼型胶基糖组合物,其中通过咀嚼所述咀嚼型胶基糖组合物10分钟所产生的料团,不比咀嚼缺少所述被包封的甜味料组合物的相应的咀嚼型胶基糖组合物10分钟后所产生的相应的料团更硬。
40.一种制备咀嚼型胶基糖组合物的方法,所述方法包括:
熔融共混
聚(醋酸乙烯酯),
约2至约20重量百分数的脂肪酸盐,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组,和
约2至约20重量百分数的填充剂;以及
甜味料
以形成被包封的甜味料组合物;其中所述包封材料至少部分地包封所述甜味料,并且其中所有重量百分数是基于所述被包封的甜味料组合物的总重量;以及
熔融共混胶基糖基础剂和所述被包封的甜味料组合物,以形成咀嚼型胶基糖组合物。
41.如权利要求40所述的方法,其中所述聚(醋酸乙烯酯)具有至少75,000原子质量单位的重均分子量。
42.如权利要求40或41所述的方法,其中所述脂肪酸盐选自由碱土金属硬脂酸盐、碱金属硬脂酸盐、碱金属蓖麻油酸盐及其组合组成的组。
43.如权利要求40-42之任一项所述的方法,其中所述脂肪酸盐包括碱土金属硬脂酸盐。
44.如权利要求40-42所述的方法,其中所述脂肪酸盐选自由C16-C36脂肪族羧酸的钠盐、C16-C36脂肪族羧酸的钾盐、C16-C36脂肪族羧酸的钙盐、C16-C36脂肪族羧酸的镁盐及其组合组成的组。
45.如权利要求40-42之任一项或权利要求44所述的方法,其中所述脂肪酸盐包括硬脂酸钠、硬脂酸钾、硬脂酸镁、硬脂酸钙、蓖麻油酸钠或其组合。
46.如权利要求40-45之任一项所述的方法,其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙及其组合。
47.如权利要求40-46之任一项所述的方法,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
48.如权利要求40-47之任一项所述的方法,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
49.如权利要求40-48之任一项所述的方法,其中所述填充剂选自由滑石、碳酸钙、磷酸二钙、硅石及其组合组成的组。
50.如权利要求40-49之任一项所述的方法,其中所述填充剂包括滑石。
51.如权利要求40-50之任一项所述的方法,包括约35至约90重量百分数的聚醋酸(乙烯)酯。
52.如权利要求40-51之任一项所述的方法,包括约5至约50重量百分数的甜味料。
53.如权利要求40-52之任一项所述的方法,其中在所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤之前,所述甜味料具有约1至约400微米的数均粒径。
54.如权利要求40-53之任一项所述的方法,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25。
55.如权利要求40-54之任一项所述的方法,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45。
56.如权利要求40-55之任一项所述的方法,其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18。
57.如权利要求40-56之任一项所述的方法,其中所述咀嚼型胶基糖组合物包括约0.25至约11重量百分数的所述被包封的甜味料组合物。
58.如权利要求40-57之任一项所述的方法,还包括研磨所述被包封的甜味料组合物以形成具有约50至约800微米的数均粒径的颗粒的步骤。
59.如权利要求40-58之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤是在约90至约120摄氏度的温度下进行的。
60.如权利要求40-59之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤包括熔融所述聚(醋酸乙烯酯),将所述脂肪酸盐与所述熔融的聚(醋酸乙烯酯)共混,以及将所述甜味料和所述填充剂与所述熔融共混的聚(醋酸乙烯酯)和脂肪酸盐共混。
61.如权利要求40-60之任一项所述的方法,其中所述共混所述胶基糖基础剂和所述被包封的甜味料组合物的步骤还包括将所述胶基糖基础剂和所述被包封的甜味料组合物与未被包封的活性物共混,所述未被包封的活性物包括未被包封的甜味料、未被包封的食品级酸或其组合。
62.如权利要求40-61之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤包括用每千克所述被包封的甜味料组合物约70至约350千焦的混合能熔融共混。
63.如权利要求40-62之任一项所述的方法,
其中所述脂肪酸盐包括硬脂酸钠、硬脂酸钾、硬脂酸镁、硬脂酸钙、蓖麻油酸钠或其组合;
其中所述填充剂包括滑石;
其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组;
其中在所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤之前,所述甜味料具有约1至约400微米的数均粒径;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45;
其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18;
其中所述咀嚼型胶基糖组合物包括约0.25至约11重量百分数的所述被包封的甜味料组合物;
其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤是在约90至约120摄氏度的温度下进行的;
其中所述方法还包括研磨所述被包封的甜味料组合物以形成具有小于或等于420微米的数均粒径的颗粒的步骤;并且
其中所述共混所述胶基糖基础剂和所述被包封的甜味料组合物的步骤还包括将所述胶基糖基础剂和所述被包封的甜味料组合物与未被包封的活性物共混,所述未被包封的活性物包括未被包封的甜味料、未被包封的食品级酸或其组合。
64.一种制备被包封的甜味料组合物的方法,所述方法包括:
熔融共混
聚(醋酸乙烯酯),
约2至约20重量百分数的脂肪酸盐,所述脂肪酸盐选自由碱金属脂肪酸盐、碱土金属脂肪酸盐及其组合组成的组,和
约2至约20重量百分数的填充剂;以及
甜味料
以形成被包封的甜味料组合物;其中所述包封材料至少部分地包封所述甜味料,并且其中所有重量百分数是基于所述被包封的甜味料组合物的总重量。
65.如权利要求64所述的方法,其中所述聚(醋酸乙烯酯)具有至少75,000原子质量单位的重均分子量。
66.如权利要求64或65所述的方法,其中所述脂肪酸盐选自由碱土金属硬脂酸盐、碱金属硬脂酸盐、碱金属蓖麻油酸盐及其组合组成的组。
67.如权利要求64-66之任一项所述的方法,其中所述脂肪酸盐包括碱土金属硬脂酸盐。
68.如权利要求64-67之任一项所述的方法,其中所述脂肪酸盐选自由C16-C36脂肪族羧酸的钠盐、C16-C36脂肪族羧酸的钾盐、C16-C36脂肪族羧酸的钙盐、C16-C36脂肪族羧酸的镁盐及其组合组成的组。
69.如权利要求64-66之任一项或权利要求68所述的方法,其中所述脂肪酸盐包括硬脂酸钠、硬脂酸钾、硬脂酸镁、硬脂酸钙、蓖麻油酸钠或其组合。
70.如权利要求64-69之任一项所述的方法,其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙及其组合。
71.如权利要求64-70之任一项所述的方法,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
72.如权利要求64-71之任一项所述的方法,其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、阿斯巴甜-乙酰磺胺酸及其组合组成的组。
73.如权利要求64-72之任一项所述的方法,其中所述填充剂选自由滑石、碳酸钙、磷酸二钙、硅石及其组合组成的组。
74.如权利要求64-73之任一项所述的方法,其中所述填充剂包括滑石。
75.如权利要求64-74之任一项所述的方法,包括约35至约90重量百分数的聚醋酸(乙烯)酯。
76.如权利要求64-75之任一项所述的方法,包括约5至约50重量百分数的甜味料。
77.如权利要求64-76之任一项所述的方法,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25。
78.如权利要求64-77之任一项所述的方法,其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45。
79.如权利要求64-78之任一项所述的方法,其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18。
80.如权利要求64-79之任一项所述的方法,还包括研磨所述被包封的甜味料组合物以形成具有约50至约800微米的数均粒径的颗粒的步骤。
81.如权利要求64-80之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤是在约90至约120摄氏度的温度下进行的。
82.如权利要求64-81之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤包括熔融所述聚(醋酸乙烯酯),将所述脂肪酸盐与所述熔融的聚(醋酸乙烯酯)共混,以及将所述甜味料和所述填充剂与所述熔融共混的聚(醋酸乙烯酯)和脂肪酸盐共混。
83.如权利要求64-82之任一项所述的方法,其中所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐、所述填充剂和所述甜味料的步骤包括用每千克所述被包封的甜味料组合物约70至约350千焦的混合能熔融共混。
84.如权利要求64-83之任一项所述的方法,
其中所述脂肪酸盐包括硬脂酸镁、硬脂酸钙或其组合;
其中所述填充剂包括滑石;
其中所述甜味料选自由罗汉果、三氯蔗糖、莫那亭、莱鲍迪苷A、甜菊苷、乙酰磺胺酸钾、阿斯巴甜、阿斯巴甜-乙酰磺胺酸及其组合组成的组;
其中在所述熔融共混所述聚(醋酸乙烯酯)、所述脂肪酸盐和所述甜味料的步骤之前,所述甜味料具有约1至约400微米的数均粒径;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述甜味料的重量比是约1∶0.25至约1∶25;
其中所述被包封的甜味料组合物中所述脂肪酸盐与所述聚(醋酸乙烯酯)的重量比是约1∶1.75至约1∶45;
其中所述被包封的甜味料组合物中所述甜味料与所述聚(醋酸乙烯酯)的重量比是约1∶0.7至约1∶18;并且
其中所述被包封的甜味料组合物具有小于或等于420微米的数均粒径。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161545842P | 2011-10-11 | 2011-10-11 | |
US61/545,842 | 2011-10-11 | ||
PCT/US2012/059328 WO2013055670A2 (en) | 2011-10-11 | 2012-10-09 | Encapsulated sweetener composition, method for the preparation thereof, and chewing gum comprising same |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103889245A true CN103889245A (zh) | 2014-06-25 |
Family
ID=47046889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280050255.8A Pending CN103889245A (zh) | 2011-10-11 | 2012-10-09 | 被包封的甜味料组合物、用于制备所述被包封的甜味料组合物的方法及包括所述被包封的甜味料的咀嚼型胶基糖 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20140242214A1 (zh) |
EP (1) | EP2765867A2 (zh) |
JP (1) | JP5995979B2 (zh) |
CN (1) | CN103889245A (zh) |
BR (1) | BR112014008837A2 (zh) |
IN (1) | IN2014CN02723A (zh) |
MX (1) | MX2014004389A (zh) |
RU (1) | RU2576456C2 (zh) |
WO (1) | WO2013055670A2 (zh) |
ZA (1) | ZA201402565B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108135244A (zh) * | 2015-10-28 | 2018-06-08 | 洲际大品牌有限责任公司 | 制备用于可食用组合物的包封组合物的方法 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016203008A1 (de) * | 2016-02-25 | 2017-08-31 | Wacker Chemie Ag | Verkapselte Süßstoffe und Verfahren zur ihrer Herstellung |
PL3422873T3 (pl) * | 2016-03-01 | 2024-06-10 | Wm. Wrigley Jr. Company | Długotrwałe formulacje słodzące |
JP7187445B2 (ja) | 2016-09-16 | 2022-12-12 | ペプシコ・インク | 非栄養甘味料の味を改善する組成物及び方法 |
WO2018064759A1 (en) * | 2016-10-04 | 2018-04-12 | Reelpur Inc. | Capsule containing pure (about 100%) stevia extract |
EP4252550A3 (en) | 2017-08-08 | 2023-11-29 | eBio Nutritional Sciences LLC | Sweetener composition and methods of making it |
EA037195B1 (ru) * | 2018-03-28 | 2021-02-18 | Акционерное Общество "Химфарм" | Биологически активная добавка для улучшения функционального состояния дыхательной системы и восстановления иммунной системы (варианты) |
AU2019360443B2 (en) | 2018-10-18 | 2024-10-31 | Kenvue Brands Llc | Novel dosage form |
EP4037681A1 (en) * | 2019-09-27 | 2022-08-10 | Johnson & Johnson Consumer Inc. | Gel-chewable dosage form |
USD1081739S1 (en) | 2021-04-06 | 2025-07-01 | Altria Client Services Llc | Die for gum forming |
US12295412B2 (en) | 2022-01-28 | 2025-05-13 | Altria Client Services Llc | Oral pouch product |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929447A (en) * | 1986-01-07 | 1990-05-29 | Warner-Lambert Company | Encapsulation composition for use with chewing gum and edible products |
CN1054173A (zh) * | 1990-02-21 | 1991-09-04 | 沃纳-兰伯特公司 | 制备含聚乙酸乙烯酯的甜味剂释放体系的改进方法 |
CN1250100C (zh) * | 2001-08-01 | 2006-04-12 | 丰泰拉技术有限公司 | 口香糖混合物的改进或关于口香糖混合物的改进 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3492131A (en) | 1966-04-18 | 1970-01-27 | Searle & Co | Peptide sweetening agents |
FR2444080A1 (fr) | 1978-12-11 | 1980-07-11 | Roquette Freres | Hydrolysat d'amidon hydrogene non cariogene pour la confiserie et procede de preparation de cet hydrolysat |
US4619834A (en) | 1985-05-06 | 1986-10-28 | General Foods Corporation | Sweetening with L-aminodicarboxylic acid aminoalkenoic acid ester amides |
US4711784A (en) * | 1986-01-07 | 1987-12-08 | Warner-Lambert Company | Encapsulation composition for use with chewing gum and edible products |
US4931293A (en) | 1986-12-23 | 1990-06-05 | Warner-Lambert Company | Food acid delivery systems containing polyvinyl acetate |
US4816265A (en) * | 1986-12-23 | 1989-03-28 | Warner-Lambert Company | Sweetener delivery systems containing polyvinyl acetate |
US4981698A (en) | 1986-12-23 | 1991-01-01 | Warner-Lambert Co. | Multiple encapsulated sweetener delivery system and method of preparation |
US5057328A (en) | 1988-11-14 | 1991-10-15 | Warner-Lambert Company | Food acid delivery systems containing polyvinyl acetate |
US5110608A (en) | 1988-12-29 | 1992-05-05 | Warner-Lambert Company | Chewing gums having longer lasting sweetness |
US5154939A (en) | 1989-04-19 | 1992-10-13 | Wm. Wrigley Jr. Company | Use of salt to improve extrusion encapsulation of chewing gum ingredients |
US5229148A (en) | 1989-04-19 | 1993-07-20 | Wm. Wrigley Jr. Company | Method of combining active ingredients with polyvinyl acetates |
US5064658A (en) | 1990-10-31 | 1991-11-12 | Warner-Lamber Company | Encapsulated synergistic sweetening agent compositions comprising aspartame and acesulfame-K and methods for preparing same |
US5227154A (en) | 1991-08-22 | 1993-07-13 | The University Of Melbourne | Phosphopeptides for the treatment of dental calculus |
US5286502A (en) | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5378131A (en) | 1993-02-18 | 1995-01-03 | The Wm. Wrigley Jr. Company | Chewing gum with dental health benefits employing calcium glycerophosphate |
DE69517836T2 (de) | 1994-03-18 | 2001-03-01 | Ajinomoto Co., Inc. | Proteinhaltiges Mittel zur Verbesserung der Geschmacksqualität von Lebensmitteln |
AU5595498A (en) | 1997-12-03 | 1999-06-16 | Wm. Wrigley Jr. Company | Improved chewing gum formulations including aspartame and sodium bicarbonate |
US7041277B2 (en) * | 2000-03-10 | 2006-05-09 | Cadbury Adams Usa Llc | Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
US6685916B1 (en) | 2002-10-31 | 2004-02-03 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces, and methods of making and using the same |
US8591973B2 (en) * | 2005-05-23 | 2013-11-26 | Kraft Foods Global Brands Llc | Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition |
US9271904B2 (en) | 2003-11-21 | 2016-03-01 | Intercontinental Great Brands Llc | Controlled release oral delivery systems |
US20050112236A1 (en) * | 2003-11-21 | 2005-05-26 | Navroz Boghani | Delivery system for active components as part of an edible composition having preselected tensile strength |
US8597703B2 (en) * | 2005-05-23 | 2013-12-03 | Kraft Foods Global Brands Llc | Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component |
US7727565B2 (en) | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
FR2889810A1 (fr) * | 2005-05-24 | 2007-02-23 | Flamel Technologies Sa | Forme medicamenteuse orale, microparticulaire, anti-mesurage |
EP1903890B1 (en) | 2005-05-23 | 2012-11-07 | Kraft Foods Global Brands LLC | Sweetness potentiator compositions |
CN101522221B (zh) * | 2006-06-28 | 2013-04-24 | 卡夫食品环球品牌有限责任公司 | 用于制造针对作为可食用组合物部分的活性组分的递送系统的工艺 |
US20090246327A1 (en) * | 2006-08-17 | 2009-10-01 | Gumlink A/S | Resin encapsulated high intensity sweetener |
EP2162013B1 (en) | 2007-07-06 | 2016-04-06 | Gumlink A/S | Compressed chewing gum comprising an encapsulation delivery system comprising natural resin |
KR101602513B1 (ko) | 2008-05-22 | 2016-03-10 | 지보당 에스아 | 냉각 조성물 |
WO2010088519A1 (en) | 2009-01-30 | 2010-08-05 | Cadbury Adams Usa Llc | A delivery system for active components as part of an edible composition |
US7923577B2 (en) | 2009-04-27 | 2011-04-12 | International Flavors & Fragrances Inc. | Menthylcarboxamides and their use as cooling agents |
US20110070171A1 (en) | 2009-09-18 | 2011-03-24 | Arkadiusz Kazimierski | 1-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds |
US20110070329A1 (en) | 2009-09-18 | 2011-03-24 | Arkadiusz Kazimierski | 1-tert-Butylcyclohexanecarboxamide and uses thereof as cooling compounds |
-
2012
- 2012-10-09 CN CN201280050255.8A patent/CN103889245A/zh active Pending
- 2012-10-09 EP EP12775416.6A patent/EP2765867A2/en not_active Withdrawn
- 2012-10-09 MX MX2014004389A patent/MX2014004389A/es unknown
- 2012-10-09 BR BR112014008837A patent/BR112014008837A2/pt not_active Application Discontinuation
- 2012-10-09 JP JP2014535784A patent/JP5995979B2/ja not_active Expired - Fee Related
- 2012-10-09 RU RU2014113963/13A patent/RU2576456C2/ru not_active IP Right Cessation
- 2012-10-09 WO PCT/US2012/059328 patent/WO2013055670A2/en active Application Filing
- 2012-10-09 IN IN2723CHN2014 patent/IN2014CN02723A/en unknown
- 2012-10-09 US US14/350,209 patent/US20140242214A1/en not_active Abandoned
-
2014
- 2014-04-09 ZA ZA2014/02565A patent/ZA201402565B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929447A (en) * | 1986-01-07 | 1990-05-29 | Warner-Lambert Company | Encapsulation composition for use with chewing gum and edible products |
CN1054173A (zh) * | 1990-02-21 | 1991-09-04 | 沃纳-兰伯特公司 | 制备含聚乙酸乙烯酯的甜味剂释放体系的改进方法 |
CN1250100C (zh) * | 2001-08-01 | 2006-04-12 | 丰泰拉技术有限公司 | 口香糖混合物的改进或关于口香糖混合物的改进 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108135244A (zh) * | 2015-10-28 | 2018-06-08 | 洲际大品牌有限责任公司 | 制备用于可食用组合物的包封组合物的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2013055670A2 (en) | 2013-04-18 |
US20140242214A1 (en) | 2014-08-28 |
ZA201402565B (en) | 2015-08-26 |
BR112014008837A2 (pt) | 2017-04-25 |
RU2576456C2 (ru) | 2016-03-10 |
EP2765867A2 (en) | 2014-08-20 |
WO2013055670A3 (en) | 2014-04-10 |
JP5995979B2 (ja) | 2016-09-21 |
RU2014113963A (ru) | 2015-11-27 |
IN2014CN02723A (zh) | 2015-07-03 |
MX2014004389A (es) | 2014-09-08 |
JP2014528255A (ja) | 2014-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103889245A (zh) | 被包封的甜味料组合物、用于制备所述被包封的甜味料组合物的方法及包括所述被包封的甜味料的咀嚼型胶基糖 | |
CN104254251A (zh) | 糖食组合物、其方法及相关的糖食制品 | |
CN105142418A (zh) | 有色蜡组合物 | |
CN105517446A (zh) | 包括微囊包封在包含蛋白质的基质中的风味物的咀嚼型胶基糖组合物 | |
CN104754951A (zh) | 咀嚼型胶基糖产品及其形成方法 | |
AU2012311206B2 (en) | Multi-region confectionery and method of production thereof | |
CN103635096B (zh) | 被包封的酸、其制备方法及包括所述被包封的酸的咀嚼型胶基糖 | |
CN103763935B (zh) | 可降解的咀嚼型胶基糖以及制作所述可降解的咀嚼型胶基糖的方法 | |
CN103826467B (zh) | 光可降解的胶基糖基础剂、包括所述光可降解的胶基糖基础剂的咀嚼型胶基糖及其制作方法 | |
WO2013192066A1 (en) | Chewing gum product and method of production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140625 |
|
RJ01 | Rejection of invention patent application after publication |